[["CD3+CD28-induced_interleukin-2_production", 0.652], ["CD28-mediated_activation", 0.6297], ["CD28-induced_IL-2_promoter_activity", 0.621], ["CD28-associated_signaling_pathway", 0.6206], ["CD28_costimulatory_pathway", 0.6042], ["CD28-mediated_signal_transduction", 0.6016], ["interleukin_2_CD28-responsive_complex", 0.5933], ["CD3/CD28-induced_IL-2_mRNA_accumulation", 0.589], ["CD28_costimulation_pathway", 0.5828], ["CD28_receptor_ligation", 0.5792], ["CD28_signaling_cascade", 0.5769], ["CD28_pathway", 0.5767], ["CD28_tyrosyl_phosphorylation", 0.5765], ["TCR-CD3/CD28-mediated_signaling", 0.5739], ["IL-1-mediated_NF-kappa_B_activation", 0.5675], ["CD30-mediated_NF-kappa_B_activation", 0.5663], ["CD40-induced_NF-kappa_B_activation", 0.5642], ["CD40-mediated_NF-kappaB_activation", 0.5627], ["CD40-mediated_NF-kappaB-dependent_transcriptional_activation", 0.5549], ["Anti-CD28-stimulated_T_cell", 0.5518], ["anti-CD3+_anti-CD28-mediated_stimulation", 0.5491], ["IL-1-induced_NF-kappa_B-dependent_gene_transcription", 0.5398], ["CD2-mediated_interleukin-2_promoter_activation", 0.5384], ["CD28-mediated_costimulation", 0.5368], ["CD2_+_CD28_activation", 0.5366], ["CD28-mediated_induction", 0.5366], ["cytokine-induced_NF-kappaB_activation", 0.5337], ["IL-1_receptor-like_NF-kappaB_signaling_cascade", 0.5325], ["NF-kappa_B-regulated_inflammatory_cytokine_gene", 0.532], ["CD2-mediated_interleukin-2_production", 0.5314], ["CD28_ligand", 0.5296], ["CD28-mediated_stabilization", 0.5248], ["NF-kappa_B-dependent_cytokine_gene_expression", 0.5222], ["oxidant-induced_NF-kappa_B_activation", 0.5194], ["inducible_interleukin-2_enhancer_function", 0.5189], ["IL-2R_Jak/STAT_pathway", 0.5187], ["TLR2-mediated_NF-kappaB_activation", 0.5171], ["mitogen-activated_protein_kinase_signaling_pathways", 0.5159], ["anti-CD2-mediated_activation", 0.5153], ["NF-kappa_B_regulated_chemokine", 0.5152], ["NF-kappaB_activation_pathway", 0.5147], ["NF-kappa_B-mediated_transcriptional_regulation", 0.5145], ["oxidant-induced_NF-kappaB_activation", 0.5142], ["CD28_costimulatory_receptor", 0.5139], ["receptor-mediated_anti-CD3/anti-CD3+_anti-CD28_stimulation", 0.5137], ["NF-kappaB-dependent_intracellular_signaling_pathway", 0.5136], ["IL-2_promoter_CD28_response_element/AP-1_sequence", 0.5133], ["NF-kappa_B-independent_transcriptional_activation", 0.5105], ["mitogen-activated_protein_kinase_signaling_cascade", 0.508], ["CD28_up-regulation", 0.5069], ["NF-kappaB-mediated_transactivation", 0.5061], ["interleukin_2_(IL-2)_synthesis", 0.5052], ["CD28_co-receptor_molecule", 0.5043], ["CsA-resistant_CD28-signaling_pathway", 0.5026], ["NF-kappa_B_transcription_factor_activation", 0.502], ["NF-kappaB_transcriptional_activation", 0.5019], ["LPS-induced_NF-kappa_B_activation", 0.5018], ["costimulatory_receptor_CD28", 0.5012], ["NF-kappaB-dependent_transcriptional_activation", 0.5009], ["interleukin-2_synthesis", 0.5005], ["CD2-mediated_interleukin-2_promoter", 0.5], ["cytokine_signaling_pathway", 0.4996], ["LPS-induced_NF-kappaB_activation", 0.4989], ["LPS-Induced_NF-kappaB_activation", 0.4989], ["anti-CD3_induced_peripheral_blood_T_cell_activation", 0.4987], ["IL-2R-associated_(Jak/STAT)_pathway", 0.4985], ["tumor_necrosis_factor-alpha-induced_NF_kappaB_activation", 0.4984], ["IL-2-mediated_proliferative_growth", 0.4984], ["mitogen-activated_protein_(MAP)_kinase_pathways", 0.4977], ["NF-kappa_B_signal_transduction_pathway", 0.4968], ["anti-CD3-induced_interleukin-2_secretion", 0.4967], ["Cdk-2-dependent_phosphorylation", 0.4964], ["NF-kappa_B_p65-dependent_transcriptional_activation", 0.4958], ["CD3/CD28_ligation", 0.4957], ["TNF-induced_NF-kappa_B_activation", 0.495], ["NF-kappa_B-mediated_gene_expression", 0.4947], ["NF-kappa_B_p65-mediated_transcriptional_activation", 0.4947], ["NF-kappa_B_precursor_activation", 0.4935], ["mitogen-activated_protein_kinase_cascade", 0.4935], ["immune_activation_pathway", 0.4934], ["CD2_signaling_pathway", 0.4933], ["CD28_activation", 0.4929], ["CD43-mediated_pathway", 0.4925], ["CoCl2-induced_NF-kappaB_activation", 0.4917], ["human_monocyte_NF-kappaB_activation", 0.4917], ["NF-kappaB-mediated_up-regulation", 0.4914], ["NF_kappa_B-mediated_gene_expression", 0.4914], ["LPS-induced_NF_kappa_B_activation", 0.4911], ["mechanism_of_inflammation", 0.4909], ["CD2-based_signaling_pathway", 0.4905], ["H2O2-induced_NF-kappaB_activation", 0.4905], ["NF-kappaB-inducing_kinase", 0.4901], ["activation_inducer_molecule_(AIM)/CD69_activation_pathway", 0.4898], ["NF-kappa_B-mediated_signal_transduction", 0.4894], ["inflammatory_mechanism", 0.4893], ["T_cell_activation_pathway", 0.489], ["cytokine_synthesis", 0.4889], ["interleukin_2_(IL-2)-dependent_activation", 0.4888], ["TNF-dependent_NF-kappa_B_activation", 0.4882], ["CD3-mediated_activation", 0.4878], ["mitogen-activated_protein_kinase_pathway", 0.4873], ["oxLDL-induced_NF-kappa_B_activation", 0.4864], ["nuclear_factor_kappaB_(NF-kappaB)-inducing_kinase", 0.486], ["interleukin_1_signaling_pathway", 0.4857], ["mitogen-activated_protein_kinase_activation", 0.4854], ["CD40-mediated_upregulation", 0.4851], ["T-cell_antigen_receptor-CD3_complex_signaling_pathway", 0.4848], ["NF-kappaB_signaling_pathway", 0.4847], ["interleukin-2_(IL-2)_gene_activation", 0.4846], ["CD40_ligand_(CD40L)_expression", 0.4843], ["NF-kappa_B-activating_cytokine", 0.484], ["I_kappa_B_alpha-bound_kinase_activity", 0.4836], ["interleukin-2_enhancer", 0.4835], ["NF-kappa_B_signalling_pathway", 0.4833], ["ROI-dependent_NF-kappaB_mediated_transcription", 0.4828], ["transcription_factor_NF-kappaB_regulation", 0.4827], ["TNF_alpha-induced_NF-kappa_B_activation", 0.4826], ["HIV-mediated_NF-kappa_B_activation", 0.4825], ["CD28+_T_cell", 0.4825], ["mitogen-activated_protein_(MAP)_kinase/extracellular_signal-regulated_kinase_kinase_1", 0.4822], ["interleukin_2_enhancer", 0.4821], ["T-cell_growth_factor_interleukin_(IL)-2", 0.4818], ["interleukin-6_kappa_B-related_motif", 0.4816], ["CD3-dependent_T_cell_activation", 0.4814], ["TNF-alpha-mediated_NF-kappaB_activation", 0.4811], ["CD2_signalling_pathway", 0.4807], ["intracellular_IL-2_production", 0.4806], ["nuclear_factor-kappa_B_(NF-kappaB)_activation", 0.48], ["CD14-mediated_signal_transduction", 0.4799], ["T_cell_interleukin-2_receptor_expression", 0.4798], ["NF-kappa_B-controlled_cytokine_promoter", 0.4796], ["CD2_plus_CD28_adhesion_molecule", 0.4792], ["TNF-stimulated_nuclear_factor-kappaB_activation", 0.479], ["monocytic_IkappaB_kinase_signalsome_activation", 0.4788], ["interleukin-2_receptor_alpha-chain_enhancer", 0.4785], ["inflammatory_pathway", 0.4783], ["interleukin-2_(IL-2)-induced_T-cell_proliferation", 0.478], ["IL-2-_and_IFNgamma-mediated_signaling", 0.4779], ["IL-2-induced_phosphorylation", 0.4775], ["tumor_necrosis_factor-induced_NF-kappaB_binding", 0.4772], ["NF-kappaB_subunit_activation", 0.477], ["NF-kappa_B-mediated_gene_transcription", 0.477], ["interleUkin_2_expression", 0.4765], ["ROI-NF-kappa_B_signalling_pathway", 0.4761], ["interleukin_2_gene_expression", 0.4761], ["IL-2_signaling", 0.476], ["CD40-mediated_NF-kappa_B_nuclear_translocation", 0.4759], ["nuclear_factor-kappa_B_(NF-kappa_B)_activation", 0.4747], ["IL-4-induced_upregulation", 0.4746], ["tumor_necrosis_factor-alpha-induced_NF-kappa_B1_transcription", 0.4745], ["interleukin_2_receptor_expression", 0.4745], ["NF-kappaB-dependent_pathway", 0.4741], ["mitogen-activated_protein_kinase-1_extracellular-regulated_kinase-kinase", 0.474], ["CD3-TCR-mediated_signal_transduction", 0.4739], ["NF-kappa_B_transcriptional_activity", 0.4739], ["IL-12_signal_transduction_pathway", 0.4737], ["CD14-dependent_activation", 0.4734], ["TCR-mediated_IL-2_production", 0.4734], ["nuclear_factor_kappa_B_(NF-kappa_B)_activation", 0.473], ["IL-2-induced_expression", 0.473], ["cytokine-stimulated_transcription_factor", 0.4729], ["inflammatory_and_destructive_mechanism", 0.4723], ["T-cell_interleukin-2_expression", 0.4718], ["T_cell_antigen_receptor-stimulated_protein_tyrosine_kinase", 0.4715], ["IL-2-driven_T_cell_proliferation", 0.4714], ["nuclear_factor_kappaB_(NF-kappaB)_activation", 0.4714], ["IL-2_gene_activation", 0.4713], ["kappa_B-dependent_IL-6_promoter_activity", 0.4711], ["NF-kappaB-mediated_transcription", 0.4709], ["CD40-mediated_up-regulation", 0.4707], ["NF-kappa_B-dependent_activation", 0.4706], ["interleukin_2_receptor_alpha_chain/CD25_promoter", 0.4705], ["protein_kinase_C_signaling_cascade", 0.4705], ["interleukin-2_expression", 0.4704], ["IL-2-mediated_T_cell_proliferation", 0.4702], ["NF_of_activated_T_cells_protein", 0.4699], ["CD40-induced_B_cell_activation", 0.4698], ["TNF-induced_NF-kappa_B_mobilization", 0.4697], ["interleukin-2_receptor_alpha_chain_(IL-2R_alpha)_expression", 0.4696], ["CD14-mediated_signal_pathway", 0.4691], ["CD28_surface_receptor", 0.469], ["signaling_pathway_molecule_analysis", 0.4689], ["anti-CD40_mAb-mediated_up-regulation", 0.4687], ["anti-CD3-stimulated_AP-1_enhancer_activity", 0.4687], ["interleukin_2_transcription", 0.4684], ["TCR/CD3_signal_transduction_pathway", 0.4684], ["nuclear_factor_kappa_B_(NF_kappa_B)_activation", 0.4684], ["IL-2_promoter-enhancer_induction", 0.4679], ["interleukin_(IL)-2_gene_expression", 0.4679], ["transcription_factor_NF_kappa_B_activity", 0.4679], ["IL-2R_alpha_kappa_B_enhancer", 0.4678], ["anti-CD28_monoclonal_antibody", 0.4677], ["mitogen-activated_protein_kinase_(MAPK)_signaling_pathway", 0.4677], ["interleukin_2_(IL-2)-induced_signal", 0.4676], ["NF-kappa_B-dependent_gene_expression", 0.4676], ["interleukin_2_(IL2)_promoter", 0.4675], ["active_NF-kappa_B_transcription_factor_complex", 0.4675], ["cytokine_signaling", 0.4674], ["cytokine-stimulated_activation", 0.4671], ["NF_kappa_B-dependent_gene_expression", 0.4671], ["interleukin_2_gene_enhancer", 0.467], ["LPS-induced_kappaB-dependent_transcription", 0.4667], ["NF-kappaB_activation_mechanism", 0.4667], ["T_cell_IL3_gene_expression", 0.4666], ["CD40-ligand+_T_cell", 0.4659], ["NF-kappaB_transcriptional_activity", 0.4656], ["IL-2_transcriptional_regulator", 0.4656], ["protein_kinase_C-mediated_signal_transduction", 0.4655], ["NF-kappa_B-dependent_transcriptional_stimulation", 0.4651], ["CD28_cell_surface_molecule", 0.4648], ["inflammatory_cytokine_production", 0.4645], ["IL-12_signaling_pathway", 0.4644], ["protein_kinase_C_signaling_pathways", 0.4643], ["interleukin_(IL)-2_promoter_activity", 0.4642], ["CD8+_T-cell_activation", 0.4642], ["interleukin-2_promoter/reporter_gene_construct", 0.4641], ["anti-CD40_+_IL-4-stimulated_B_cell", 0.4637], ["CD4+_T_cell_proliferative_response", 0.4635], ["interleukin_(IL)-2_gene_induction", 0.4635], ["CD2_receptor_activation", 0.4635], ["constitutive_NF-kappa_B_activation", 0.4633], ["inflammatory_cytokine_expression", 0.4632], ["mitogen-activated_protein_kinase_family", 0.4632], ["NK-kappa_B_transcription_factor_complex", 0.4631], ["intracellular_signaling_cascade", 0.4631], ["normal_CD40-induced_monocyte_activation", 0.463], ["IL-2-induced_activation", 0.463], ["anti-CD40_+_IL-4-mediated_proliferation", 0.4628], ["CD3-dependent_phosphorylation", 0.4626], ["interleukin-2_receptor_alpha_chain_expression", 0.4624], ["interleukin_2-induced_T_cell_growth", 0.4624], ["RANKL-mediated_NF-kappaB_activation", 0.4623], ["proinflammatory_cytokine_signaling_cascade", 0.4623], ["cytokine-induced_signal_transduction_pathway", 0.4621], ["NF-kappaB/Rel_pathway", 0.4619], ["Interleukin-3_expression", 0.4619], ["mitogen-activated_protein_kinase", 0.4618], ["CD23-induced_NF-kappaB", 0.4617], ["mitogen-activated_kinase", 0.4615], ["NF-kappaB-dependent_activation", 0.4614], ["CD40_signaling_pathway", 0.4613], ["nuclear_transcription_factor-kappaB_activation", 0.4606], ["IL-4-activated_transcription_factor_signal_transducer_and_activator_of_transcription_6", 0.4606], ["CD43/leukosialin-mediated_pathway", 0.4605], ["NF-kappaB_pathway", 0.4604], ["IL-2-induced_monocyte-derived_nuclear_protein", 0.4603], ["costimulation-induced_mitogen-activated_protein_kinase_(MAPK)_activation", 0.4602], ["interleukin_3_(IL3)_gene_expression", 0.4599], ["interleukin-2_(IL-2)_gene_expression", 0.4598], ["Interleukin-2_(IL-2)_gene_expression", 0.4598], ["NF-kappaB-dependent_gene_expression", 0.4596], ["cell_signaling_pathway", 0.4593], ["IL-2-induced_proliferation", 0.4592], ["cell-type-specific_interleukin-2_receptor_alpha-chain_gene_expression", 0.4592], ["interleukin-2_gene_expression", 0.4592], ["IL-12-mediated_activation", 0.4591], ["intracellular_IL-2_signaling", 0.459], ["CD40_signaling_cascade", 0.4588], ["interleukin-2_(IL-2)_gene_induction", 0.4586], ["endogenous_NF-kappa_B-dependent_granulocyte-macrophage_colony_stimulating_factor_gene", 0.4585], ["interleukin_(IL)-1-mediated_activation", 0.4585], ["IL-2-independent_activation", 0.4582], ["distal_interleukin_2_(IL-2)_enhancer", 0.4582], ["interleukin-2_(IL-2)_expression", 0.458], ["IL-2-induced_tyrosine_phosphorylation", 0.4577], ["IL-2-induced_Stat3_activation", 0.4572], ["IL-6-stimulated_1A9-M_cell", 0.4571], ["interleukin-7_signaling", 0.4569], ["kinase_C_activation", 0.4569], ["cytokine-induced_endothelial_cell_activation", 0.4569], ["IL-2-induced_T_cell_growth", 0.4565], ["interleukin_2_receptor_beta_chain", 0.4564], ["precursor_interleukin-1_alpha_cytokine", 0.4564], ["NF-kappa_B-dependent_transcription", 0.4561], ["mitogen-activated_protein_kinase_kinase", 0.4561], ["NF-kappaB-dependent_reporter_gene_expression", 0.4558], ["CD40-induced_up-regulation", 0.4558], ["cytoplasmic_inhibitor_of_NF-kappa_B", 0.455], ["IL-2-induced_T_cell_proliferation", 0.4549], ["interleukin(IL)-2_expression", 0.4548], ["IL-4-induced_up-regulation", 0.4546], ["NF-kappa_b_activation", 0.4545], ["NF-kappa_B_activation", 0.4545], ["CD23-triggered_NF-kappaB_activation", 0.4542], ["IL-2-mediated_cell_cycle_progression", 0.454], ["T_helper_cell_cytokine_gene_expression", 0.454], ["interleukin-5_synthesis", 0.454], ["IL-12_signaling", 0.4539], ["p50/NF-kappa_B-mediated_inhibition", 0.4539], ["interleukin_2_receptor_alpha_(IL-2R_alpha)_chain", 0.4537], ["active_protein-tyrosine_kinase_regulatory_pathway", 0.4537], ["interleukin-2_(IL-2)-dependent_growth", 0.4536], ["CD28-dependent_effect", 0.4536], ["tumor_necrosis_factor_(TNF)-mediated_activation", 0.4535], ["murine_interleukin_(IL)-2_receptor_alpha_chain/CD25", 0.4535], ["interleukin-2_gene_transcription", 0.4535], ["IL-7R_signaling_event", 0.4534], ["interleukin-2_receptor_(IL-2R)_generation", 0.4533], ["cdk2_inhibitor", 0.4531], ["mitogen-activated_protein_kinase_(MAPK)_pathway", 0.4529], ["IL-7_signaling_pathway", 0.4528], ["protein_kinase_C-mediated_signal_transduction_event", 0.4526], ["prolonged_protein_kinase_C_activation", 0.4526], ["anti-CD3_mAb-stimulated_T_cell", 0.4525], ["CD3/CD4+_intrafollicular_T_cell", 0.4525], ["interleukin_2_(IL-2)_production", 0.4524], ["anti-CD3/anti-CD28_mAb", 0.4524], ["NF-kappa_B/Rel_activation", 0.4523], ["CD2_pathway", 0.4522], ["fibrinogen-induced_NF-kappa_B_activation", 0.452], ["IL-2-stimulated_cell", 0.452], ["IL-2-inducible_enhancer", 0.4519], ["IL-2_promoter_activation", 0.4519], ["mitogen_activated_protein_(MAP)_kinase", 0.4515], ["cytosolic_NF-kappa_B_inhibitor", 0.4515], ["T-cell_receptor_(TCR)/CD3_engagement", 0.4514], ["CD-40_pathway", 0.4513], ["transcriptional_regulator_nuclear_factor_(NF)-kappa_B", 0.4512], ["I_kappa_B_phosphorylation", 0.4511], ["NF-kappa_B-mediated_gene_expressio", 0.4511], ["interleukin-4_(IL-4)-mediated_B-cell_activation", 0.451], ["IL-2-induced_growth", 0.451], ["interleukin-2_(IL-2)_production", 0.4508], ["kappa_B_(kappa_B)_enhancer_binding_protein", 0.4507], ["anti-CD3-induced_tyrosine_phosphorylation", 0.4506], ["CD28_stimulation", 0.4506], ["interleukin-1_signaling_mediator", 0.4505], ["T_cell_antigen_receptor-induced_Erk2_kinase_activation", 0.4504], ["parasite-induced_NF-kappaB_activation", 0.4502], ["functional_T-cell_receptor_signaling_pathway", 0.4501], ["interleukin-2-gene_expression", 0.4501], ["biologically_functional_kappa_B_motif", 0.45], ["interleukin-1_receptor_synthesis", 0.4499], ["TCR-stimulated_CD95_ligand_expression", 0.4497], ["IL-2-dependent_T_cell_proliferation", 0.4497], ["protein_kinase_C_signaling_pathway", 0.4493], ["CD14-mediated_signaling", 0.4493], ["IL-2-induced_T-cell_proliferation", 0.4492], ["IL-2-dependent_proliferation", 0.449], ["IL-7R_signaling", 0.4484], ["protein_kinase_C_activation", 0.4483], ["NF-_kappaB_activation", 0.4483], ["nuclear_factor_of_activated_T_cells_(NF-AT)-driven_gene_expression", 0.4483], ["AP-1/NF-kappa_B_pathway", 0.4482], ["inflammatory_cascade", 0.4482], ["interleukin_(IL)-2-receptor_expression", 0.4481], ["protein_tyrosine_kinase_activation", 0.448], ["nuclear_transcription_factor_C/EBP_beta_(NF-IL-6)", 0.4479], ["IL-2R_beta_membrane_expression", 0.4479], ["IL-2_transcriptional_blockade", 0.4476], ["Interleukin-2_promoter_activity", 0.4476], ["interleukin-2_promoter_activity", 0.4476], ["NK-kappa_B_activation", 0.4475], ["CD4(+)_T-cell_activation", 0.4475], ["NF-kappa_B_signaling", 0.4473], ["IL-1_signaling_pathway", 0.4473], ["cytokine_activation", 0.4472], ["cytokine-induced_activation", 0.4472], ["IL-2-induced_IL-2R_alpha_promoter_activity", 0.447], ["T_cell_receptor_signal_transduction_cascade", 0.447], ["IL-2_induced_signal_transduction", 0.447], ["cytokine_receptor_activation", 0.447], ["protein-tyrosine_kinase_regulatory_pathway", 0.4467], ["interleukin-2-receptor_alpha-subunit_enhancer", 0.4466], ["cytokine_up-regulation", 0.4466], ["IL-12-induced_phosphorylation", 0.4466], ["interleukin-8_gene_expression", 0.4466], ["5-LOX-dependent_NF-kappaB_activation", 0.4465], ["anti-CD2_pathway", 0.4464], ["interleukin-2_IL-2_receptor_beta-chain", 0.4464], ["nuclear_factor_(NF)-kappaB_pathway", 0.4463], ["CD2_signaling", 0.4463], ["NF-kappaB_activation.", 0.4461], ["CD28-specific_mAb_BW_828", 0.4461], ["interleukin-6_gene_expression", 0.4461], ["IL-2R_alpha_kappa_B-specific_oligonucleotide_probe", 0.4461], ["IL-6_kappa_B-related_kappa_B_motif", 0.446], ["NF-kappaB-dependent_transcription", 0.446], ["IL-12-dependent_transactivation", 0.4459], ["mitogen-activated_protein_(MAP)_kinase", 0.4457], ["interleukin-2_(IL-2)-dependent_T-cell_line", 0.4457], ["interleukin_2_(IL-2)_gene_promoter", 0.4456], ["IL-4_signaling_molecule", 0.4455], ["cytokine-producing_effector_cell", 0.4454], ["IkappaB_kinase_(IKK)_signalsome_activation", 0.4454], ["mouse_interleukin_2_receptor_beta_chain_[IL-2Rbeta]_extracellular_domain", 0.4454], ["interleukin_(IL)-2_promoter", 0.4452], ["LPS-induced_bioactive_IL-12_production", 0.4452], ["IL-2R_associated_JAK/STAT_protein", 0.445], ["IL-6-mediated_MM_cell_growth", 0.4449], ["c-Jun_N-terminal_kinase_(JNK)_cascade", 0.4449], ["CD40/CD40L_pathway", 0.4448], ["IL-2R_alpha_regulation", 0.4448], ["protein-tyrosine_kinase_activation", 0.4446], ["NF-kappa_B1_gene_expression", 0.4446], ["NF-kappaB_activation", 0.4446], ["kappa_B-dependent_pathway", 0.4445], ["CD3+_intrafollicular_T_cell", 0.4445], ["T-_and_B-cell_activation", 0.4442], ["anti-CD3_monoclonal_antibody-induced_T-cell_proliferation", 0.4442], ["CD1+relB+_dendritic_cell", 0.4438], ["CD1+RelB+_dendritic_cell", 0.4438], ["interleukin-12_fusion_protein", 0.4435], ["activation-inducer_molecule/CD69", 0.4435], ["protein_kinase_A_signaling_pathway", 0.4434], ["IL3_gene_expression", 0.4434], ["IL-2_receptor_signal_transduction", 0.4434], ["eukaryotic_transcription_factor_NF-kappa_B", 0.4431], ["interleukin-2_(IL-2)_promoter", 0.443], ["interleukin_2_receptor_alpha_chain", 0.4428], ["cytokine_signalling", 0.4426], ["interleukin-2_(IL-2)_receptor_alpha_chain", 0.4425], ["NF-kappa_B-regulated_gene", 0.4425], ["I_kappa_B_alpha-associated_protein_kinase", 0.4424], ["interleukin-12_expression", 0.4423], ["CD40_ligand-positive_(CD40L+)_reactive_T_lymphocyte", 0.4422], ["interleukin-8_(IL-8)_gene_transcription", 0.4422], ["NF_kappa_B_activation", 0.442], ["NDP_kinase_expression", 0.442], ["parasite-induced_constitutive_NF-kappaB_activation", 0.4419], ["immunoglobulin_kappa_3'_enhancer", 0.4418], ["T_cell_antigen_receptor_(TCR)-associated_protein_tyrosine_kinase", 0.4418], ["interleukin-2_receptor_(IL-2R)_alpha_chain_promoter", 0.4416], ["nuclear_factor_(NF)-kappa_B_activation", 0.4416], ["phytohemagglutinin/anti-CD28_activated_T_lymphocyte", 0.4416], ["monocyte_TF_activation", 0.4416], ["IL-7-signaling_pathway", 0.4415], ["cellular_NF-kappa_B_activity", 0.4412], ["interleukin-2_production", 0.4412], ["IL-1_beta_promoter/enhancer_sequence", 0.4411], ["IL-1-induced_synthesis", 0.4411], ["CD40-regulated_antiapoptotic_molecule", 0.441], ["CD40_pathway", 0.441], ["IL-1-induced_NF-kappa_B_DNA_nuclear_localization", 0.441], ["intracellular_signaling_pathway", 0.441], ["Regulated_upon_Activation,_Normal_T_cell_Expressed_and_Secreted", 0.4409], ["regulated_upon_activation,_normal_T_cell_expressed_and_secreted", 0.4409], ["nuclear_factor_(NF)-kappaB_activation", 0.4409], ["NF-kappa_B/Rel_transcription_factor", 0.4407], ["cytokine-induced_endothelial_activation", 0.4407], ["IL-1-induced_IL-2_production", 0.4407], ["CD14_gene_regulation", 0.4406], ["TNF-related_apoptosis-inducing_ligand", 0.4405], ["interleukin_(IL)-8_production", 0.4405], ["anti-CD28_antibody", 0.4402], ["kappaB-dependent_transcriptional_activity", 0.4401], ["nuclear_factor_of_activated_T_lymphocytes_(NFAT)-induced_Fas_ligand_transcription", 0.4401], ["interleukin_2_production", 0.44], ["CD28_auxiliary_receptor", 0.44], ["tyrosine_kinase_activation", 0.44], ["IL-2_promoter-enhancer", 0.4399], ["IL-2-driven_cell_growth", 0.4399], ["Interferon_Consensus_Sequence_binding_protein_for_Activated_T_cell", 0.4397], ["NF-kappa_B/Rel_transcription_factor_family", 0.4394], ["tumor_necrosis_factor-alphaand_interleukin-1betaproduction", 0.4392], ["interleukin-6_expression", 0.4391], ["phorbol_ester-inducible_neutrophil_respiratory_burst_activation", 0.4391], ["monocyte/macrophage-_and_B-cell-specific_transcription_factor", 0.439], ["cytokine-dependent_upregulation", 0.4389], ["interleukin-2_(IL-2)_receptor_common_gamma_chain", 0.4387], ["IL-2_receptor_(IL-2R)_alpha_chain", 0.4387], ["IL-2-driven_proliferation", 0.4386], ["inflammatory_mediator_expression", 0.4386], ["T-cell_interleukin-2", 0.4386], ["nuclear_factor-kappaB_(NF-kappaB)_regulation", 0.4383], ["NF-kappa_B-related_transcription_factor", 0.4381], ["stress-activated_kinase_pathway", 0.4379], ["CD40-stimulated_B_cell", 0.4378], ["I_kappa_B_alpha_phosphorylation", 0.4375], ["cytokine_interleukin-2", 0.4373], ["interleukin_2_promoter", 0.4373], ["interleukin-12_receptor_component", 0.4372], ["interleukin_(IL)-2_homology_NFAT-1_region", 0.4372], ["anti-CD3/IL-2-activated_LN_cell", 0.4372], ["transcription_(STAT)_signaling_pathway", 0.4371], ["cytokine_receptor_signaling", 0.437], ["IL-2R_alpha_cell_surface_expression", 0.437], ["CD40_survival_signaling", 0.437], ["monocyte_tissue_factor_activation", 0.437], ["CD3_pathway", 0.4369], ["monocytic_IkappaB_kinase", 0.4365], ["IL-5-specific_regulatory_mechanism", 0.4363], ["interleukin-5_signaling", 0.4363], ["NF-kappa_B-dependent_IL-6_expression", 0.4363], ["IL-2_gene_promoter_activity", 0.4362], ["NF-kappaB-dependent_up-regulation", 0.4361], ["NF-kappaB/Rel_transcription_factor_family", 0.436], ["B-cell-derived_NF-kappa_B", 0.436], ["NF-kappaB_signaling", 0.436], ["IL-2-gene_regulation", 0.4356], ["protein_kinase_C-mediated_gene_transcription", 0.4356], ["interleukin-1_beta_production", 0.4356], ["interleukin-2_receptor_alpha_chain", 0.4356], ["IL-1-stimulated_activation", 0.4355], ["IL-4-mediated_phosphorylation", 0.4352], ["B_cell-associated_surface_molecule_CD40", 0.4351], ["IL-2-producing_cell", 0.435], ["interleukin_2_receptor_alpha-chain", 0.4349], ["T-cell_signaling_molecule", 0.4349], ["IL-4-mediated_tyrosine_phosphorylation", 0.4349], ["tumor_necrosis_factor_alpha-mediated_activation", 0.4348], ["cytokine_regulation", 0.4348], ["Fcgamma_receptor-mediated_mitogen-activated_protein_kinase_activation", 0.4348], ["interleukin2", 0.4346], ["interleukin-2", 0.4346], ["Interleukin-2", 0.4346], ["NF-AT_(nuclear_factor_of_activated_T_cells)_binding_site", 0.4346], ["immune/inflammatory_effector_cell", 0.4345], ["intrafollicular_CD3+_T_cell", 0.4344], ["monocyte/B-cell-specific_transcription_factor", 0.4343], ["protein_kinase_cascade", 0.4341], ["anti-CD28_MoAb_costimulation", 0.434], ["class_II_transactivator-independent_endothelial_cell_MHC_class_II_gene_activation", 0.434], ["CD2_signalling", 0.4339], ["intracellular_signaling_molecule", 0.4338], ["mitogen-activated_protein_p38_kinase", 0.4338], ["inflammatory_effector_gene_product", 0.4338], ["NF-kappa_B_transcription_factor_complex", 0.4337], ["LPS-induced_NF-kappa_B_binding_activity", 0.4337], ["interleukin-2_(IL-2)_receptor_gamma_chain_(gamma(c))", 0.4336], ["proximal_IL-2_promoter-enhancer", 0.4335], ["anti-CD28_Ab_stimulation", 0.4335], ["Interleukin_2", 0.4335], ["interleukin_2", 0.4335], ["interleUkin_2", 0.4335], ["nuclear_factor_of_activated_T_cells_(NF-AT)_activation", 0.4334], ["anti-CD28_costimulation", 0.4334], ["cytokine-induced_proliferation", 0.4334], ["T_cell_antigen_receptor-induced_MAPK_activation", 0.4332], ["intracellular_signalling_pathway", 0.4331], ["IL-12-induced_activation", 0.433], ["IL-2-_preactivated_NK_cell", 0.4329], ["IkappaB_kinase_complex_activation", 0.4329], ["IL-6_kappa_B_binding_factor_II", 0.4328], ["NF-kappaB_nuclear_activation", 0.4328], ["T-cell_IL-5_synthesis", 0.4328], ["IL-2-mediated_survival", 0.4328], ["TCR-regulated_nuclear_factor_of_activated_T_cells_(NF-AT)_region", 0.4327], ["nuclear_factor-kappa_B_(NF-kappa_B)/Rel_transcription_factor", 0.4327], ["IL-4_signaling_pathway", 0.4326], ["protein_kinase_C-activating_phorbol_esters,_such_as_PMA", 0.4325], ["protein_kinase_C_pathway", 0.4324], ["nuclear_factor_of_activated_T_cells_transcriptional_activation", 0.4324], ["TNF-induced_activation", 0.4321], ["mouse_interleukin_2_receptor_beta_chain", 0.4321], ["interleukin-4_expression", 0.432], ["immunoreactive_I_kappa_B-alpha_protein_levels", 0.4319], ["CD28_expression", 0.4319], ["CD40_signaling,", 0.4318], ["transcription_factor_NF-kappa_B", 0.4318], ["activated_protein_kinase_B", 0.4318], ["novel_nuclear_factor_of_activated_T_cells-binding_factor", 0.4318], ["mitogen-activated_protein_kinase-targeted_hematopoietic_tyrosine_phosphatase", 0.4317], ["protein_kinase_C_stimulation", 0.4317], ["IL-4_gene_expression_level", 0.4316], ["interleukin-beta", 0.4315], ["p38_mitogen-activated_protein_kinase", 0.4315], ["tumor_necrosis_factor_receptor_signaling_pathway", 0.4313], ["inducible_IL-2R_alpha_gene_expression", 0.4313], ["anti-CD3-induced_proliferation", 0.4313], ["extracellular_signal-regulated_kinase", 0.4313], ["T_cell_receptor-derived_Type_I_pathway", 0.4313], ["IL-2_receptor_beta_chain", 0.4313], ["cellular_signaling_pathways", 0.4311], ["IL-2_receptor_expression", 0.4311], ["IL-4_signaling", 0.431], ["cytokine_signaling_3", 0.4308], ["NF_kappa_B/rel_transcription_factor_family", 0.4308], ["interleukin-2_promoter", 0.4308], ["Interleukin-2_promoter", 0.4308], ["IL-1-induced_activation", 0.4308], ["CD4_cell_activation", 0.4308], ["intracellular_signalling_agents", 0.4307], ["proliferative_signaling", 0.4306], ["IL-2_gene_expression", 0.4305], ["IL-2R_regulation_gene", 0.4303], ["MAP_kinases/extracellular_signal_regulated_kinase", 0.43], ["signaling_pathway_molecule", 0.43], ["CD34(+)_bone_marrow_cell_clonogenic_function", 0.43], ["IL-12-induced_gene_expression", 0.4299], ["CD3_receptor-mediated_signalling", 0.4299], ["in_vitro_kinase_activity", 0.4299], ["interleukin_8_promoter_activity", 0.4299], ["RANK-mediated_NF-kappaB_signaling", 0.4295], ["transcription_factor_nuclear_factor_of_activated_T_cells", 0.4294], ["c-Jun_N-terminal_kinase_cascade", 0.4294], ["interleukin_(IL)-2", 0.4294], ["IL-2_receptor_beta-chain", 0.4293], ["nuclear_factor-kappa_B_activation", 0.4291], ["activation-dependent,_T_cell-specific_transacting_factor", 0.4289], ["anti-CD3-induced_ERK_activation", 0.4289], ["NF-kappaB_transcription_factor_family", 0.4289], ["IL-2_receptor_alpha_(IL-2R_alpha)_gene_transcription", 0.4288], ["kappa_immunoglobulin_intron_enhancer", 0.4288], ["factor-regulated_signaling_pathway", 0.4287], ["up-regulated_monocyte_gene_expression", 0.4287], ["T_cell_receptor_signaling_pathway", 0.4287], ["interleukin-2_(IL-2)", 0.4286], ["interleukin-4-induced_tyrosine_phosphorylation", 0.4284], ["NF-kappaB_inhibitory_molecule", 0.4284], ["TNF-alpha-stimulated_nuclear_factor-kappa_B", 0.4284], ["interleukin-2_(IL-2)_secretion", 0.4284], ["IL-4-dependent_activation", 0.4283], ["ligand-activated_transcription_factor", 0.4283], ["NF_kappaB_activation", 0.428], ["mitogen-activated_protein_kinase_(MAPK)_activity", 0.428], ["interfollicular_Bcl-6+/CD3+_cell", 0.4279], ["intracellular_IL-2_protein", 0.4278], ["IL-2-mediated_IFN-gamma_production", 0.4277], ["stimulated_IL-2_secreting_cell", 0.4277], ["anti-CD3_stimulated_T_cell", 0.4276], ["interleukin-4-dependent_transcription_factor", 0.4275], ["interleukin-10-stimulated_STAT_molecule", 0.4274], ["T-lymphocyte_activation_mechanisms", 0.4273], ["signal-dependent_NF-kappa_B_activation", 0.4271], ["ligand_activated_transcription_factor", 0.427], ["inhibitor_of_NF-kappa_B", 0.427], ["CD27_ligand_(CD70)_transfectant", 0.427], ["NK_cell-mediated_K562_cancer_cell_killing", 0.4269], ["interleukin-2_receptor_alpha-chain", 0.4269], ["NF_kappaB-regulated_gene", 0.4268], ["cytotoxic_cytokine_synthesis", 0.4266], ["CD40-mediated_function", 0.4265], ["immunoglobulin_kappa_enhancer", 0.4264], ["IL2_transcription", 0.4264], ["anti-CD3-mediated_response", 0.4263], ["IL-3-regulated_factor", 0.4258], ["anti-CD3-induced_increase", 0.4257], ["novel_signaling_molecule", 0.4257], ["IL-6_protein_expression", 0.4256], ["cytokine-mediated_inflammatory_disease", 0.4255], ["IL-4_promoter_activation", 0.4252], ["Th2_cytokine_gene_expression", 0.4251], ["interleukin_2-induced_lymphocyte_proliferation", 0.4251], ["IL-2_promoter-driven_transcription", 0.425], ["basal_NF_kappaB_activation", 0.4247], ["interleukin_(IL)_-3", 0.4247], ["receptor_activator_of_NF-kappaB", 0.4246], ["CD3-induced_HSI_phosphorylation", 0.4245], ["interleukin_(IL),1_beta", 0.4245], ["NFkappaB/inhibitor-kappaB_(IkappaB)_system", 0.4244], ["nuclear_factor-kappaB_activation", 0.4243], ["stress-activated_protein_kinase/c-Jun_NH2-terminal_kinase", 0.4241], ["anti-CD3_mAb-induced_proliferation", 0.424], ["active_signaling_pathway", 0.4239], ["NF-kappa_B_transcription_factor", 0.4239], ["LPS-induced_NF-kappa_B", 0.4239], ["cytokine_gene_regulation", 0.4238], ["IL-1R-associated_kinase", 0.4238], ["CD28_response_complex", 0.4236], ["anti-CD3_activation", 0.4235], ["interleukin-1_(IL-1)_signaling", 0.4234], ["CD3/TCR_pathway", 0.4234], ["CD4+_T_helper_2_(Th2)_cell", 0.4234], ["cytokine-mediated_JAK3/STAT5a/b_signal_transduction", 0.4233], ["NF-kappa_B_inhibitor", 0.4233], ["Rel-related,_mitogen-inducible,_kappa_B-binding_protein", 0.4233], ["IL-2R_alpha_transcription", 0.4233], ["endothelial_cell_activation", 0.4232], ["IL-4-triggered_transcriptional_activation", 0.4232], ["interleukin-8_production", 0.4231], ["c-Jun_N-terminal_kinase_activation", 0.4231], ["transcription_factor_NF_kappa_B", 0.423], ["IL-2_transcription", 0.4229], ["cellular_signaling_pathway", 0.4229], ["CD40-activated_monocyte", 0.4226], ["FN-induced_IL-1beta_protein_production", 0.4226], ["CD34+_myelomonocytic_cell_line", 0.4225], ["nuclear_factor_kappaB_activation", 0.4225], ["interleukin_2_receptor", 0.4225], ["transcription_factor_NF-kappaB", 0.4225], ["lipopolysaccharide-induced_NF-kappa_B_activation", 0.4224], ["CD40-mediated_enhancement", 0.4224], ["CD16_(Fc_gamma_RIIIA)-induced_expression", 0.4222], ["T_cell_receptor_triggered_activation", 0.4221], ["IL-2R_alpha_enhancer", 0.4221], ["wild-type_IL-2R_alpha_kappa_B_enhancer", 0.4219], ["T_cell_receptor_(TCR)/CD3_stimulation", 0.4216], ["CD3/CD28_coligation", 0.4216], ["linker_for_activation_of_T_cells", 0.4215], ["interleukin-4-mediated_IgE_production", 0.4214], ["nuclear_factor_(NK)-_kappa_B_DNA-binding_activity", 0.4214], ["LPS-induced_NF-kappaB_DNA_binding", 0.4214], ["MAP_kinase_signal_transduction_pathway", 0.4214], ["T_cell_proliferation_response", 0.4211], ["auxiliary_receptor_CD28", 0.4211], ["kappa_immunoglobulin_enhancer", 0.4207], ["IL-4-induced_tyrosine_phosphorylation", 0.4207], ["cytokine-induced_vascular_cell_adhesion_molecule-1_expression", 0.4206], ["nuclear_transcription_factor_NF-kappa_B", 0.4206], ["cyclosporin_A_(CsA)/FK506-sensitive_nuclear_factor_of_activated_T_cells", 0.4206], ["oxidoreductive_regulatory_pathway", 0.4206], ["NF-IL-6_DNA_binding_activity", 0.4204], ["intercellular_adhesion_molecule-1_(ICAM-1,_CD54)/MAC-1_(CD11b/CD18)_dependent_adhesion", 0.4204], ["IL-2R(alpha)_chain_mRNA_induction", 0.4202], ["activated_kinase", 0.4202], ["CD28_MoAb_costimulation", 0.4201], ["interleukin(IL)-2", 0.42], ["IL-2_inhibition", 0.42], ["CD40_signaling", 0.42], ["LPS-induced_IL-6_mRNA_and_protein_expression", 0.4198], ["NF-kappaB_transcription_factor", 0.4198], ["PMA/Iono-stimulated_IL-2_transcription", 0.4195], ["NF-kappa_B_binding_protein", 0.4195], ["anti-inflammatory_cytokine", 0.4194], ["IL-2_promoter_activity", 0.4194], ["IL-1_signaling", 0.4192], ["antigen-stimulated_B-cell-mediated_immune_response", 0.4191], ["IL-2_promoter_stimulation", 0.419], ["inflammatory_pathogenesis", 0.419], ["interleukin-1_beta_(IL-1_beta)_mRNA", 0.4187], ["J393/CD43-mediated_apoptosis", 0.4187], ["protein_kinase_C_signaling", 0.4186], ["p38_mitogen-activated_protein_(MAP)_kinase", 0.4186], ["NF-kappa_B_DNA_binding_motif", 0.4186], ["distal_NF-kappa_B_motif", 0.4185], ["CD95_ligand_reporter_activity", 0.4185], ["IL-2R_alpha_gene_expression", 0.4185], ["cytokine-secreting_effector_Th_cell", 0.4184], ["NF-kappaB-dependent_promoter_activity", 0.4184], ["IL-2-induced_mRNA_expression", 0.4183], ["IL-2_receptor_alpha_chain", 0.4183], ["T-cell-receptor-mediated_T-cell_activation", 0.4183], ["Kit_ligand-dependent_proliferation", 0.4183], ["JAK3-mediated_Type_II_signaling_pathway", 0.4182], ["T_cell_pathway", 0.4182], ["T_cell_receptor_alpha_(TCR_alpha)_enhancer", 0.4182], ["NF-kappa_B1_transcription", 0.4181], ["T_cell_proliferative_response", 0.418], ["NF-kappaB_transcriptional_factor", 0.4179], ["calcium-independent_anti-CD28_Ab", 0.4179], ["IL-3-dependent_pro-B_cell", 0.4176], ["IL2_enhancer", 0.4175], ["extracellular-regulated_kinase_1/2", 0.4175], ["protein_kinase_A_pathway", 0.4175], ["interleukin-6_production", 0.4174], ["NF-kappa_B-like_family_of_transcription_factor", 0.4173], ["cellular_factor_NF-kappa_B", 0.4172], ["NF-kappaB_inhibitory_subunit", 0.417], ["stress-activated_protein_kinase_(SAPK)/Jun_N-terminal_kinase", 0.417], ["natural_killer_cell_(NK)_activation", 0.4169], ["IL-5_promoter_activation", 0.4169], ["CD28RE/AP-1-specific_complex", 0.4169], ["IL-2_gene_transcription", 0.4167], ["NF-kappaB_inhibitor", 0.4166], ["IL-2_receptor_alpha-chain", 0.4165], ["NF-kappa_B_p65_mRNA_accumulation", 0.4165], ["protein_kinase_C-activating_phorbol_ester", 0.4164], ["75-kDa_hematopoietic_cell-specific_intracellular_signaling_protein", 0.4164], ["CD28_binding", 0.4163], ["IL-4_(5_ng/mL)-mediated_proliferation", 0.4163], ["T_cell_receptor_alpha_(TCR-alpha)_enhancer", 0.4161], ["IL-2_transcriptional_inhibitor", 0.416], ["CD4(+)_T_helper_2_(Th2)_cell", 0.416], ["T_cell_activation-induced_apoptosis", 0.4159], ["multiple_kinase_pathway", 0.4159], ["TNF-alpha-mediated_activation", 0.4159], ["anti-CD28_mAb", 0.4158], ["T-cell_receptor_alpha_(TCR_alpha)_enhancer", 0.4157], ["gene_activation_pathway", 0.4157], ["I-kappa_B_mRNA_expression", 0.4157], ["T-cell_gene_activation", 0.4157], ["B_cell_antigen-specific_signaling_response", 0.4157], ["NF-kappa_B_p65_DNA_binding_activity", 0.4156], ["IL-5_signaling", 0.4154], ["C5a-induced_interleukin-8_gene_expression", 0.4153], ["interleukin_(IL)-1_beta", 0.4152], ["interleukin_2_receptor_alpha-chain_(IL-2R_alpha)_gene", 0.4152], ["immunomodulatory_cytokine", 0.4152], ["nuclear_factor.kappa_B_activation", 0.4149], ["IL-2_enhancer", 0.4149], ["T_cell_activation", 0.4148], ["interleukin-4-induced_transcription_factor", 0.4147], ["NF-kappa_B/c-Rel_protein", 0.4146], ["T_cell_receptor_(TCR)-mediated_signal_transduction", 0.4146], ["NF-kappa_B_DNA_binding_activity", 0.4146], ["proximal_NF-kappa_B_motif", 0.4145], ["inflammatory_cytokine", 0.4145], ["Jak_2-STAT_1_pathway", 0.4144], ["interleukin_2_alpha-chain_receptor", 0.4144], ["ligand-inducible_transactivation_function", 0.4142], ["murine_interleukin_(IL)-2_receptor_alpha_chain", 0.4141], ["CD4_transduction_pathway", 0.414], ["cellular_inhibitor_kappaB_alpha", 0.414], ["LPS-induced_NF-kappa_B/c-Rel_nuclear_translocation", 0.4139], ["regulatory_cytokine", 0.4139], ["inflammatory_cytokine_gene", 0.4138], ["T-cell-specific_activation", 0.4138], ["interleukin_(IL)-2-receptor", 0.4138], ["NF-kappa_B-independent_HIV_promoter_domain_activity", 0.4137], ["IL-7-induced_proliferation", 0.4137], ["CD40_signaling_determinant", 0.4136], ["CD40-mediated_cell_survival", 0.4136], ["CD3-mediated_stimulation", 0.4136], ["IL-5-stimulated_cell", 0.4134], ["CD3-directed_cytolysis", 0.4134], ["IL-4_gene_regulation", 0.4133], ["IL-6_gene_expression", 0.4132], ["IL-2R_alpha_gene_transcription", 0.4132], ["IL-2Ralpha_gene_expression", 0.4132], ["TNF_receptor_surface_expression", 0.4131], ["interleukin_(IL)-4_stimulation", 0.413], ["kappaB-driven_gene_expression", 0.413], ["antigen-dependent_T_cell_activation", 0.4129], ["NK_cell_activation", 0.4128], ["interleukin_1_production", 0.4128], ["IL-3-mediated_STAT5b", 0.4127], ["interleukin_1beta_protein_production", 0.4126], ["peripheral_blood_T_cell_activation", 0.4126], ["NF-kappa_B-binding_motif", 0.4125], ["T_cell_receptor_(TcR)/CD3_complex", 0.4124], ["IL-2_receptor_component", 0.4124], ["interleukin_2_receptor_gamma_chain", 0.4123], ["IL-2-induced_IL-6_mRNA_expression", 0.4122], ["interleukin-2_secretion", 0.4122], ["IL-2_mRNA_production", 0.412], ["optimal_IL-4-signaling", 0.4118], ["IL2_regulatory_region", 0.4117], ["IL-4-induced_gene_expression", 0.4117], ["T-cell_receptor_(TCR)-CD3_complex", 0.4117], ["cytokine_stimulating_growth", 0.4116], ["IL-2-secreting_cell", 0.4116], ["nuclear_factor_of_activated_T_cells_(NFAT)_transcriptional_complex", 0.4116], ["T-cell_activation", 0.4115], ["ligand-induced_phosphorylation", 0.4114], ["anti-CD3-stimulated_cord_blood_mononuclear_cell", 0.4113], ["T-cell_receptor_signaling_pathway", 0.4113], ["CaM_kinase_II", 0.4111], ["interleukin_(IL)-1_alpha-stimulated_VCAM-1_expression", 0.411], ["IL-2_receptor_alpha_chain_promoter", 0.411], ["activated_CD4+_T_cell", 0.4109], ["NF-ATp-mediated_transactivation", 0.4109], ["LPS-induced_TF_gene_expression", 0.4107], ["C5a-induced_IL-8_expression", 0.4107], ["modulate_surface_immunoglobulin-triggered_B-cell_activation", 0.4107], ["IL-5_promoter/enhancer-_luciferase_gene_construct", 0.4106], ["interleukin_(IL)_6", 0.4105], ["TNF-alpha-induced_activation", 0.4105], ["novel_T-cell-specific_transcriptional_activator", 0.4105], ["intracellular_signal_transduction_molecule", 0.4104], ["interleukin_(IL)-2_gene", 0.4104], ["cytokine_IL-2", 0.4104], ["CD28-dependent_induction", 0.4103], ["IL-1/tumor_necrosis_factor-responsive_element", 0.4103], ["T-cell_proliferative_activity", 0.4103], ["pro-inflammatory_cytokine", 0.4102], ["CD40-stimulated_B_lymphocyte", 0.4101], ["CD8-mediated_inhibition", 0.4099], ["human_interleukin-2_receptor_beta-chain_promoter", 0.4099], ["CD40-dependent_B_cell_culture_system", 0.4098], ["CD28_costimulation", 0.4097], ["B_cell_octamer-binding_protein_1/octamer-binding_factor_1/Oct_coactivator", 0.4097], ["CD40_ligand", 0.4096], ["IL-2-induced_PBMC", 0.4096], ["IL-2_cis-regulatory_element", 0.4095], ["tumor_necrosis_factor_receptor_expression", 0.4095], ["human_monocyte_IL-1_receptor_antagonist_(IL-1ra)_messenger_ribonucleic_acid_(mRNA)_expression", 0.4095], ["p38alpha_mitogen-activated_protein_kinase", 0.4094], ["IL-4R_alpha-associated_kinase", 0.4094], ["putative_IkappaBalpha_kinase", 0.4094], ["IL-1_beta_gene_expression", 0.4093], ["stress-activated_protein_(SAP)_kinase", 0.4092], ["protein_kinase_C-independent_mechanism", 0.4092], ["ligand-independent_mechanisms", 0.4092], ["Jak/Stat_signaling_pathway", 0.4091], ["IL-2_receptor_(IL-2R)_alpha", 0.409], ["IL-2_receptor_alpha_expression", 0.409], ["MAP_kinase_cascade", 0.4089], ["extracellular_signal-related_kinase", 0.4089], ["anti-CD3/CD28", 0.4088], ["kappaB-dependent_transcription", 0.4088], ["IL-8_gene_expression", 0.4088], ["T_cell_stimulation-induced_expression", 0.4088], ["interleukin-6_mRNA_production", 0.4087], ["NF-kappaB_transcription", 0.4087], ["stress-activated_protein_kinase", 0.4086], ["interleukin_1_beta", 0.4084], ["interleukin-7_receptor_alpha_chain", 0.4084], ["T_cell-specific_enhancer", 0.4084], ["IL-2-induced_signal", 0.4083], ["NFkappaB-mediated_cytokine_production", 0.4082], ["cytokine_receptor_expression", 0.4082], ["high-level_enhancer_activity_in_cell", 0.4082], ["IL-4-induced_nuclear-activating_factor", 0.4081], ["IL-5_signal_transduction_mechanism", 0.4081], ["IL-2mRNA_synthesis", 0.4081], ["NF-kB_dependent_T_cell_gene", 0.4081], ["interleukin-1_beta_converting_enzyme", 0.408], ["IL-6-induced_downregulation", 0.408], ["CD16-induced_activation", 0.408], ["cytokine_interleukin_(IL)-1_beta", 0.408], ["CD27+_B_cell", 0.4079], ["interleukin_1_beta_(IL-1_beta)_gene", 0.4079], ["(LPS)-induced_human_monocyte_TNF-alpha_production", 0.4078], ["IL-4-stimulated_cell", 0.4078], ["cell-specific_mechanism", 0.4077], ["inducible_nuclear_factor-kappaB_(NF-kappaB)_(Rel_A)_binding_site", 0.4076], ["IL-9-mediated_cell_growth", 0.4076], ["NK-_kappa_B_DNA-binding_activity", 0.4076], ["in_vitro_kinase_assay", 0.4076], ["interleukin2independent", 0.4075], ["IL-2_in_vitro", 0.4075], ["NF-kappa_B-related_protein", 0.4074], ["epithelial_cell-initiated_inflammation", 0.4073], ["IL-4-producing_Th2_cell", 0.4072], ["dominant-negative_mutant_tumor_necrosis_factor_receptor_I_(TNFRI)_expression_vector", 0.4072], ["12-O-tetradecanoyl-phorbol-13-acetate_(TPA)-stimulated_B_cell", 0.4071], ["macrophage_inflammatory_protein-2", 0.4071], ["IL-2_protein", 0.407], ["IL-2_mRNA_induction", 0.407], ["interleukin-2_receptor", 0.4069], ["interleukin_2_(IL-2)_gene", 0.4068], ["IL-2_producing_EBV-B_cell", 0.4068], ["interleukin_2_gene", 0.4068], ["CD19-mediated_signal_transduction", 0.4068], ["interleukin-3", 0.4067], ["Interleukin-3", 0.4067], ["CD40-CD40_ligand", 0.4067], ["CD95_ligand_gene_expression", 0.4066], ["interferon_(IFN)-activated_NK_cell", 0.4066], ["CD28-dependent_elevation", 0.4066], ["cytokine-induced_function", 0.4065], ["ubiquitous_(Spl,_c-Jun_and_TBP)_or_haemopoietic_(NF-E2)_transcription_factor", 0.4065], ["interleukin-beta_gene", 0.4063], ["analogous_cell-cycle-regulated_phosphorylation", 0.4063], ["mitogen-activated_Rel-/-_T_cell", 0.4063], ["T-cell_regulatory_cytokine", 0.4063], ["NF-kappaB-directed_transcription", 0.4063], ["LPS-stimulated_IL-6_secretion", 0.4062], ["CD28_surface_molecule", 0.4062], ["inflammatory_c_ytokine_mRNA", 0.4062], ["anti-CD2-activated_purified_T_cell", 0.406], ["IL-2-dependent_cell_transformation", 0.406], ["NF-kappa_B_family_protein", 0.406], ["cell-to-cell_activation", 0.406], ["IL-2R_beta_mRNA_level", 0.4057], ["T-cell_receptor_gene_activation", 0.4056], ["IL-4_Stat_activation_cycle", 0.4056], ["antigen-induced_IL-2_secretion", 0.4056], ["IL-5_promoter/enhancer_luciferase_gene_construct", 0.4055], ["NF-kappa_B-like_transcription_factor", 0.4055], ["interleukin-5/receptor_interaction", 0.4055], ["IL-2_receptor_(IL-2R)_alpha_chain_gene", 0.4055], ["interleukin_4_(IL-4)_promoter", 0.4054], ["T_cell_receptor_(TCR)_mediated_signaling", 0.4053], ["IL-2R_alpha_protein", 0.4053], ["nuclear_factor_(NF)-kappa_B_DNA_binding_activity", 0.4052], ["cell-specific_pathway", 0.4052], ["interleukin-6_level", 0.4052], ["IL-4/IL-13-stimulated_monocyte", 0.4052], ["novel_T_cell-specific_negative_regulatory_element", 0.4052], ["c-Jun_NH2-terminal_kinase_activation", 0.4052], ["IL-4-induced_Stat6_phosphorylation", 0.4051], ["interleukin_3", 0.4051], ["protein_kinase_C_(PKC)_activation", 0.4051], ["Jak/Stat_(signal_transducer_and_activator_of_transcription)_pathway", 0.4051], ["interleukin_3-mediated_survival", 0.405], ["NF.kappa_B_activation", 0.405], ["cyclic_adenosine_monophosphate_(cAMP)_response_element_binding_(CREB)/activating_transcription_factor_1_(ATF-1)_family", 0.4049], ["ligand-induced_activation_event", 0.4049], ["CD3-T-cell_receptor_complex", 0.4049], ["JAK3-dependent_and_independent_pathway", 0.4047], ["NF-kappa_B/Rel_family_protein", 0.4047], ["NF_of_activated_T_cell", 0.4047], ["IkappaB_kinase", 0.4046], ["interleukin-4_promoter", 0.4046], ["Jak_2-STAT_1_signaling_pathway", 0.4044], ["NF-kappa_B_DNA-binding_activity", 0.4043], ["IL-2-induced_IFN-gamma_production", 0.4043], ["IL-1_beta_and_IL-6_gene", 0.4042], ["MAP_kinase_extracellular_signal-regulated_kinase", 0.4042], ["IL-6_kappa_B_motif", 0.4041], ["human_interleukin_2_gene_promoter", 0.404], ["cyclin-dependent_kinase_(cdk)_inhibitor", 0.4039], ["IL-2_mRNA_expression", 0.4039], ["NF-kappa_B_inhibition", 0.4039], ["cytokine_gene_transcription", 0.4038], ["FK506-mediated_inhibition", 0.4038], ["interleukin-1_beta_mRNA_level", 0.4037], ["10-amino_acid_CD40_cytoplasmic_signaling_determinant", 0.4037], ["IL-1_beta_mRNA_expression", 0.4037], ["immunomodulatory_stress_response", 0.4036], ["interleukin-1_beta_(IL-1_beta)_gene", 0.4036], ["TNF-alpha-stimulated_Jurkat_cell", 0.4036], ["LPS_stimulated_vascular_cell_adhesion_molecule_(VCAM)-1_surface_expression", 0.4036], ["NF-kappa_B/I_kappa_B_protein_family", 0.4036], ["extracellular_signal-regulated_kinase_(Erk)_pathway", 0.4035], ["antigen-processing_pathway", 0.4034], ["MAP_kinase_extracellular_signal-regulated_kinase_(ERK)_2", 0.4034], ["MAPK/extracellular_signal-regulated_kinase_kinase_(MAPK_kinase)_inhibitor", 0.4033], ["IL-2Rbeta_DNA_binding_motif", 0.4033], ["interleukin-2_receptor_alpha", 0.4033], ["IL-2-dependent_cell", 0.4033], ["primary_TCR-mediated_activation", 0.4033], ["transcription_factor_nuclear_factor-kappa_B", 0.4033], ["human_IL2_upstream_enhancer", 0.4032], ["NF_kappaB-dependent_enzyme", 0.4032], ["I_kappa_B_beta_inhibitor", 0.4032], ["cdk_inhibitor", 0.4032], ["T-cell-expressed_cytokine", 0.4032], ["FcR-mediated_MAPK_activation", 0.4031], ["interleukin-1_production", 0.403], ["T_cell_activation_gene", 0.403], ["interleukin-1_alpha_production", 0.4029], ["NF-kappaB_inhibition", 0.4029], ["nuclear_factor_KB_(NF-KB)_activation", 0.4029], ["CD3-stimulated_human_peripheral_T_lymphocyte", 0.4028], ["nuclear_factor_(NF)-kappa_B_binding_activity", 0.4027], ["NDP_kinase_activity", 0.4027], ["B7-independent_T_cell_costimulatory_molecule", 0.4027], ["SH2_domain_activated_Syk-family_kinase", 0.4026], ["mouse_interleukin-2_receptor_alpha_gene_expression", 0.4026], ["IL-2_receptor_stimulation", 0.4025], ["CD28-derived_signal", 0.4025], ["tumor_necrosis_factor_(TNF)_receptor_family", 0.4025], ["down-regulation_of_inflammation", 0.4024], ["cell_cycle_control_kinase_cdc2", 0.4024], ["T-cell_antigen_receptor_signal_transduction", 0.4024], ["physiological_cell_death_pathway", 0.4024], ["IL-2_receptor_alpha_chain_(IL-2R_alpha)_gene", 0.4023], ["CD30-mediated_effect", 0.4023], ["extracellular_signal-regulated_kinase_(ERK)_1_activation", 0.4023], ["IL-2R_enhancer", 0.4023], ["redox-regulatory_mechanism", 0.4022], ["monocyte-macrophage_colony_stimulating_factor_(M-CSF)_receptor", 0.4022], ["tumor_necrosis_factor_(TNF)-receptor_superfamily", 0.4021], ["JAK-STAT_signaling_pathway", 0.4021], ["anti-CD3-stimulated_cell", 0.4021], ["primary_CD8+_T-PLL_cell", 0.402], ["tumor_necrosis_factor_alpha_(TNF-alpha)_mRNA_production", 0.402], ["MAP_kinase_(MAPK)_pathways", 0.402], ["interleukin_(IL)_6-induced_B_cell_differentiation", 0.402], ["IL-2Rbeta_promoter_activity", 0.402], ["PMA/anti-CD28_mAb", 0.402], ["PAF-stimulated_kappa_B_binding_activity", 0.402], ["TNF-alpha_promoter-driven_reporter_gene_activity", 0.4019], ["transcription_factor_nuclear_factor_kappa_B", 0.4019], ["I_kappa_B_alpha_subunit_expression", 0.4019], ["interleukin-2_sequence_specific_oligonucleotide_probe", 0.4018], ["NF-kappaB/Rel_family_protein", 0.4018], ["T_cell_signaling", 0.4018], ["cAMP-dependent_protein_kinase_A_(PKA)_signal_transduction_pathway", 0.4017], ["cytokine_gene_expression", 0.4017], ["interleukin", 0.4016], ["interleukin_2_receptor_alpha-chain_gene", 0.4016], ["ligand-induced_tyrosine_phosphorylation", 0.4015], ["phorbol_ester/ionomycin-induced_NF-AT_activation", 0.4015], ["I_kappa_B-alpha_proteolysis", 0.4014], ["interleukin_1-beta", 0.4014], ["T_cell_activation_factor", 0.4014], ["LPS-mediated_endothelial_activation", 0.4014], ["immunological_activation", 0.4013], ["human_IL-2_activated_NK_cell", 0.4013], ["interleukin-1_gene_transcription", 0.4012], ["IL1-induced_activity", 0.4012], ["mature_CD4(+)_CD8(-)_CD3(+)_thymocyte", 0.4011], ["CD40-_TRAF2_interaction", 0.4011], ["IL-4_gene_expression", 0.4011], ["IL-2-dependent_cell_line", 0.4009], ["interleukin-1beta_gene_transcription", 0.4009], ["interleukin_(IL)-8", 0.4009], ["conserved_signaling_pathway", 0.4008], ["lymphoid_enhancer_factor_and_T-cell_factor", 0.4008], ["NF-kappa_B_DNA_binding_protein", 0.4008], ["Interleukin-2_(IL-2)_gene", 0.4007], ["interleukin-2_(IL-2)_gene", 0.4007], ["NF-kappa_B_protein_complex", 0.4007], ["ligand-inducible_phosphorylation", 0.4007], ["IL-2_promoter_repression", 0.4005], ["CD34+CD71+_cell", 0.4005], ["IL-12p40_mRNA_expression", 0.4005], ["interleukin-1_(IL-1)_stimulation", 0.4004], ["monocyte/macrophage_activation", 0.4004], ["T-cell-specific_enhancer", 0.4004], ["protein_kinase_C_activator", 0.4003], ["CD28_surface_expression", 0.4002], ["monocyte-derived_cytokine", 0.4002], ["T-cell_receptor_(TCR)_variable_region_beta-chain_families", 0.4001], ["stromal-derived_cytokine_interleukin-7", 0.4001], ["NFAT_(nuclear_factor_of_activated_T_cells)_transcription_factor_family", 0.4001], ["CD4-mediated_enhancement", 0.4], ["IL-5_gene-nonexpressing_T-cell_line", 0.4], ["interleukin-4-induced_CD23b_mRNA", 0.3999], ["NF-kappa_B_protein", 0.3999], ["interleukin-1_beta_converting_enzyme_(ICE)_gene", 0.3998], ["IL-1RI-associated_kinase", 0.3997], ["cytokine_expression", 0.3997], ["JAK2_signaling_pathway", 0.3996], ["T_cell_receptor/CD3_complex", 0.3996], ["I_kappa_B_alpha_gene_expression", 0.3995], ["ligand_activation", 0.3995], ["TNF-alpha-stimulated_cell", 0.3995], ["chemokine_pathway", 0.3993], ["IL-10's_cytokine_synthesis_inhibitory_activity", 0.3992], ["cytokinestimulated", 0.3991], ["IL-2R_beta_gene", 0.399], ["T_cell_receptor-CD3_complex", 0.399], ["IL-2_gene_promoter", 0.399], ["NF-kappa_B/Rel_protein_family", 0.3989], ["T_cell-derived_cytokine", 0.3988], ["NF-kappaB_protein_activity", 0.3988], ["T-cell_receptor-CD3_complex", 0.3988], ["signal-mediating_kinase", 0.3986], ["monocytic_cell_type-specific_transcriptional_induction", 0.3985], ["monocyte_regulatory_cytokine", 0.3985], ["IL-2-independent_T-cell_transformation", 0.3985], ["T_helper_cell_cytokine_gene", 0.3984], ["interleukin-6_protein", 0.3984], ["serum-equilibrated_PtdIns_also_binds_to_mCD14-expressing_cell", 0.3982], ["nuclear_factor_kappa_B_(NF-kappa_B)_activity", 0.3982], ["inducible_activation_of_transcription", 0.3982], ["CD40L+_reactive_T_cell", 0.3982], ["putative_additional_lymphoid-specific_transcription_factor", 0.3982], ["nuclear_factor_kappa_B_transcription_factor_family", 0.3982], ["kinase_activity", 0.3982], ["T_cell_antigen_receptor_(TCR)_signaling", 0.3982], ["protein_kinase_C_activity", 0.3981], ["FK506-sensitive_pathway", 0.3981], ["NF-IL6_mRNA_level", 0.3981], ["IL-1RI-associated_protein_kinase", 0.3981], ["NK_cell_mediated_cytolysis", 0.398], ["mitogen-activated_protein_kinase_(MAPk)_homologue", 0.398], ["interleukin_12", 0.3979], ["human_interleukin-4_promoter_activity", 0.3979], ["CD3-stimulated_T_lymphocyte", 0.3979], ["intracellular_signalling_event", 0.3978], ["apoptosis_signaling_pathway", 0.3978], ["T_cell-dependent_B_cell_immunopoiesis", 0.3977], ["IL-2R_beta-chain", 0.3977], ["oligo_sequence_I_stimulated_proliferation", 0.3976], ["Recombinant_human_tumor_necrosis_factor_(TNF)_binding_protein-1", 0.3976], ["cytokines", 0.3976], ["interleukin-2_[IL-2]-dependent_HT-2_line", 0.3976], ["tumor_necrosis_factor_alpha_(TNF-alpha)_release", 0.3976], ["immune_costimulatory_molecule", 0.3976], ["alpha_CD3/IL-2", 0.3975], ["NF-kappa_B/Sp1_enhancer", 0.3975], ["interleukin-1beta_transcription", 0.3975], ["Jurkat_cells_(p56(lck)_activation", 0.3975], ["IL-4_down-regulated_mRNA_accumulation", 0.3974], ["IkB_alpha_phosphorylation", 0.3974], ["IkappaB_alpha_kinase", 0.3974], ["T_cell_receptor(TcR)_delta_transcript", 0.3974], ["CD40L_fusion_protein", 0.3974], ["CD2:lymphocyte_function-associated_Ag-3_pathway", 0.3972], ["IL-2R_alpha_transcript", 0.3972], ["immune_activation", 0.3972], ["interleukin_(IL)_4", 0.397], ["interleukin_3_mRNA", 0.397], ["T-cell_receptor/CD3_complex", 0.3969], ["gliadin_peptide-HLA_class_II_molecule-T_cell_interaction", 0.3969], ["IL-2Ralpha_promoter", 0.3968], ["high_affinity_IL-2_receptors", 0.3968], ["nuclear_transcription_factor_kappa_B", 0.3967], ["human_T_cell_IL-5_synthesis", 0.3967], ["IL-1-induced_gene_transcription", 0.3966], ["cytokine_receptor_superfamily", 0.3966], ["interleukin-1alpha_promoter", 0.3966], ["signal-regulated_protein_kinase_(ERK)_activation", 0.3966], ["CD3/T_cell_receptor", 0.3965], ["anti-CD3-induced_shift", 0.3963], ["CD40-inducible_molecule", 0.3963], ["NF-kappa_B/Rel_binding_motif", 0.3963], ["intermediate_CD4(+)_CD8(-)_CD3(-)_thymocyte", 0.3963], ["phorbol_ester-responsive_protein_kinase_C", 0.3961], ["CD2_antigen-derived_signal", 0.396], ["lipopolysaccharide-stimulated_interleukin-1_beta_messenger_RNA_level", 0.396], ["interleukin_(IL)-6", 0.3959], ["T-cell_receptor_(TCR)-triggered_apoptosis", 0.3959], ["IL-5_gene_expression", 0.3959], ["T-cell_receptor_activation", 0.3959], ["Il-2_receptor", 0.3958], ["IL-2_receptor", 0.3958], ["interleukin-1_beta", 0.3957], ["IL-2-induced_heterodimerization", 0.3957], ["protein_tyrosine_kinase(s)", 0.3956], ["CCK(B)_receptor_antagonist", 0.3956], ["CD34(+)_bone_marrow_cell", 0.3956], ["inducible_transcriptional_activation", 0.3956], ["CaM_kinases", 0.3956], ["CD40-stimulated_human_B_lymphocyte", 0.3955], ["interleukin-2_gene", 0.3954], ["IL-12-dependent_up-regulation", 0.3954], ["NF-kappa_B-regulated_promoter", 0.3954], ["T-cell_receptor_(TCR)_beta-chain_promoter", 0.3954], ["cell_signaling", 0.3953], ["CD27-_B_cell", 0.3953], ["proinflammatory_cytokine_cascade", 0.3953], ["nuclear_factor_kappa_B_(NF-kappa_B;_heterodimer_of_p50_and_p65)_protein", 0.3952], ["IL-1_receptor-associated_kinase", 0.3952], ["NF-IL6_protein", 0.3952], ["IL-2_regulatory_region", 0.3951], ["immunologic_(type_II)_nitric_oxide_synthase_expression", 0.395], ["cytokine_gene_induction", 0.3949], ["Lck-mediated_activation", 0.3949], ["nuclear_transcription_factor-kappa_B_p65_(Rel_A)_subunit", 0.3949], ["interleukin-2_receptor_alpha-chain_gene", 0.3949], ["LPS-induced_TNF_mRNA_accumulation", 0.3948], ["tyrosine_kinase-dependent_pathway", 0.3948], ["intracellular_signalling_network", 0.3947], ["interleukin-4_receptor_alpha_chain", 0.3947], ["nuclear_factor_of_activated_T_cells_(NFAT)_family_protein", 0.3946], ["signal-regulated_protein_kinase", 0.3945], ["novel_B_cell-specific_coactivator", 0.3945], ["immunoglobulin_heavy-chain_(IgH)_enhancer", 0.3945], ["IL-2_gene_promoter_region", 0.3944], ["nuclear_factor_of_activated_T_cells-family_protein", 0.3944], ["T-cell_signaling", 0.3944], ["intracellular_protein_expression", 0.3943], ["interleukin-2_NFAT-driven_reporter_gene", 0.3943], ["PKC-mediated_cellular_response", 0.3943], ["nuclear_factor-kappa_B_(NF-kappa_B)/Rel_protein", 0.3942], ["anti-CD28_MoAb", 0.3942], ["signaling_pathway", 0.3941], ["activation-induced_phosphorylation", 0.3941], ["NF-kappaB-like_transcription_factor", 0.3941], ["interleukin_6-induced_differentiation", 0.394], ["TNF_alpha_induced_activation", 0.394], ["CD28_signal", 0.3939], ["IL-6_gene_transcription", 0.3939], ["IL-10-induced_Stat3_phosphorylation", 0.3939], ["IL-2R_alpha_promoter", 0.3938], ["interferon_regulatory_factor_family_transcription_factor", 0.3938], ["LPS-induced_nuclear_factor-kappaB", 0.3936], ["caspase-3_activation", 0.3936], ["CD4-CD8-_murine_T_lymphocyte_precursor", 0.3936], ["NF-kappa_B/Rel_protein", 0.3936], ["interleukin_(IL)-12", 0.3936], ["minimally_oxidized_LDL_(MM-LDL)_activated_endothelial_cell", 0.3936], ["IL-6-induced_B-cell_differentiation", 0.3935], ["monocyte_activation", 0.3935], ["Jak_kinase_pathway", 0.3935], ["nuclear_factor_of_activated_T_cells_activity", 0.3935], ["interleukin-1-beta", 0.3935], ["NF-kappaB_DNA_binding_activity", 0.3935], ["interleukin-2_dependence", 0.3934], ["activation_pathway", 0.3933], ["IL-1-induced_production", 0.3933], ["IkappaB_kinase_alpha", 0.3932], ["nuclear_factor_of_activated_T_cells_protein", 0.3932], ["NF-kappa_B_binding_motif", 0.3932], ["interleukin-1_beta_mRNA", 0.3932], ["mitogen-activated_protein_kinase_kinase_(MEK)_inhibitor", 0.3931], ["50_kDa_NF-kappa_B_protein", 0.3931], ["NF-kappa_B_enhancer", 0.3931], ["cytoplasmic_NF-kappa_B/Rel_complex", 0.3931], ["IL-2_synthesis", 0.393], ["transcription_factor_nuclear_factor-kappaB", 0.3929], ["interleukin_3_mRNA_levels", 0.3929], ["IL-4-inducible_gene_expression", 0.3929], ["IL-1_receptor-associated_protein_kinase", 0.3929], ["IL-7R_signal_transduction", 0.3928], ["kappa_B_motif-specific_DNA-binding_activity", 0.3928], ["interleukin-3_(IL-3)-dependent_murine_pro-B_cells", 0.3927], ["interleukin-8_gene", 0.3927], ["Rel/NF-kappa_B_protein", 0.3925], ["NF-kappaB_family_protein", 0.3925], ["IL-2_receptor_alpha", 0.3925], ["NF-kappa_B-inducible_early_gene", 0.3923], ["cytokine_signaling_abnormality", 0.3923], ["TNF-_and_LPS-stimulated_increase", 0.3922], ["IL-3-dependent_murine_pro-B_cell", 0.3921], ["CD8+_T_cell_prolymphocytic_leukemia_(T-PLL)_cells", 0.3921], ["interleukin-2_receptor-alpha_(IL-2R_alpha)_gene", 0.3921], ["IkappaB-alpha_phosphorylation", 0.392], ["Tpl-2_kinase", 0.392], ["intracytoplasmic_signalling_cascade", 0.3919], ["IL-4-induced_gene_transcription", 0.3918], ["NF-kappa_B_protein_level", 0.3916], ["protein-tyrosine_kinase", 0.3916], ["Jak-_STAT_pathway", 0.3915], ["CD40-inducible_gene", 0.3915], ["IL-2-inducible_DNA_binding_activity", 0.3915], ["interleukin-12", 0.3914], ["Interleukin-12", 0.3914], ["CCK(B)_receptor", 0.3914], ["inhibitory_molecule_I_kappa_B_alpha", 0.3913], ["nuclear_factor_of_activated_T_cells_(NFAT)_binding_site", 0.3913], ["intercellular_adhesion_molecule-1_gene_expression", 0.3913], ["intracellular_signaling_protein", 0.3913], ["interleukin-8", 0.3912], ["protein_tyrosine_kinase_activity", 0.3912], ["CD28_minimal_promoter", 0.3912], ["interleukin-1beta_mRNA_transcription", 0.3912], ["anti-CD3_activated_T_cell", 0.3912], ["NF-kappaB-driven_reporter_activation", 0.3912], ["I_kappa_B_beta_protein", 0.3911], ["cytokine-induced_T_cell_response", 0.3911], ["NF-kappa_B/Rel/NFAT_transcription_factor", 0.3909], ["IL-2-gene_transcription_rate", 0.3909], ["N-terminal_acidic_transcriptional_activation", 0.3909], ["okadaic_acid-induced_IL-6_gene_expression", 0.3909], ["nuclear_transcription_factor_kappa_beta", 0.3908], ["macrophage_activation", 0.3908], ["IL-5_producing_cell", 0.3908], ["interleukin-6_(IL-6)", 0.3906], ["constitutively_activated_tumor_necrosis_factor_receptor", 0.3906], ["NF-kappaB-regulated_promoter", 0.3906], ["Th2-specific_cytokine", 0.3905], ["IL-1_receptor_antagonist_(IL1-RA)_gene_expression", 0.3905], ["IL-4_receptor_engagement", 0.3905], ["protein_kinase_C_phosphorylation_site", 0.3903], ["T-cell-expressed_cytokine_gene", 0.3903], ["interleukin-2_(IL-2)_deprivation", 0.3903], ["cellular_gene_activation", 0.3902], ["IL-12R_beta_2_subunit", 0.3902], ["T-cell_receptor_C_alpha_gene_enhancer", 0.3902], ["NK_cell-target_cell_interaction", 0.3902], ["interleukin_2_receptor_alpha_subunit", 0.3902], ["interleukin-2-gene", 0.3902], ["hematopoietically_expressed_adaptor_protein", 0.3902], ["inflammatory_activator", 0.39], ["normal_CD56+,_CD16-_NK_precursor_cell", 0.39], ["T-cell_enhancer", 0.3899], ["IL-2_promoter-beta-galactosidase_reporter_gene_construct", 0.3899], ["protein_kinase_A-related_cAMP_response_element", 0.3898], ["tumor_necrosis_factor_alpha_(TNF-alpha)-responsive_NF-kappaB/C-EBP_composite_element", 0.3898], ["human_interleukin-1_beta_promoter", 0.3898], ["IL-2-mRNA_accumulation", 0.3897], ["purine-box/antigen_receptor_response_element_(ARRE)/nuclear_factor_of_activated_T-cells_(NF-AT)_target_sequence", 0.3897], ["critical_signaling_pathway", 0.3897], ["NF-kappa_B_mRNA", 0.3896], ["IL-7_receptor_alpha_chain", 0.3896], ["cAMP-_and_protein_kinase_C_(PKC)-dependent_pathway", 0.3896], ["c-fos_and_c-jun_protein_expression", 0.3895], ["IL-6_protein_secretion", 0.3895], ["IL-6-mediated_autocrine_tumor_cell_growth", 0.3895], ["cytokine-inducible_SH2-containing_protein", 0.3895], ["tyrosine_kinase_oncogene", 0.3894], ["interleukin-3_(IL-3)-induced_commitment", 0.3893], ["T_lymphocyte_associated_transcription_factor", 0.3893], ["interleukin-1_(IL-1)-responsive_cell", 0.3893], ["NF-kappaB-like_nuclear_transcription_factor", 0.3891], ["granulocyte-macrophage_colony-stimulating_factor_gene_expression", 0.389], ["mature_CD4(+)_CD8(-)_CD3(+)_subset_of_thymocyte", 0.389], ["transcription_(STAT)_pathway", 0.389], ["IL-2-independent_cell_line", 0.3889], ["NF-kappa_B_mRNA_level", 0.3889], ["IL-4-binding_IL-4Ralpha_chain", 0.3888], ["interleukin_8", 0.3888], ["IL-2-treated_cell", 0.3888], ["I_kappa_B-mediated_inhibition", 0.3887], ["non-IL-2-producing_cell", 0.3887], ["B_cell-specific_transcriptional_coactivator", 0.3887], ["reactive_oxygen_intermediate_formation", 0.3887], ["LPS-stimulated_TF_mRNA_accumulation", 0.3887], ["Rel-related_NF-kappa_B2_gene", 0.3886], ["Bcl6+/CD3+/CD20-/CD57-_T_cell", 0.3884], ["IL-4-specific_gene_expression", 0.3884], ["IL-6_mRNA_expression", 0.3884], ["tumor_necrosis_factor_gene_expression", 0.3884], ["Jak-STAT_1_signaling_pathway", 0.3884], ["LPS-induced_IL-6_mRNA", 0.3883], ["cell_activation", 0.3883], ["granulocyte-colony-stimulating_factor_(G-CSF)_signal_transduction_pathway", 0.3881], ["interleukin_1_receptor_(IL-1R)_superfamily", 0.3881], ["B-cell_activation", 0.3881], ["IL-4-mediated_response", 0.388], ["oxidative_stress-dependent_activation", 0.3879], ["T_cell-specific_tyrosine_kinase", 0.3879], ["intracellular_signaling", 0.3878], ["interleukin-6_gene", 0.3876], ["N-terminal_phosphorylation", 0.3875], ["NF-kappaB_DNA-binding_activity", 0.3875], ["IL-2_receptor_alpha_chain_gene", 0.3875], ["pro-inflammatory_function", 0.3875], ["kappa_B-directed_transcription", 0.3874], ["human_interleukin-2_(IL-2)_receptor_alpha_chain_gene", 0.3873], ["LPS-induced_monocyte_IL-1ra_secretion", 0.3873], ["nuclear_factor_of_mitogenic-activated_T_cells", 0.3873], ["hematopoietic_cell-specific_transcription_factor", 0.3873], ["CD2_T_lymphocyte_glycoprotein_surface_molecule", 0.3872], ["NF-kappaB-controlled_beta-globin_reporter_gene", 0.3872], ["IL-2R_beta_chain", 0.3871], ["IL-6-induced_cell", 0.3871], ["IL2_mRNA", 0.3871], ["chemokine_gene_expression", 0.3871], ["cytokine_receptor_dimerization", 0.387], ["IL-2R_alpha-chain", 0.387], ["cellular_protein_tyrosine_kinase", 0.3869], ["NF-kappa_B-dependent_gene", 0.3869], ["stress_kinase", 0.3869], ["LMP1(1-231)-mediated_NF-kappaB_activation", 0.3869], ["interferon-alpha_/beta-induced_tyrosine_phosphorylation", 0.3868], ["cell_mediated_immune_response", 0.3868], ["NF-kappaB-mediated_induction", 0.3868], ["CD36-Ox_LDL_interaction", 0.3868], ["interleukin_6_gene", 0.3868], ["human_interleukin-3_promoter", 0.3867], ["T_cell-mediated_immune_response", 0.3867], ["cytosolic_signal_transducers_and_activators_of_transcription_(STAT)_protein", 0.3867], ["interleukin-2_(IL-2)R_alpha", 0.3867], ["IL-2_independent_cell_line", 0.3867], ["interleukin-2_receptor-alpha", 0.3867], ["interleukin-1beta-converting_enzyme_family_protease_inhibitor", 0.3866], ["reactive_CD3+/CD4+_T_cell", 0.3866], ["proinflammatory_cytokine_pathway", 0.3865], ["IL-1_beta-stimulated_HUVEC", 0.3865], ["AIM/CD69_cell-surface_expression", 0.3864], ["NFkappaB-mediated_gene_expression", 0.3864], ["IL-1_beta-induced_mRNA", 0.3864], ["IkappaB_kinase_complex", 0.3864], ["CD36-producing_CHO_cell", 0.3864], ["IL-3/IL-5/GM-CSF_receptor_beta-subunit", 0.3863], ["murine_kappa_light_chain_enhancer_motif", 0.3863], ["inflammatory_reaction", 0.3863], ["murine_B-cell_specific_transcriptional_coactivator", 0.3862], ["CD40_antigen_expression", 0.3862], ["NF-IL6_mRNA", 0.3862], ["NDP_kinase", 0.3862], ["B_cell_activation", 0.3862], ["interleukin_6_(IL-6)_receptor", 0.3861], ["PAF_activated_MAP_kinase_kinase-3", 0.386], ["N-terminal_c-Jun_kinase", 0.386], ["phosphorylated_I_kappa_B_alpha", 0.386], ["tumour_necrosis_factor_(TNF)_transcript", 0.386], ["immunoglobulin_kappa_(GGAAAGTCCC)_enhancers", 0.386], ["B_cell-specific_activation", 0.3859], ["platelet-endothelial_cell_adhesion_molecule-1_(PECAM-1)_phosphorylation", 0.3859], ["NF-kappa_B-dependent-gene", 0.3859], ["monocytic_nuclear_factor-kappa_B", 0.3859], ["lymphotoxin_(LT;_TNF-beta)_gene_induction", 0.3859], ["CaM_kinase", 0.3859], ["NK_cell-mediated_EC_activation", 0.3859], ["interleukin-7", 0.3858], ["FK506.FKBP12_drug-immunophilin_complex", 0.3857], ["NF-kappa_B_p65_DNA_binding", 0.3857], ["IL-2_receptor_alpha_(IL-2R_alpha)_gene", 0.3857], ["human_endothelial_cell_activation", 0.3857], ["B_cell-specific_tyrosine_kinase_gene_blk", 0.3857], ["human_T-cell_FK506-binding_protein", 0.3857], ["tyrosine-protein_kinase", 0.3857], ["serine_kinase_target", 0.3856], ["interleukin_(IL)-1beta", 0.3855], ["protein_kinase_C-dependent_signal", 0.3855], ["oxidant_stress-induced_signaling", 0.3854], ["tumor_necrosis_factor-alpha_(TNF-alpha)_messenger_RNA_levels", 0.3854], ["Interleukin-6", 0.3854], ["interleukin-6", 0.3854], ["Jak2_tyrosine_kinase", 0.3854], ["JAK2_tyrosine_kinase", 0.3854], ["T-helper_cell_activation", 0.3854], ["NF-kappa_B_signal_transduction", 0.3853], ["IL-1_gene_expression", 0.3852], ["IL-1R-associated_kinase_(IRAK)", 0.3851], ["IL-6-induced_macrophage-differentiation", 0.3851], ["interleukin_1", 0.3851], ["IL-12_receptor_(IL-12R)_beta_2_subunit", 0.385], ["OKT8+_suppressor/cytotoxic_T_cell", 0.385], ["myeloid-_and_B-cell_specific_transcription_factor", 0.3849], ["ex_vivo_activation", 0.3849], ["monocytic_I_kappa_B_alpha/MAD-3_mRNA_level", 0.3849], ["CD14-mediated_translocation", 0.3848], ["hGATA-3_T_cell_transcription_factor", 0.3848], ["heme_biosynthetic_pathway", 0.3848], ["T-cell-specific_transcriptional_regulator", 0.3847], ["IFNgamma-driven_enhanceosome_formation", 0.3847], ["CD3_antigen-derived_signal", 0.3846], ["IL-2R_stimulation", 0.3846], ["IL-4-triggered_transcriptional_control", 0.3845], ["NF_kappa_B_protein", 0.3845], ["phospholipase_C/protein_kinase_C_pathway", 0.3845], ["T_cell_antigen_receptor-induced_activation", 0.3844], ["JAK-STAT_pathway", 0.3844], ["Jak-STAT_pathway", 0.3844], ["Jak-Stat_pathway", 0.3844], ["cytokine-induced_reduction", 0.3844], ["CCAAT_enhancer_binding_protein_alpha_(C/EBPalpha)-deficient_mouse", 0.3843], ["in_vivo_activation", 0.3843], ["STAT_signaling_pathway", 0.3843], ["IL-2+_cell", 0.3842], ["IL-6_promoter_activity", 0.3842], ["38-kD_murine_MAP_kinase", 0.3841], ["anti-tumor_necrosis_factor_alpha_(TNF-alpha)_monoclonal_antibody", 0.384], ["IL-12-inducible_gene", 0.3839], ["NF-kappa_B_functional_activity", 0.3839], ["IL-9-induced_cell_growth", 0.3838], ["interleukin_6", 0.3836], ["endotoxin-stimulated_inflammatory_c_ytokine_mRNA_level", 0.3836], ["regulatory_pathway", 0.3836], ["CD34_mRNA_transcript", 0.3835], ["transcription_factor_activation", 0.3833], ["TCR-induced_protein_tyrosine_phosphorylation", 0.3833], ["p42/p44_mitogen-activated_protein_kinase", 0.3833], ["T_lymphocyte_activation", 0.3833], ["IL-2R(alpha)_chain_mRNA", 0.3833], ["interleukin_(IL)-4", 0.3833], ["ligand-dependent_recruitment", 0.3832], ["phorbol_ester-sensitive_protein_kinase_C", 0.3832], ["active_TFIIIB_molecule", 0.3832], ["T_cell_antigen_receptor/CD3_complex", 0.3831], ["FcR-mediated_nuclear_factor_activation", 0.3831], ["anti-inflammatory_effect", 0.383], ["TCR_signaling_pathway", 0.383], ["T_cell_differentiation_and_activation", 0.3829], ["IL-4_promoter_activity", 0.3828], ["cytokine_generation", 0.3828], ["mammalian_IL2_promoter", 0.3828], ["IL-2-deprived_cell", 0.3827], ["neonatal_T_cell_IL-2_production", 0.3827], ["immunoprecipitated_kinase", 0.3826], ["IL-4-induced_CD23_mRNA", 0.3826], ["tyrosine_kinase_csk", 0.3826], ["Th2-type_cytokine", 0.3826], ["TH2_cytokine_pattern", 0.3826], ["macrophage_colony-stimulating_factor_protein", 0.3825], ["JAK2/STAT5_pathway", 0.3824], ["signaling_molecules", 0.3824], ["IL-2-induced_beta-casein_expression", 0.3824], ["T_cell-specific_transcription_factor", 0.3824], ["ex_vivo_proliferative_response", 0.3824], ["interleukin-1_receptor_type_I", 0.3823], ["IL-18-induced_activation", 0.3823], ["murine_and_human_Interleukin_2_(Il-2)_gene", 0.3823], ["Cbl-b-mediated_activation", 0.3823], ["apoptosis-inducing_ligand", 0.3823], ["in_vitro_activation", 0.3823], ["T_cell_receptor_(TCR)_signaling", 0.3823], ["inflammatory_gene_product", 0.3822], ["human_IL-2_receptor_alpha_chain_promoter", 0.3821], ["CD14_receptor_system", 0.3821], ["T_cell_transmembrane_signaling", 0.3821], ["interferon_signal_transduction_pathway", 0.382], ["nuclear_CaM_kinase_II", 0.382], ["IL-1R_gene_expression", 0.382], ["IL-2R(alpha)_chain", 0.382], ["CD4_signaling", 0.382], ["PtdIns_3-kinase_activity", 0.382], ["tumor_necrosis_factor_receptor_superfamily", 0.3819], ["anti_inflammatory_activity", 0.3819], ["protein_tyrosine_kinase", 0.3819], ["(IL-2Rbeta)/IL-4Ralpha_cytokine_receptor_chimera", 0.3818], ["lipopolysaccharide-induced_interleukin-1_beta_protein_production", 0.3818], ["c-sis/platelet-derived_growth_factor-B_promoter", 0.3818], ["T_cell_receptor_signaling", 0.3818], ["Th2_cytokine_profile", 0.3817], ["T_cell_activation-induced_FasL_expression", 0.3817], ["natural_ligand_CD80", 0.3817], ["CD4(+)_CD8(-)_CD3(+)_thymocyte", 0.3817], ["IL-12R_beta_2_chain", 0.3817], ["anti-CD28", 0.3816], ["inflammatory_signal", 0.3816], ["NF-kappa_B_target_gene", 0.3816], ["55_kD_TNF_receptor_(TR55)_level", 0.3815], ["NF-kappaB_protein", 0.3815], ["macrophage_colony-stimulating_factor_receptor", 0.3814], ["stimulated_by_tumor_necrosis_factor-alpha", 0.3814], ["cytoplasmic_NF-kappaB", 0.3813], ["cellular_kinase", 0.3813], ["PKC-mediated_signaling_event", 0.3813], ["ets_transcription_factor/oncoprotein_family", 0.3813], ["CD14_positive_monocytic_cell_line", 0.3813], ["interleukin-6-induced_apoptosis", 0.3812], ["CD20(B1)_gene", 0.3812], ["interleukin-1_induction", 0.3812], ["cytokine_stimulation", 0.3812], ["IL-13-induced_expression", 0.381], ["interleukin_(IL)-5", 0.381], ["IL-12_receptor", 0.3809], ["interleukin-10_(IL-10)_production", 0.3809], ["murine_macrophage_inflammatory_protein_1_alpha", 0.3808], ["NF-kappa_B-regulated_promoters", 0.3808], ["TNF-mediated_apoptosis", 0.3808], ["cytokine-stimulated_human_saphenous_vein_endothelial_cell", 0.3807], ["CD40-mediated_differentiation", 0.3807], ["tumor_necrosis_factor_receptor-associated_factor_3_binding_site", 0.3806], ["B_cell-specific_regulation", 0.3806], ["TCR-directed_T-cell_activation", 0.3806], ["IL-1_beta_protein", 0.3805], ["Th2_cytokine_gene", 0.3805], ["nuclear_factor_NF-kappa_B_(positions_-72_to_-63)_motif", 0.3805], ["anti-CD3_mAb_stimulation", 0.3804], ["NF-kappa_B_inducer", 0.3803], ["cell_regulation", 0.3803], ["Jun_kinase_activation", 0.3803], ["T_lymphocyte_gene_regulation", 0.3803], ["cytokine-stimulated_human_umbilical_vein_endothelial_cells", 0.3802], ["IL-2R_beta_chain_expression", 0.3801], ["endogenous_kinase", 0.3801], ["B-lymphocyte_cell_cycle_activation", 0.3801], ["Ras/protein_kinase_C_pathway", 0.38], ["STAT3_tyrosine_phosphorylation", 0.38], ["NF-kappaB/Rel_protein", 0.3799], ["NF-IL6_enhancer", 0.3799], ["C5a-induced_IL-8_production", 0.3799], ["IL-6_gene_promoter", 0.3799], ["p50_NF-kappa_B_protein", 0.3798], ["c-sis/platelet-derived_growth_factor-B_(PDGF-B)_proto-oncogene", 0.3798], ["IL-2Ralpha_expression", 0.3797], ["TNF-alpha-inducible_promoter_activity", 0.3797], ["IL-8_transcription", 0.3797], ["NF-kappaB-dependent_mechanism", 0.3797], ["Th2_type_cytokine", 0.3797], ["restricted_protein_kinase_C_(PKC)_isoform", 0.3797], ["c-fos_promoter_sis-inducible_element_IFN-gamma-activated_sequence-binding_complex", 0.3796], ["murine_immunoglobulin_heavy-chain_(IgH)_enhancer", 0.3795], ["interleukin_4", 0.3794], ["protein_kinase_C_substrate", 0.3793], ["IL-1_receptor_antagonist_secretion", 0.3793], ["Fos_kinase", 0.3793], ["mitogenic_signalling_response", 0.3793], ["nuclear_factor-IL6_(NF-IL6)_binding_site", 0.3793], ["IL-6_transcription", 0.3792], ["activated_endothelial_cell", 0.3792], ["cell_cycle_signaling", 0.3792], ["NF-kappa_B_DNA_binding_activit", 0.3792], ["IL-4_gene_transcription", 0.3792], ["CD40-mediated_event", 0.3791], ["nuclear_factor_of_activated_T_cells_(NF-AT)_factor", 0.3791], ["kinases", 0.3791], ["TCC-inducible_mitotic_signaling", 0.3791], ["intracellular_killing", 0.3791], ["immune_response_regulation", 0.379], ["cell-cycle_gene_activation", 0.379], ["immunoglobulin_heavy_chain_enhancer", 0.379], ["IL-4_receptor_alpha-chain", 0.3789], ["IL-4_transcription", 0.3789], ["T_cell_transcription_factor", 0.3789], ["IL-1_beta_mRNA_level", 0.3789], ["IL-6-induced_signal", 0.3789], ["NF-kappa_B1_(p50)_subunit", 0.3788], ["B_cell-specific_transcriptional_coactivator_protein", 0.3788], ["IL-2R_alpha_gene", 0.3788], ["pro-inflammatory_mediator", 0.3788], ["IL-4_luciferase_reporter_gene", 0.3787], ["nuclear_factor_of_activated_T_cells_(NFAT)-dependent_gene", 0.3787], ["NF-kappa_B-independent_mechanism", 0.3787], ["cytokine-encoding_gene", 0.3787], ["IL-4_target_gene", 0.3786], ["Jak_tyrosine_kinase", 0.3786], ["NF-kappaB_protects_EBV-infected_cell", 0.3786], ["T-cell_antigen_receptor_engagement", 0.3784], ["BSAP-stimulated_CD19_gene_transcription", 0.3784], ["tetracycline-regulated_promoter", 0.3783], ["inflammatory_process", 0.3783], ["cellular_transactivation_factor", 0.3783], ["TCR-stimulated_apoptosis", 0.3783], ["LPS-mediated_activation", 0.3782], ["homodimerizing_cytokine_receptor", 0.3782], ["T_lymphocyte-specific_transcription_factor", 0.3781], ["CD8(+)-T-cell_epitope", 0.3781], ["CD14+_monocyte", 0.3781], ["mitogen-inducible_transcription_factor", 0.378], ["PKC/Ras-mediated_pathway", 0.378], ["NF-kappa_B-independent_HIV_promoter", 0.378], ["cytokine-activated_Janus_kinase-STAT_signaling_pathway", 0.378], ["inhibition_of_T_cell_activation", 0.378], ["endothelial_activation", 0.3779], ["C/EBPalpha_mRNA_expression", 0.3779], ["immune_response_in_vivo", 0.3779], ["cellular_transcriptional_nuclear_factor-KB", 0.3779], ["human_prointerleukin_1_beta", 0.3778], ["interleukin_(IL)-1alpha", 0.3778], ["CD3/TcR-dependent_signal_transduction", 0.3778], ["inhibitory_I_kappa_B_protein", 0.3778], ["TFIID-dependent_RNA_polymerase_II_transcription_system", 0.3777], ["IkappaB_phosphorylation/proteolysis", 0.3777], ["interleukin-4", 0.3777], ["TPA-mediated_activation", 0.3777], ["mitogenic_T_cell_activation_signal", 0.3777], ["NK_cell-mediated_cytolysis", 0.3777], ["protein_tyrosine_kinase_(PTK)-specific_inhibitor", 0.3777], ["NF_kappaB_family_protein", 0.3776], ["IL-9-induced_activation", 0.3776], ["T-cell_antigen_receptor-CD3_complex", 0.3776], ["calcineurin-nuclear_factors_of_activated_T_cell-dependent_pathway", 0.3776], ["IL-6_receptor", 0.3775], ["inefficient_NF-kappaB_activation", 0.3775], ["IL-12p40_mRNA", 0.3775], ["immunosuppressive_cytokine", 0.3774], ["IL-1alpha_gene_transcription", 0.3774], ["distal_IL-2_enhancer", 0.3774], ["IL-1_beta_convertase_mRNA_accumulation", 0.3773], ["COX-2_protein_expression", 0.3773], ["lymphoid_enhancer-binding_factor_1", 0.3773], ["IL-1_receptor_(IL-1R)-initiated_signal", 0.3772], ["lipopolysaccharide-induced_monocyte_interleukin-1_receptor_antagonist_synthesis", 0.3772], ["tyrosine_kinase", 0.3771], ["N-terminal_acidic_transcriptional_activation_domain", 0.3771], ["T-cell_developmental_pathway", 0.377], ["chronic_inflammatory_reaction", 0.377], ["IL-2_mRNA_response", 0.3769], ["cytokine_production", 0.3769], ["B_cell_growth_regulation", 0.3769], ["IL-1-induced_response", 0.3769], ["growth_signaling_pathway", 0.3769], ["nuclear_factors_of_activated_T-cell_(NFAT)_site", 0.3769], ["human_IL-3_proximal_promoter", 0.3768], ["nuclear_factor_(NF)-kappa_B_activity", 0.3768], ["IL-6-induced_apoptosis", 0.3767], ["lymphokine_gene_expression", 0.3767], ["thymocyte-thymic_epithelial_cell_interaction", 0.3767], ["extracellular_signal-regulated_kinase_(ERK)_1", 0.3767], ["cell-specific_translational_regulation", 0.3766], ["Tcf-mediated_transcription", 0.3766], ["I_kappa_B_inhibitor", 0.3766], ["TCR-induced_phosphorylation", 0.3766], ["NF-kappaB-controlled_gene", 0.3765], ["CD95_(Fas)_ligand_expression", 0.3765], ["low-affinity_IL-12R_beta1_subunit", 0.3765], ["primary_human_CD34+_hemopoietic_progenitor_cell", 0.3765], ["I_kappa-beta_protein", 0.3765], ["JAK/STAT_pathway", 0.3765], ["Jak/Stat_pathway", 0.3765], ["interleukin-6-induced_IgM_production", 0.3764], ["NF-kappa_B_dependent_reporter_gene_construct", 0.3763], ["tumor_necrosis_factor-alpha_(TNF-alpha)-treated_endothelial_cell", 0.3763], ["intracellular_mechanism", 0.3763], ["TLR2-mediated_signal_transduction", 0.3763], ["interferon_regulatory_factor-1_gene_expression", 0.3762], ["CD14_receptor", 0.3762], ["TPA-induced_transcription", 0.3762], ["I_kappa_B_synthesis", 0.3762], ["intracellular_pathway", 0.3761], ["cell-associated_recognition_molecule", 0.3761], ["nuclear_factor_of_activated_T_cells_(NFAT)_protein", 0.3761], ["NF-kappaB_DNA-binding_complex", 0.3761], ["anti-CD28_Ab", 0.3761], ["tumor_necrosis_factor_alpha_gene_expression", 0.3761], ["MAP_kinase_pathway", 0.376], ["Th2-associated_cytokine", 0.376], ["lymphoid-enhancer_binding_factor_1", 0.376], ["vitro_activated_helper_T_cell", 0.3759], ["CD3/T-cell_antigen_receptor", 0.3759], ["inflammatory_effect", 0.3759], ["tumor_necrosis_factor_receptor_1_(TNFR1)-associated_death_domain_protein", 0.3758], ["anti_CD28", 0.3758], ["immunoglobulin_heavy-chain_enhancer", 0.3757], ["co-transfected_IL-2_promoter", 0.3757], ["endogenous_NF-kappa_B_p50_subunit", 0.3757], ["stress-induced_signaling_pathway", 0.3756], ["tyrosine_kinase_inhibition", 0.3756], ["Rel/NF-kappaB_protein", 0.3755], ["NF-kappaB_regulation", 0.3755], ["tumor_necrosis_factor_receptor-activated_factor_6", 0.3754], ["inhibitory_protein_I_kappa_B", 0.3754], ["colony-stimulating_factor_1_(macrophage_colony-stimulating_factor)_receptor_promoter", 0.3754], ["Syk_kinases-interacting_protein", 0.3754], ["IL-2R_gamma-chain", 0.3753], ["in_vitro_CD4_cross-linking", 0.3753], ["redox_sensitive_cytosolic_transcription_factor", 0.3753], ["NF-kappa_B_regulation", 0.3752], ["protein_kinase_C_(PKC)_isoform", 0.3752], ["granulocyte-macrophage_colony-stimulating_factor_promoter_activity", 0.3751], ["FN-induced_IL-1beta_response", 0.3751], ["NF-kappa_B_regulatory_element", 0.3751], ["CD4+_human_helper_T_cell_clone_SP-B21", 0.3751], ["Th1/Th2-like_cytokine", 0.375], ["CD2:lymphocyte_function-associated_Ag-3", 0.375], ["tumor_necrosis_factor_induced_apoptosis", 0.375], ["whole-cell_competitive_binding_assay", 0.375], ["IL-10_receptor_activation", 0.375], ["cell-type-specific_transactivation", 0.375], ["cytokine_level", 0.3749], ["Jak-Stat1_pathway", 0.3749], ["NF-kappa_B_subunit", 0.3749], ["growth_factor-stimulated_cell_proliferation", 0.3748], ["tyrosine_kinase_activity", 0.3748], ["B-cell-specific_regulation", 0.3748], ["cytokine_effect", 0.3748], ["T-cell-specific_transcription_factor", 0.3748], ["antigen-_or_cAMP-activated_Th2_cell", 0.3747], ["cellular_gene_regulatory_molecule", 0.3747], ["12-O-tetradecanoylphorbol-13-acetate_(TPA)-induced_HL-60_cell_differentiation", 0.3746], ["thymidine_kinase_promoter-driven_reporter_construct", 0.3746], ["serine_kinase_activity", 0.3746], ["Ig-mediated_B-cell_activation", 0.3745], ["in_vitro_primary_immune_response", 0.3745], ["tyrosine_protein_kinase_activity", 0.3745], ["I_kappa_B_alpha-dependent_mechanism", 0.3745], ["T-cell_transcription_factor", 0.3745], ["human_interleukin_2_(IL-2)_gene", 0.3744], ["B_cell_specific_transcription_factor", 0.3744], ["kappa_B/Rel_DNA-binding_motif", 0.3744], ["context-dependent_apoptosis_regulator", 0.3744], ["interleukin_(IL)-1", 0.3743], ["macrophage_transcription_factor", 0.3742], ["cell-death_pathway", 0.3742], ["CD3+_T_cell", 0.3742], ["non-IL-2-secreting_cell", 0.3741], ["cell_proliferative_signal", 0.3741], ["C5a-induced_interleukin-8_gene", 0.3741], ["CD3+/CD4+_T_cell", 0.3739], ["lymphoid-specific_transcription_factor_Oct-2A", 0.3739], ["downstream_T_lymphocyte-specific_enhancer_element", 0.3739], ["cell-mediated_immune_response", 0.3738], ["oxidative-stress_sensitive_transcription_factor", 0.3738], ["c-Fos_protein_expression", 0.3737], ["lymphoid-specific_immunoglobulin_mu_heavy_chain_gene_enhancer", 0.3737], ["T-lymphocyte_activation", 0.3737], ["kappa_B_site-dependent_transcription", 0.3736], ["NH2-terminal_kinase_activity", 0.3736], ["two-phase_neutrophil-endothelial_cell_adhesion_response", 0.3735], ["vivo_enhancer_activity", 0.3735], ["IL-5_gene_transcription", 0.3735], ["CD36_gene_promoter", 0.3734], ["CCAAT/enhancer-binding_protein-beta", 0.3734], ["acute_inflammatory_reaction", 0.3734], ["NF-IL6_gene", 0.3733], ["interleukin-9-mediated_cell_proliferation", 0.3733], ["LPS-inducible_nuclear_factor-kappa_B/Rel_complex", 0.3733], ["anti-inflammatory_(non_T)_effect", 0.3732], ["LPS-inducible_factor_NF-kappa_B", 0.3732], ["IL-2-secreting_Jurkat_T_cell", 0.3732], ["TNF_signaling", 0.3731], ["NF-kappa_B2_p100_gene_product", 0.373], ["activation-induced_expression", 0.373], ["protein_kinase_A/protein_kinase_C_inhibitor", 0.3729], ["nuclear_factor_of_activated_T_cells_(NFAT)_family", 0.3729], ["activated_IL-2_expression", 0.3728], ["TNF-alpha_activation", 0.3727], ["SH2_domain_containing_tyrosine_kinase_Syk", 0.3726], ["NF-kappa_B_transactivator", 0.3725], ["IL-6_protein", 0.3725], ["B_cell-specific_transcriptional_promoter_activity", 0.3725], ["human_primary_CD34(+)_cell", 0.3725], ["CD4+_T-cell_clonal_lines", 0.3724], ["NF_kappa_B2_motif", 0.3724], ["tumor_necrosis_factor-alpha_(TNF-alpha)_inhibitor", 0.3724], ["activation-induced_lymphocyte_proliferation", 0.3723], ["kappa_B_binding_protein", 0.3723], ["human_tumor_necrosis_factor_alpha_(TNF-alpha)_gene_promoter", 0.3723], ["enhancer-mediated_activation", 0.3722], ["gene_transcription_activation", 0.3722], ["human_interferon_beta_(IFN-beta)_regulatory_element", 0.3721], ["immune_mechanism", 0.3721], ["IkappaBalpha_kinase_(IKK)_complex", 0.3721], ["T_cell_antigen_receptor_complex_induction", 0.372], ["IFN-induced_NK_cell_killing", 0.3719], ["leukocyte-endothelial_cell_interaction", 0.3719], ["pneumoniae-mediated_activation", 0.3719], ["immunomodulatory_activity", 0.3719], ["Th2_cytokine", 0.3719], ["TH2_cytokine", 0.3719], ["tyrosine_protein_kinase", 0.3719], ["macrophage_colony-stimulating_factor_(M-CSF)_receptor", 0.3719], ["T-cell_antigen_receptor_(TCR)_signaling_cascad", 0.3718], ["IL-10-stimulated_STAT_protein", 0.3718], ["cytoplasmic_signaling_molecule", 0.3718], ["STAT3_serine_kinase", 0.3718], ["CD40-mediated_immunoglobulin", 0.3718], ["stimulated_T-cell_nuclear_extract", 0.3718], ["TNF-alpha-induced_ICAM-1_transcription", 0.3717], ["C5a-induced_kappaB_binding_activity", 0.3717], ["protein_kinase_A-dependent_fashion", 0.3717], ["operative_kinase", 0.3716], ["NF-kappa_B/Rel_subunit", 0.3716], ["activator_of_protein_kinase_C", 0.3716], ["nuclear_factor-kappa_B_mobilization", 0.3716], ["T-cell_gene_expression", 0.3716], ["endogenous_c-fos_mRNA_expression", 0.3716], ["IL-4_receptor_stimulation", 0.3716], ["IL-1beta_mRNA_expression", 0.3716], ["cytoplasmic_tyrosine_kinase_Tec_family", 0.3715], ["chronic_immune-mediated_inflammation", 0.3715], ["immunmodulatory_effect", 0.3715], ["lipid_kinase_activity", 0.3715], ["protein_kinase_C_inhibitor", 0.3714], ["IL-5_transcription", 0.3714], ["CD40-activated_human_B_lymphocyte", 0.3714], ["T_cell_cytokine", 0.3713], ["IL-1beta_promoter_activity", 0.3712], ["in_vitro_polyclonal_B_cell_immunoglobulin_(Ig)_response", 0.3712], ["signalling_pathway", 0.3712], ["inhibitor-kappaB_alpha", 0.3712], ["CD4+CD45RO+_T_cell", 0.3712], ["IL-6-responsive_gene", 0.3711], ["NF-kappa_B_DNA_binding", 0.371], ["TCR/CD28_costimulation", 0.371], ["CD40_activation", 0.3709], ["NF-kappaB_oligoprobe", 0.3709], ["nuclear_factor-kappa_B_DNA-binding_activity", 0.3709], ["CD4+_T_helper_(pTh)_cell", 0.3709], ["minimal_B_cell-specific_enhancer", 0.3708], ["signaling_molecule", 0.3708], ["lymphocyte-specific_protein_tyrosine_kinase", 0.3708], ["IL-1alpha_promoter_activity", 0.3708], ["thrombin_receptor_activation_peptide", 0.3707], ["B_cell_IgE_synthesis", 0.3707], ["monocyte-mediated_killing", 0.3707], ["interferon-gamma-induced_intercellular_adhesion_molecule-1_gene_transcription", 0.3707], ["activated_monocytes/macrophages", 0.3706], ["TNF/neuron_growth_factor_receptor_family", 0.3706], ["Th1_cell-mediated_immune_response", 0.3706], ["CD3_receptor", 0.3706], ["R24-stimulated_increase_in_proliferation", 0.3705], ["Jak2_kinase", 0.3705], ["JAK2_kinase", 0.3705], ["TNF_mRNA_expression", 0.3705], ["NF-kappa_B_p65_subunit", 0.3705], ["IL-2_autocrine_human_T_cell_line", 0.3705], ["NF-kappa_B_related_polypeptide", 0.3704], ["cell-specific_transcription_factor", 0.3703], ["PKC-induced_activation", 0.3703], ["signal_transducer_and_activator_of_transcription_(STAT)_transcription_factor_activity", 0.3703], ["IL-1_beta_convertase", 0.3702], ["PKC-induced_nuclear_NF-kB_activity", 0.3702], ["immunohistochemical_procedure", 0.3702], ["interleukin4", 0.3702], ["monocytic_differentiation_pathway", 0.3701], ["N-terminal_regulatory_serine", 0.3701], ["B_cell-specific_enhancer_elements", 0.3701], ["primary_CD4+_T_cell", 0.3701], ["protein_tyrosine_kinase_dependent", 0.37], ["PtdIns_3-kinase", 0.3699], ["IL-1_beta_mRNA", 0.3699], ["NF-kappaB1_p105_precursor_protein", 0.3698], ["monocyte-specific_promoter_activity", 0.3698], ["anti-CD3-activated_peripheral_human_T_lymphocyte", 0.3698], ["TNFRI_death_domain_interacting_protein", 0.3697], ["interleukin-1_alpha", 0.3697], ["signal_transducer_and_activation_of_transcription_(STAT)_transcription_factor", 0.3697], ["mouse_IL-2_enhancer", 0.3696], ["tumor_necrosis_factor-alpha_(TNF-alpha)-induced_degradation", 0.3696], ["JNK_signal_transduction_pathway", 0.3695], ["NF-kappa_B_antagonist", 0.3695], ["NF-kappaB-responsive_reporter_gene", 0.3694], ["immune_inflammatory_state", 0.3694], ["LPS-stimulated_Raw_264.7_cell", 0.3694], ["IL-2_receptor_complex", 0.3693], ["NF-AT_transcriptional_activity", 0.3693], ["immunohistochemical_analysis", 0.3693], ["JAK_phosphorylation", 0.3693], ["Il-2_gene", 0.3693], ["IL-2_gene", 0.3693], ["myeloid-committed_CD34+Thy-l-CD45RA+_subset", 0.3691], ["anti-inflammatory_activity", 0.3691], ["monocytic_specific_promoter_activity", 0.3691], ["IL-12_induced_developmental_stage", 0.3691], ["B_cell-enriched_transcription_factor", 0.3691], ["plasma_cell_pathway", 0.3691], ["protein_kinase_B", 0.3691], ["IL-6-type_cytokine_receptor", 0.369], ["cytokine_signal", 0.369], ["IL-2_mRNA", 0.369], ["endothelial_leukocyte_adhesion_molecule_(ELAM)_mRNA_synthesis", 0.369], ["IL-2_promoter-chloramphenicol_acetyltransferase_construct", 0.3689], ["TPA-induced_activation", 0.3689], ["CD44_promoter-chloramphenicol_acetyltransferase_reporter_construct", 0.3689], ["inflammatory_activity", 0.3688], ["eukaryotic_transcription_regulatory_factor", 0.3688], ["protein_kinase_C", 0.3688], ["CD20+_B_cell", 0.3688], ["cytokine_mRNA_accumulation", 0.3687], ["lymphoid-restricted,_octamer_site-mediated_immunoglobulin_gene_promoter_activity", 0.3687], ["CD4_gene_expression", 0.3687], ["CD4-expressing_T_lymphocyte", 0.3687], ["nuclear_regulatory_factor-kappa_beta", 0.3686], ["T-cell_mitogenesis", 0.3686], ["activation-induced_cell_death", 0.3686], ["B_and_T_cell_mitogenesis", 0.3686], ["immunoregulatory_cytokine", 0.3685], ["tyrosine_kinase_enzymatic_activity", 0.3685], ["gamma_interferon-induced_tyrosine_phosphorylation", 0.3685], ["NF-kappa_B-directed_luciferase_activity", 0.3684], ["interleukin-2_(IL-2)_nonresponsive_state", 0.3684], ["anti-CD3_activated_Hut-78_T_cell", 0.3683], ["12-O-tetradecanoyl_12-phorbol_13-acetate-stimulated_T_cell", 0.3683], ["interferon_regulatory_factor_2", 0.3683], ["IL-3_gene", 0.3682], ["tumor_necrosis_factor_receptor-associated_death_domain_protein", 0.3682], ["normal_immunoregulatory_signal_transduction", 0.3681], ["mononuclear_cell_activation", 0.3681], ["human_prointerleukin_1_beta_(proIL-1_beta)_gene", 0.3681], ["I_kappa_B_alpha_synthesis", 0.3681], ["tumor_necrosis_factor-alphaproduction", 0.3681], ["interleukin-5_gene", 0.368], ["B-cell_lineage-specific_transcription_factor", 0.368], ["lymphocyte-activating_cytokine", 0.368], ["constitutive_NF-kappa_B_activity", 0.368], ["serine_kinase", 0.368], ["IL4_transcription_initiation_site", 0.3679], ["B_cell-expressed_transcription_factor", 0.3679], ["cytokine_induction", 0.3679], ["CD48_gene", 0.3679], ["Jak3_kinase", 0.3679], ["JAK3_kinase", 0.3679], ["hemopoietic_helix-loop-helix_transcription_factor", 0.3678], ["DEX-mediated_IkappaBalpha_induction", 0.3678], ["IL-4-positive_T_cell", 0.3677], ["critical_immunoregulatory_cytokine", 0.3677], ["CD2-activated_LPMC", 0.3677], ["highly_purified_CD34+_cell", 0.3677], ["IL-1beta-converting_enzyme_family_protease_inhibitor", 0.3677], ["human_CD34(+)_hematopoietic_progenitor_cell", 0.3677], ["NK_cell_induced_cytolysis", 0.3676], ["early_and_the_late_IL-6-induced_junB_transcription_wave", 0.3675], ["lymphoid-specific_Ets_transcription_factor", 0.3675], ["human_interleukin_9_(IL-9)_gene_expression", 0.3674], ["rapid_transcriptional_activation", 0.3674], ["proinflammatory_lymphokine_interleukin-1beta", 0.3674], ["immunoglobulin_light-chain_enhancer_E_lambda_2.4", 0.3674], ["Interleukin-5", 0.3674], ["interleukin-5", 0.3674], ["NH2-terminal_kinase", 0.3673], ["mitogenic_anti-CD2_antibody", 0.3673], ["TCR-induced_tyrosine_phosphorylation", 0.3673], ["mitogenic_signaling", 0.3673], ["interleukin-2_receptor-gamma", 0.3672], ["c-fos_mRNA_expression", 0.3672], ["Janus_tyrosine_kinase_(JAK)-STAT_signaling_pathway", 0.3672], ["IL-3-mediated_commitment", 0.3672], ["IL-2_stimulation", 0.3671], ["Rel/NF-kappaB-responsive_gene", 0.3671], ["NF-kappa_B-DNA_interaction", 0.3671], ["IL-4-triggered_activation", 0.367], ["IL-4-induced_STAT5_activity", 0.367], ["purified_human_p65_NF-kappa_B_subunit", 0.367], ["PI_3-kinase_activation", 0.3669], ["NF-kappa_B_specific_32P-labelled_oligonucleotide", 0.3669], ["thromboxane_receptor_gene_expression", 0.3669], ["tumour_necrosis_factor_alpha_expression", 0.3669], ["primary_B_cell_transformation_assay", 0.3668], ["IL-6-type_cytokine", 0.3668], ["CD8+_T_cell_prolymphocytic_leukemia_cell", 0.3667], ["LPS-stimulated_IL-1ra_secretion", 0.3667], ["cAMP-,_phorbol_ester-_,_and_Ca(2+)-inducible_enhancer", 0.3667], ["agonistic_anti-CD30_monoclonal_antibody", 0.3667], ["target_gene_IL-8", 0.3666], ["p65-mediated_activation", 0.3665], ["lymphoid_cell-specific_transcription_factor", 0.3664], ["lipopolysaccharide-stimulated_interleukin-1_beta_messenger_RNA", 0.3664], ["IL-2_receptor_alpha_subunit", 0.3664], ["Nef_phosphorylation", 0.3664], ["immunodominant,_CD8(+)_cytotoxic_T_lymphocyte_(CTL)_response", 0.3663], ["intercellular_adhesion_molecule-1_(ICAM-1)_expression", 0.3663], ["monocyte_interleukin-1_receptor", 0.3663], ["delayed-early_IL-3-responsive_gene", 0.3663], ["nuclear_factor_of_activated_T_cells", 0.3662], ["cord_blood-derived_CD34(+)_stem/progenitor_cell", 0.3662], ["interleukin-1", 0.3662], ["TGF-beta_1-mediated_modulation", 0.3662], ["monocyte/macrophage_tumor_necrosis_factor", 0.3662], ["human_IL-2R_alpha_promoter", 0.366], ["cytokine_expression_pattern", 0.3659], ["PWM-induced_B-cell_mitogenesis", 0.3659], ["TPA-induced_monocytic_differentiation", 0.3659], ["protein_kinase_C-dependent", 0.3659], ["IL-2_promoter_factor", 0.3659], ["TGF-beta_2_transcription", 0.3658], ["Bcl-2_phosphorylation", 0.3658], ["NF-kappa_B_motif", 0.3658], ["IL-2R_alpha_mRNA", 0.3657], ["chimeric_type_II/type_I_interleukin-1_receptor", 0.3657], ["aberrant_intracellular_signaling", 0.3657], ["CD2_protein", 0.3656], ["CD40_ligation", 0.3656], ["IL-2R_gamma_chain", 0.3655], ["IL-1-induced_gene", 0.3655], ["lymphokine-activated_killer_(LAK)_cell", 0.3655], ["cytokine_inducible", 0.3655], ["IL-12_signal_transduction", 0.3655], ["IL-13-induced_regulatory_factor", 0.3654], ["T-helper_cell_cytokine", 0.3654], ["CD30-CD30L_interactions", 0.3653], ["TF_antigen_expression", 0.3652], ["interleukin_1_receptor", 0.3652], ["autoregulatory_mechanism_for_transcription", 0.3652], ["JNK-mediated_phosphorylation", 0.3652], ["CD40_receptor", 0.3652], ["intracellular_oxidant_stress", 0.3651], ["IL-3_gene_5'_and_3'_flanking_sequence", 0.3651], ["intracellular_signal_transduction", 0.3651], ["lymphocyte_gene_activation", 0.365], ["cell_growth_regulator", 0.365], ["B_cell-specific_transcriptional_activity", 0.365], ["epitope_peptide-loaded_dendritic_cell", 0.365], ["intrafollicular_CD57+_cell", 0.365], ["IFN-regulated_signal_transduction_pathway", 0.365], ["T_cell-specific_negative_regulation", 0.365], ["CD4_cell_proliferation", 0.365], ["CD8+_T_cell_supernatant", 0.3649], ["1311-base_pair_human_tumor_necrosis_factor_(TNF)_alpha_promoter_region", 0.3649], ["interleukin-6_site", 0.3649], ["cell-type-specific_regulation", 0.3649], ["STAT_tyrosine_phosphorylation", 0.3648], ["LPS_cellular_signaling", 0.3648], ["interfollicular_Bcl-6+_cell", 0.3647], ["IL-4-induced_effect", 0.3647], ["IL-2_repression", 0.3647], ["kappa_B-specific_DNA-binding_activity", 0.3647], ["thrombin-induced_activation", 0.3647], ["HS-40_enhancer-zeta_2_globin_promoter_interaction", 0.3647], ["normal_T-cell_activation", 0.3646], ["kinase", 0.3646], ["lymphoid-specific_transcription_factor_Oct2", 0.3646], ["monocytic_I_kappa_B_alpha/MAD-3_mRNA", 0.3646], ["cytolytic_effector_T-cell", 0.3645], ["TNF-alpha-induced_HIV_activation", 0.3645], ["antioncogenic_transcription_factor_interferon_regulatory_factor", 0.3645], ["activated_human_CD4_T_cell", 0.3644], ["lymphocyte-specific_immunoglobulin_mu_heavy-chain_gene_intronic_enhancer", 0.3644], ["cell_type-specific_activation", 0.3644], ["kappa_B-specific_DNA_binding_protein", 0.3644], ["cyclosporin_A-sensitive_tumor_necrosis_factor-alpha_gene_transcription", 0.3644], ["receptor_signaling_pathway", 0.3644], ["granulocyte-macrophage_colony-stimulating_factor_production", 0.3643], ["cyclin/cdks_activation", 0.3643], ["TNF_gene_expression", 0.3642], ["PP-2A-opposing_kinase", 0.3642], ["IL2R_gamma_c", 0.3641], ["protein_kinase_C_dependent", 0.364], ["negative_regulatory_protein_kinase", 0.364], ["interleukin_16_promoter", 0.364], ["CD18-mediated_leukocyte_adhesion", 0.364], ["CD34(+)_blast_cell", 0.3639], ["cyclooxygenase-2_expression", 0.3639], ["human_monocyte_nuclear_factor-kappaB", 0.3639], ["TCR-mediated_activation", 0.3639], ["conserved_lymphokine_element_0", 0.3639], ["Hodgkin's_disease-derived,_T_cell-like,_CD30+_cell", 0.3638], ["protein_tyrosine_kinase_inhibitor", 0.3638], ["TNF-alpha-induced_HIV-1_expression", 0.3638], ["protein_kinase_C_(PKC)_enzymatic_activity", 0.3638], ["IL-6_mRNA_level", 0.3638], ["T_cell_receptor_(TCR)_gene_rearrangement", 0.3638], ["immunomodulatory_role", 0.3637], ["CaM_kinase_family", 0.3637], ["STAT_and_IFN_regulatory_factor_(IRF)_family_transcription_factor", 0.3636], ["fibroblast_activation", 0.3636], ["nuclear_factor_of_activated_T_cell_(NFAT)_family_members", 0.3636], ["interleukin-4_gene", 0.3636], ["mitogen-induced_T_cell_proliferation", 0.3636], ["IL-6-responsive_gene_element", 0.3635], ["interferon_gamma_induction_pathway", 0.3635], ["oxidoreductive_regulation", 0.3635], ["CD56+_CD16+_natural_killer_cell", 0.3634], ["IL-1_beta_gene", 0.3634], ["G(Anh)MTetra-induced_IL-1_beta_and_IL-6_mRNA_expression", 0.3633], ["cyclin/cdks_(cyclin-dependent_kinase)_complex", 0.3633], ["human_T-cell_receptor_delta_gene_enhancer", 0.3633], ["human_interleukin-7_receptor_complex", 0.3632], ["IL-4_receptor", 0.3632], ["cellular_tumor_necrosis_factor_receptor-associated_factor", 0.3632], ["several_signaling_molecule", 0.3632], ["cell_cycle-dependent_transcription_factor", 0.3631], ["human_toll_signaling_pathway", 0.3631], ["CD40-mediated_immunoglobulin_class_switching", 0.3631], ["cell_type-specific_regulation", 0.363], ["T_cell_mitogenesis", 0.3629], ["IL-9_gene_expression", 0.3629], ["multi-protein_hematopoietic-specific_transcription_factor_complex", 0.3629], ["CCK-8-induced_luciferase_activity", 0.3629], ["various_cellular_activation_agent", 0.3629], ["p24_antigen_release", 0.3629], ["LPS-mediated_TF_expression", 0.3628], ["granulocyte/macrophage_colony-stimulating_factor_basic_promoter", 0.3628], ["TGF-beta_1_signaling_pathway", 0.3627], ["inducible_transcriptional_activity", 0.3627], ["cytokine-production_pattern", 0.3627], ["IL-4/IL-13-inducible_gene_expression", 0.3626], ["NF_kappa_B_enhance", 0.3626], ["IFNgamma-driven,_Stat1-dependent_gene_activation", 0.3626], ["NF-kappa_B_mobilization", 0.3626], ["NF-kappa_B1_gene", 0.3625], ["pluripotent_activator_of_inflammation", 0.3625], ["interleukin-10_receptor_expression", 0.3625], ["CD40L-transfected_murine_L-cell", 0.3625], ["phorbol_ester-stimulated_cell", 0.3624], ["anti-CD3_stimulation", 0.3624], ["IL3_gene", 0.3624], ["Nuclear_Factor_of_Activated_T_cell", 0.3623], ["Jak/Stat_signal_pathway", 0.3623], ["nuclear_factor-kappa_B_activity", 0.3622], ["nuclear_factor_regulated_by_IL-3/adenovirus_E4_promoter_binding_protein", 0.3622], ["CD34_mRNA", 0.3622], ["IL-2-gene", 0.3622], ["kinase_inhibitor_H7", 0.3622], ["LDL-enhanced_endothelial_recruitment", 0.3622], ["immunoglobulin_light-chain_enhancer", 0.3621], ["CD23_gene_expression", 0.3621], ["murine_B-cell_specific_coactivator", 0.3621], ["cytokine_promoter", 0.362], ["in_vitro_expression_assay", 0.362], ["mononuclear_phagocyte_activation", 0.362], ["double-positive_(DP)_CD4(+)_CD8(+)_CD3(+/-)_thymocyte", 0.362], ["NF-kappa_B_p50_subunit", 0.3619], ["cytokine", 0.3619], ["SAP_kinase", 0.3619], ["NF-kappa_B1_precursor", 0.3618], ["cyclic_AMP_response_element_binding_protein/activating_transcription_factor_(CREB/ATF)_family", 0.3618], ["nuclear_factor_of_activated_T_cells_site", 0.3618], ["cytokine_therapy", 0.3616], ["IL-2_promoter_sequence", 0.3616], ["IL-4_regulatory_element", 0.3616], ["NF_kappa_B_independent_cis-acting_sequence", 0.3616], ["T_cell_receptor_(TCR)_cross-linking", 0.3615], ["ATRA-induced_CD38+_cell", 0.3614], ["PMA-induced_IL-2_production", 0.3614], ["55_kd_tumor_necrosis_factor_receptor", 0.3614], ["LPS-inducible_IL-6_promoter", 0.3614], ["CD19/Vav/phosphatidylinositol-3_kinase_complex", 0.3613], ["potent_proinflammatory_cytokine_mRNA_expression", 0.3612], ["cell_cycle_regulation", 0.3612], ["IL-4-dependent_regulation", 0.3612], ["CD8+_cytotoxic_T_lymphocyte_(CTL)_response", 0.3612], ["kappa_B/Rel_family_protein", 0.3612], ["activation-induced_transcription", 0.3611], ["interleukin-1alpha", 0.3611], ["nuclear_NF-kappa_B_protein", 0.3611], ["interleukin-4-responsive_element", 0.3611], ["CD34+_cell", 0.361], ["IL-1beta_gene_transcription", 0.361], ["IL-4_receptor_alpha-chain_cytoplasmic_domain", 0.3609], ["granulocyte-macrophage_colony-stimulating_factor_promoter", 0.3609], ["endogenous_IL-2_gene", 0.3609], ["T-cell_mediated_response", 0.3609], ["ets-related_transcriptional_regulator", 0.3608], ["human_interleukin_2", 0.3608], ["TGF-beta_1-mediated_growth_inhibition", 0.3608], ["human_tumor_necrosis_factor_alpha_gene_regulation", 0.3608], ["2-phase_neutrophil-endothelial_adhesion_response", 0.3607], ["protein_kinase_C_(PKC)_activity", 0.3607], ["neutrophil_IL-8_release", 0.3606], ["endogenous_tyrosine_kinase_receptor", 0.3606], ["CD28-responsive_complex", 0.3606], ["TNF-alpha-induced_apoptosis", 0.3606], ["thrombin_activation", 0.3606], ["exogenous_cytokine", 0.3606], ["tumour_necrosis_factor_(TNF)_induction", 0.3605], ["nuclear_factor_for_activated_T_cell", 0.3605], ["IL-7_receptor_(IL-7R)_alpha_subunit", 0.3605], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_gene_regulatory_element", 0.3605], ["human_CD34(+)_bone_marrow_cell_survival", 0.3604], ["mitogenic_activation", 0.3603], ["HIV-2_enhancer_activation", 0.3603], ["interleukin1", 0.3603], ["cytokine-mediated_inflammatory_lung_disease", 0.3603], ["IL-4-inducible_gene", 0.3603], ["differentiation-dependent_peroxisomal_proliferator-activated_receptor_gamma", 0.3602], ["vertebrate_T-cell-specific_transcriptional_regulation", 0.3602], ["LPS-induced_IL-1ra_synthesis", 0.3602], ["kinase_C", 0.3602], ["T_cell_receptor-beta_(TcR-beta)_gene_rearrangement", 0.3602], ["NF-kappa_B-dependent_luciferase_construct", 0.3602], ["B_cell_enhancer_site", 0.3601], ["CD28RE/AP-1_sequence", 0.3601], ["Jak1-dependent_intracellular_signal", 0.3601], ["cis-acting_regulatory_motif", 0.3601], ["c-Jun_N-terminal_kinase", 0.3601], ["c-Jun_NH2-terminal_kinase", 0.3601], ["IL-4/IL-13-inducible_transcription_factor", 0.3601], ["NF-kappa_B-independent_activity", 0.3601], ["T-cell_receptor_(TcR)_gene_rearrangement", 0.36], ["inducible_autoregulatory_pathway", 0.36], ["optimal_T_cell_activation", 0.3599], ["JNK-mediated_transcriptional_activation", 0.3599], ["PMA-induced_IkB_alpha_phosphorylation/degradation", 0.3599], ["macrophage_colony-stimulating_factor_gene", 0.3598], ["tumor_necrosis_factor_alpha_(TNF-alpha)_mRNA", 0.3598], ["75-kDa_heterodimeric_cytokine", 0.3598], ["USF/c-Myc-_mediated_up-regulation", 0.3598], ["protein_kinase", 0.3598], ["NF-kappa_B_activating_signal", 0.3597], ["CD95_(APO-1/Fas)_ligand_promoter", 0.3597], ["activated_NK_cell", 0.3597], ["p65_(Rel-A)_phosphorylation", 0.3597], ["novel_transcription_factor", 0.3597], ["Tcf-1-mediated_transcription", 0.3596], ["competitive_enzyme-linked_immunosorbent_assay", 0.3596], ["kappa_B_binding_motif", 0.3595], ["I_kappa_B_alpha/MAD-3_gene_transcription", 0.3594], ["kappa_immunoglobulin_light_chain_gene", 0.3594], ["activation_protein_1-dependent_transcriptional_activation", 0.3594], ["interleukin-2-receptor_alpha-subunit", 0.3593], ["TNF_alpha_activation", 0.3593], ["ERK-2_pathway", 0.3592], ["B_cell-specific_OTF-2", 0.3592], ["IL-7-treated_cell", 0.3592], ["phosphatidylinositol_3-kinase-linked_pathway", 0.3592], ["cytokine_release", 0.3592], ["tyrosine_kinase-dependent", 0.3592], ["human_interleukin-3_(IL-3)_gene", 0.3591], ["zinc-mediated_immune_modulation", 0.3591], ["oxidative_signalling_process", 0.3591], ["NF-kappaB-dependent_promoter", 0.3591], ["immunohistochemical_finding", 0.359], ["immunohistochemical_technique", 0.359], ["receptor-associated_protein_kinase", 0.359], ["CD4+_macrophage", 0.359], ["IkappaBalpha_phosphorylation", 0.3589], ["PKC,_Ca(2+)-dependent_pathway", 0.3589], ["IL-2R-alpha_expression", 0.3589], ["cell-cycle_regulation", 0.3588], ["E2F-mediated_transcriptional_activity", 0.3588], ["cytokine_differential_induction", 0.3588], ["T_cell_activation_signal", 0.3587], ["anergic_CD4+_Th_cell", 0.3587], ["I-kappa_B_mRNA", 0.3587], ["tumor_necrosis_factor_receptor_(TNFR)-associated_factor", 0.3586], ["cytokine_receptor", 0.3586], ["functional_anti-tumor_immunity", 0.3586], ["CD19-expressing_B-cell_line", 0.3586], ["I_kappa_B_protein_level", 0.3585], ["astrocyte-derived_kappa_B-binding_factor", 0.3585], ["monocytic/macrophage_pathway", 0.3584], ["Syk-family_tyrosine_kinase", 0.3584], ["microbicidal_pathway", 0.3584], ["B_cell-specific_transcription_factor", 0.3584], ["IL-2_DNA_enhancer_element", 0.3584], ["T-cell-receptor-mediated_trans_activation", 0.3583], ["Bcl-6+/CD3+_cell", 0.3583], ["TF_mRNA_expression", 0.3583], ["activation-induced_apoptosis", 0.3582], ["cdc2_mRNA_expression", 0.3582], ["LPS-stimulated_human_monocytic_cell_line", 0.3582], ["protein_kinase_C_subfamily", 0.3582], ["I_kappa_B_alpha_protein", 0.3581], ["NF-kappaB_subunit", 0.3581], ["protein_kinase_A", 0.358], ["CD3(+)_T-lymphocyte_cytoplasm", 0.358], ["novel_B_cell-derived_coactivator", 0.358], ["STAT_serine_phosphorylation", 0.358], ["transcription_factor_activation_protein_1", 0.358], ["human_prointerleukin_1_beta_gene", 0.358], ["PKC-dependent_pathway", 0.358], ["cell_surface_protein_expression", 0.358], ["NF-kappa_B_gene", 0.3579], ["kappaB-binding_protein", 0.3579], ["B_cell-specific_co-activator", 0.3579], ["Immunohistochemistry", 0.3579], ["immunohistochemistry", 0.3579], ["human_immunoglobulin_heavy-chain_enhancer", 0.3579], ["cytoplasmic_tyrosine_kinase", 0.3578], ["hematopoietic-specific_transcription_factor", 0.3578], ["IRF_family_transcription_factor_gene_expression", 0.3578], ["T_cell_antigen_receptor_stimulation", 0.3578], ["Syk-deficient_DT-40_B_cell", 0.3576], ["macrophage-colony-stimulating_factor", 0.3576], ["T_cell_receptor_(TCR)_alpha", 0.3576], ["TPA-induced_mononuclear_cell_differentiation", 0.3576], ["anergic_CD4+_T_cell", 0.3575], ["CD28_responsive_complex", 0.3575], ["B_cell_signaling", 0.3575], ["nuclear_factor_(NF)-kappa_B_subunit", 0.3575], ["mitogen_activation", 0.3574], ["immune_regulation", 0.3574], ["T_cell_specific-transcription", 0.3574], ["tyrosine-protein_kinase-specific_inhibitor", 0.3574], ["IL-5-inducible_gene", 0.3574], ["human_T_cell_receptor_gamma_(TCRG)_enhancer", 0.3574], ["TNF-alpha_gene_expression", 0.3574], ["steroid-induced_monokine_gene_expression", 0.3573], ["monocytes_reduced_proliferation", 0.3573], ["p38_kinase_activity", 0.3573], ["cAMP/PKA_activation_pathway", 0.3573], ["cytosolic_activation", 0.3573], ["cytokine-inducible_neutrophil_chemoattractant", 0.3572], ["anti-inflammatory_mediator", 0.3572], ["IL-4/IL-13-induced_gene_expression", 0.3572], ["immune_hyperactivation", 0.3572], ["regulate_B_lymphocyte_function", 0.3572], ["human_interleukin_2_gene", 0.3572], ["IL-2R-alpha", 0.3572], ["B-cell-specific_transcription_factor", 0.3571], ["Jak1_phosphorylation", 0.3571], ["NF_kappa_B2_nucleoprotein_complex", 0.3571], ["CD16_ligand_binding", 0.357], ["turn_affect_neutrophil-to-tumor_cell_binding", 0.357], ["anti-ERK_(extracellular_signal-regulated_kinase)_antibody", 0.357], ["transcription_activation_function", 0.3569], ["I_kappa_B_molecule", 0.3569], ["40-kDa_transcriptional_activator", 0.3569], ["Janus_tyrosine_kinase-3_(JAK3)_phosphorylation", 0.3568], ["B_cell-specific_coactivator", 0.3568], ["4-h_NK_cytolysis_assay", 0.3567], ["CD34+_progenitor_cell", 0.3567], ["PKC-independent_pathway", 0.3567], ["T_helper_2-type_cytokine", 0.3566], ["interleukin_(IL)-10", 0.3566], ["B-cell_specific_gene_expression", 0.3566], ["human_CD40-activated_B_lymphocyte", 0.3565], ["T_cell_inhibitory_activity", 0.3565], ["lymphoid-specific_transcription_factor", 0.3565], ["transcriptional_up-regulation", 0.3565], ["NF-kappa_B-binding_complex", 0.3565], ["receptor_tyrosine_kinase", 0.3563], ["cyclin_E-associated_kinase_activity", 0.3563], ["essential_cis-acting_enhancer_motif", 0.3563], ["IFN-stimulated_gene_factor_3_transcription_factor_complex", 0.3563], ["interleukin-10_inhibition", 0.3563], ["murine_cDNA_encoding_transcription_factor", 0.3563], ["T_cell_activation_signals", 0.3563], ["IL-4-induced_activatio", 0.3563], ["proteolysis-resistant_nuclear_factor-kappaB_inhibitor", 0.3562], ["cytokine_modulating_activity", 0.3562], ["mitogen-stimulated_T_cell", 0.3561], ["lymphocyte-specific_transcription_factor", 0.3561], ["CD8+_T-lymphocyte", 0.3561], ["IL-4R_alpha_cytoplasmic_domain", 0.3561], ["novel_human_myeloid-selective_CCAAT/enhancer_binding_protein_gene", 0.356], ["IL-2_promoter_level", 0.356], ["cell_type-specific_enhancer", 0.3559], ["IL-6_synthesis", 0.3559], ["kappa_B-binding,_truncated_protein", 0.3559], ["tumor_necrosis_factor-alpha_(TNF-alpha)_messenger_RNA", 0.3558], ["CD4(+)_T_helper_cell", 0.3558], ["cell-mediated_immunity", 0.3557], ["human_interleukin_(IL)_4_gene", 0.3557], ["IKK_complex-associated_protein", 0.3557], ["macrophage_tissue_factor_expression", 0.3557], ["B_cell-specific_activating_protein_(BSAP/PAX5)", 0.3556], ["phorbol_ester-induced_up-regulation", 0.3555], ["IL-4-induced_complex", 0.3555], ["constitutive_NF-kappaB_activity", 0.3555], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_gene_promoter", 0.3555], ["B_cell_transcription_factor", 0.3554], ["CD8+_T_cell", 0.3554], ["CD1a+cell", 0.3554], ["cytokine_secretion", 0.3554], ["hematopoietic-specific_Ets_family_transcription_factor", 0.3553], ["nuclear_factor_kB_(NF-kB)_regulatory_elements", 0.3552], ["B-cell-specific_coactivator", 0.3552], ["CD28_engagement", 0.3552], ["Jak_kinase_specific_antibody", 0.3552], ["T_cell_proliferation", 0.3552], ["cellular_activation", 0.3551], ["human_antigen-specific_CD4(+)_T_cell_line", 0.3551], ["heterodimeric_cytokine", 0.3551], ["calcium-independent,_CD28-specific_pathwa", 0.3551], ["B-cell-specific_enhancer_element", 0.355], ["nuclear_factor_of_activated_T_cells_(NFAT)_domain", 0.355], ["downstream_signaling_pathway", 0.355], ["macrophage_pathway", 0.355], ["macrophage_colony-stimulating_factor", 0.355], ["CLB-CD28/1", 0.355], ["early_TCR-mediated_signaling_event", 0.3549], ["primary_human_CD4+_T_cell", 0.3549], ["regulatory_gene_expression", 0.3548], ["human_immunodeficiency_virus_type_2_enhancer_activation", 0.3548], ["CD5+_B_cell", 0.3548], ["Rel/nuclear_factor_kappaB_(NF-kappaB)_factors", 0.3548], ["murine_IL-2_promoter", 0.3547], ["cytokine_gene", 0.3547], ["B_cell_membrane_Ig_expression", 0.3547], ["cytoplasmic_serine_kinase", 0.3545], ["human_interleukin-2_receptor_alpha", 0.3545], ["IL-9-induced_cell_proliferation", 0.3545], ["nuclear_factor_of_activated_T_cells-1", 0.3545], ["NF-kappaB-_luciferase_activity", 0.3544], ["CD30_signal_transduction", 0.3544], ["high-affinity_IL-2R", 0.3544], ["jak_kinase", 0.3544], ["Jak_kinase", 0.3544], ["JAK_kinase", 0.3544], ["IL-1beta-converting_enzyme_family", 0.3544], ["CD14+_adherent_human_monocyte", 0.3544], ["activation_of_transcription", 0.3543], ["Activation_of_transcription", 0.3543], ["polyclonal_activation", 0.3543], ["hematopoietic_cell_specific_molecule", 0.3543], ["RA-mediated_type_II_TGase_up-regulation", 0.3542], ["monocyte-specific_transcription", 0.3542], ["immunoglobulin_heavy-chain_gene_expression", 0.3542], ["IL-12-nonresponsive_Th_cell", 0.3541], ["granulocyte-macrophage_colony-stimulating_factor_receptor", 0.3541], ["inducible_autoregulated_inhibitory_pathway", 0.3541], ["proinflammatory_cytokine_release", 0.3541], ["monocyte-derived_IL-1beta", 0.3541], ["interferon-induced_transcription_factor_complex", 0.354], ["kappaB-dependent_reporter_assay", 0.354], ["IkappaB_alpha_regulation", 0.354], ["adult_CD4+CD45RO-_T_cell", 0.354], ["c-kit_ligand", 0.354], ["TNF_receptor-associated_factor_2", 0.3539], ["Th2_lymphocyte-mediated_effect", 0.3539], ["Rel/kappaB_binding_protein", 0.3538], ["MAP_kinase-related_kinase", 0.3538], ["B-cell_transcription_factor", 0.3538], ["CD40-positive_immunogenic_human_MM", 0.3538], ["cytokine_receptor_gamma_chain", 0.3538], ["LPS-stimulated_whole-blood_cell_culture", 0.3538], ["IL-1ra_protein_secretion", 0.3537], ["immunologic_(type_II)_nitric_oxide_synthase", 0.3537], ["apoptosis_pathway", 0.3536], ["interleukin-1beta_protein", 0.3536], ["IL-5_receptor", 0.3535], ["cyclin_D-associated_kinase_activity", 0.3534], ["reactive_oxygen_intermediate", 0.3534], ["c-Raf-induced_phosphorylation", 0.3534], ["human_T_cell_receptor_C_alpha_enhancer", 0.3534], ["IL-4R_alpha-chain_(IL-4Ralpha)_gene", 0.3533], ["IL-8_mRNA", 0.3533], ["polarized_Th2_cytokine_profile", 0.3533], ["myeloid-associated_growth_factor_receptor_transcript", 0.3532], ["hematopoietic_precursor_cell_line_32Dcl3", 0.3532], ["human_interleukin-6_(IL-6)_gene", 0.3532], ["cytokine-mRNA", 0.3531], ["anti-inflammatory_agent", 0.3531], ["cell_type-specific_enhancer_region", 0.3531], ["cellular_pathway", 0.3531], ["NFAT_(nuclear_factor_of_activated_T_cells)_family", 0.3531], ["mitogen-activated_mature_T_lymphocyte", 0.353], ["phorbol_ester-induced_cell", 0.353], ["CD-associated_HLA_class_II_molecule", 0.353], ["protein_kinase_C_independent", 0.3529], ["CD8+_T_lymphocyte", 0.3529], ["cytokine-mRNA_level", 0.3529], ["T_cell-receptor_engagement", 0.3529], ["human_B-cell_activation", 0.3529], ["T_cell_protein_binding", 0.3527], ["IL-2_immunotherapy", 0.3526], ["inflammatory_model", 0.3526], ["Janus_kinase-signal_transducer_activator_of_transcription_signaling_pathway", 0.3526], ["human_monocytic_M-CSF_receptor_promoter", 0.3525], ["interferon-inducible_regulatory_element", 0.3525], ["CD19+_B-cell", 0.3525], ["human_monocyte_IL-1_receptor_antagonist_(IL-1ra)_messenger_ribonucleic_acid", 0.3525], ["T_cell-B_cell_interaction", 0.3524], ["cytokine-induced_HIV-1_expression", 0.3524], ["cellular_I_kappa_B_beta_pool", 0.3524], ["TCR-mediated_signaling_processes", 0.3524], ["NF-kappa_B_DNA_binding_site", 0.3524], ["normal_CD34+_bone_marrow_cell", 0.3523], ["immuno-modulatory_effect", 0.3523], ["IL-6_receptor_subunit", 0.3523], ["cytokine-modulating_activity", 0.3523], ["Syk_tyrosine_kinase", 0.3522], ["tyrosine_kinase_inhibitor", 0.3522], ["stimulated_endothelial_cell", 0.3521], ["c-raf_kinase", 0.3521], ["B_cell_lineage-specific_activator_protein", 0.3521], ["proteolytic_activation", 0.3521], ["tumor_necrosis_factor/nerve_growth_factor_receptor_superfamily", 0.352], ["monocyte_IL-1ra_secretion", 0.352], ["cyclin-dependent_kinase", 0.352], ["human_B-cell_specific_transcription_factor", 0.3519], ["transcriptional_regulatory_function", 0.3519], ["CCAAT_enhancer_binding_protein_alpha", 0.3519], ["primary_CD45R0_T_cell", 0.3519], ["protein_tyrosine_phosphorylation", 0.3519], ["immunoreactive_IkappaB_alpha", 0.3519], ["cell-specific_gene_expression", 0.3518], ["Oct2-mediated_enhancer_activation", 0.3518], ["human_IL4_promoter-mediated_transcription", 0.3518], ["kappaB-regulated_luciferase_encoding_vector", 0.3517], ["stimulated_purified_T_helper_lymphocyte", 0.3517], ["Janus_kinase_1_(Jak1)_activation", 0.3517], ["CD20_E_box_binding_protein", 0.3517], ["CD19_gene_expression", 0.3516], ["signaling_cascade", 0.3516], ["transcriptional_transactivation_function", 0.3516], ["NF-kappaB/IkappaB_complex", 0.3516], ["PI_3-kinase_effector", 0.3516], ["tumor_necrosis_factor-responsive_gene", 0.3516], ["cell_type-specificity_of_immunoglobulin_gene_expression", 0.3515], ["interleukin-3_locus", 0.3515], ["p24_antigen_production", 0.3514], ["human_interleukin_4_receptor_alpha_chain", 0.3514], ["IL-8_gene", 0.3513], ["pleiotropic_cellular_transcription_factor", 0.3512], ["interleukin-11", 0.3512], ["anergized_CD4+_T_cell", 0.3512], ["cytokine_mRNA_level", 0.3512], ["simian_virus_40_enhancer_TC-II_(NF-kappa_B)_element", 0.3511], ["pro-/antiinflammatory_cytokine_secretion", 0.3511], ["IL-6_gene", 0.3511], ["cytokine-based_therapy", 0.351], ["differential_lymphokine_expression", 0.351], ["IL2Rbeta_promoter", 0.351], ["cell-type_specific_transcription_factor", 0.351], ["kappa_B_DNA-binding_protein", 0.351], ["C/EBPalpha_target_gene", 0.351], ["human_CD34+_hematopoietic_progenitor_cell", 0.3509], ["cyclin_E-dependent_kinase_activity", 0.3509], ["T-cell_proliferation", 0.3509], ["beta-catenin-lymphoid_enhancer_factor_1_complex", 0.3508], ["lymphoid-specific_(OTF-2)_octamer_binding_protein", 0.3508], ["TNF_(tumor_necrosis_factor)_gene", 0.3508], ["anti-inflammatory_therapy", 0.3508], ["CREB)/activating_transcription_factor-1_(ATF-1)_family", 0.3506], ["SLP-76-dependent_interleukin_(IL)-2_promoter", 0.3506], ["kappa_B-responsive_gene", 0.3506], ["protein_kinase_C--responsive_element", 0.3505], ["Il-2_secreting_El4_cell", 0.3505], ["regulatory_molecule", 0.3505], ["nuclear_factor-kappa_B_(NF-kappaB)_family", 0.3504], ["IL-1_beta_convertase_mRNA", 0.3504], ["TCR-mediated_signaling_event", 0.3503], ["I_kappa_B_alpha-deficient_mice", 0.3503], ["CD4+,_DQA1*0501/DQB1*0201_(DQ2.1)-restricted,_HSV-2-specific_T_cell_clone", 0.3503], ["anti-_CD40_monoclonal_antibody", 0.3503], ["cytokine-dependent_cell_line", 0.3503], ["nuclear_factor_(NF)_activation", 0.3502], ["recombinant_human_soluble_dimeric_TNF_receptor", 0.3502], ["lymphokine-activated_killer_cell", 0.3502], ["cellular_transcriptional_coactivator", 0.3501], ["LPS-stimulated_THP-1-hGH_cell", 0.3501], ["IL-2-dependent_growth", 0.3501], ["cAMP-dependent_protein_kinase_A", 0.35], ["interferon-gamma_receptor_(IFN-gammaR)_expression", 0.35], ["CCAAT/enhancer-binding_protein_(C/EBP)_family", 0.35], ["CD4+_CD8int/-_cell", 0.35], ["signal_transducers_and_activators_of_transcription_(STAT)_2_protein", 0.35], ["CD4+_T_cell_response", 0.3499], ["human_immunodeficiency_virus_type_1_kappa_B_enhancer", 0.3499], ["IL-6_transcription_rate", 0.3498], ["IL-9_promoter_activity", 0.3498], ["naive_CD4+_T_helper_(Th)_cell", 0.3498], ["macrophage_inflammatory_protein-1alpha", 0.3497], ["myelomonocytic_specific_tyrosine_kinase_hck_gene", 0.3497], ["novel_human_myeloid-cell-specific_C/EBP-epsilon_transcription_factor", 0.3497], ["interleukin-4_Stat", 0.3497], ["I_kappa_B_protein", 0.3497], ["CD4+CD45R0+_cell", 0.3497], ["phosphatidyl_inositol_3_kinase/PKB", 0.3497], ["IL-6_mRNA", 0.3497], ["anti-CD3_treatment", 0.3497], ["Erk2_kinase", 0.3496], ["ERK2_kinase", 0.3496], ["NF-kB_binding_protein", 0.3496], ["NF-kappaB_DNA_binding", 0.3496], ["PHA-induced_T-cell_mitogenesis", 0.3495], ["CD8(+)_cytotoxic_T_lymphocyte", 0.3495], ["244-bp_deoxycytidine_kinase_core_promoter", 0.3495], ["cyclin_D-associated_kinase", 0.3494], ["TNF-mediated_cytotoxicity", 0.3493], ["intestinal_epithelial_cell_inflammatory_response", 0.3492], ["IL-10_receptor_expression", 0.3492], ["Bcl-2_upregulation", 0.3492], ["polyoma_enhancer_A-binding_protein-3_site", 0.3492], ["cord_lymphocyte_activation", 0.3492], ["macrophage_gene_regulation", 0.3492], ["mutated_NF_kappa_B_promoter", 0.3492], ["increased_transcriptional_initiation", 0.3492], ["transcription_regulatory_function", 0.3492], ["regulation_of_gene_expression", 0.3491], ["T-cell_immortalization_mechanism", 0.3491], ["MHC-peptide_ligand_interaction", 0.3491], ["intracellular_domain_of_the_IL-4_receptor", 0.3491], ["anti-I_kappa_B-alpha_antibody", 0.3491], ["B-cell-specific_coregulator", 0.3491], ["T-cell-specifically_expressed_gene", 0.3491], ["cAMP-dependent_protein_kinase_activity", 0.3491], ["phosphorylation_level", 0.3491], ["phorbol_ester-induced_mononuclear_cell_differentiation", 0.349], ["CD2_antibody", 0.349], ["lipid_kinase", 0.349], ["AIM_activation_pathway", 0.349], ["IL-2_ligation", 0.349], ["NF-kB_activation", 0.349], ["548_bp_IL-2_promoter-_luciferase_reporter_construct", 0.349], ["activation-inducible_protein", 0.349], ["malignant_cell_cytokine_production", 0.3489], ["soluble_cytokine", 0.3489], ["CD20_mRNA", 0.3489], ["myelomonocytic_specific_tyrosine_kinase", 0.3489], ["human_interleukin-5_(hIL-5)_stimulation", 0.3489], ["membrane-mediated_signaling_event", 0.3489], ["serine_phosphorylation_response", 0.3488], ["IL-4_signal_transduction", 0.3488], ["thromboxane_receptor_promoter_activity", 0.3488], ["antigen-specific_T_cell_stimulation", 0.3488], ["hematopoietic_transcription_factor", 0.3486], ["IL-13_gene_expression", 0.3486], ["IL-12R_beta_2", 0.3485], ["normal_B-cell-specific_transcription", 0.3485], ["bHLH_heterodimer-dependent_gene_expression", 0.3485], ["kappa_B-dependent_gene", 0.3485], ["IL-4R_alpha-chain", 0.3485], ["cell-intrinsic_mechanism", 0.3484], ["tumor_necrosis_factor_receptor-associated_factor_3", 0.3484], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_receptor_alpha_subunit", 0.3484], ["c-fos_and_jun_B_mRNA", 0.3484], ["chemotactic_and_inflammatory_cytokine", 0.3484], ["nuclear_factor_of_activated_T_lymphocytes", 0.3484], ["IL-5-producing_T_cell_clone", 0.3484], ["IFN-activated_NK_cell", 0.3484], ["T-cell-specific_transcription", 0.3483], ["nuclear_factor-kappaB_(NF-kappaB)_binding_site", 0.3482], ["antigen_receptor-stimulated_T_cell", 0.3482], ["CD38_protein_level", 0.3482], ["human_immunoglobulin_heavy-chain_gene_enhancer", 0.3481], ["tumor_necrosis_factor_alpha_release", 0.3481], ["IL-1beta_transcription", 0.3481], ["tumor_necrosis_factor_receptor-associated_protein", 0.348], ["TCR-induced_activation", 0.348], ["intracellular_adhesion_molecule-1_induction", 0.348], ["cellular_survival-promoting_protein", 0.348], ["consensus_NF-kappa_B_oligonucleotide", 0.348], ["T-cell_activation_signal", 0.348], ["cytokine_pattern", 0.348], ["CD40-CD40L_interaction", 0.348], ["CD95_ligand", 0.348], ["interleukin-1_receptor", 0.3479], ["Mycobacterium_tuberculosis-_induced_interleukin-2_receptor_expression", 0.3479], ["TNF-alpha_gene_transcriptio", 0.3479], ["nuclear_factor_kappaB_activity", 0.3479], ["CD36_gene", 0.3478], ["cAMP-dependent_protein_kinase_specific_inhibitor", 0.3478], ["soluble_tumor_necrosis_factor_receptor", 0.3478], ["CD30_ligation", 0.3477], ["kinasedeficient", 0.3477], ["high_affinity_IL-2R", 0.3477], ["TCR-mediated_signaling", 0.3476], ["kappaB_DNA_binding_activity", 0.3476], ["T_cell_receptor_(TcR)_stimulation", 0.3476], ["T_cell_receptor_(TCR)_stimulation", 0.3476], ["tyrosine_kinase_receptor", 0.3475], ["Bipotential_T/natural_killer_(NK)_progenitor_cell", 0.3475], ["CD28_mAb", 0.3475], ["cellular_transcription_factor_E2F", 0.3475], ["interferon_beta_gene_transcription", 0.3474], ["CD16_ligand", 0.3474], ["immediate-early_activation_gene_expression", 0.3474], ["Duffy_Antigen_Receptor_for_Chemokines", 0.3474], ["c-sis/platelet-derived_growth_factor-B", 0.3474], ["interleukin6", 0.3474], ["TNF-alpha_promoter_element_kappa_3", 0.3473], ["T_cell_antigen_receptor_signal", 0.3473], ["nuclear_factor-activated_T_cells", 0.3473], ["B_lymphocyte-specific_gene_expression", 0.3473], ["interleukin-1beta", 0.3472], ["JAK_kinase_family", 0.3471], ["CD28_MoAb", 0.3471], ["anti_CD20_monoclonal_antibody", 0.3471], ["CD8+_T-cell", 0.3471], ["nuclear_factor_kappa_B_subunit_p65_mRNA", 0.347], ["T_cell_functional_response", 0.347], ["luciferase_reporter_gene_activation", 0.347], ["immunoglobulin_heavy_chain_expression", 0.347], ["cellular_gene_expression", 0.347], ["ligand-dependent_repression", 0.3469], ["granulocyte-macrophage_colony-stimulating_factor_receptor_alpha_gene", 0.3469], ["cytokine_mRNA", 0.3469], ["NF-kappa_B2_p100_gene", 0.3469], ["CD4+_T-cell_deletion", 0.3469], ["factor_of_activated_T_cell", 0.3469], ["tumor_necrosis_factor_receptor_1", 0.3468], ["Ras_pathway_activation", 0.3468], ["NF-AT-dependent_transcription", 0.3468], ["agonist-induced_monocytic_cell_adhesion", 0.3468], ["NF-kappaB_formation", 0.3467], ["JNK_MAP_kinase", 0.3467], ["myb-transformed_hemopoi-etic_cell", 0.3466], ["B_cell_immunoglobulin_production", 0.3466], ["tumor_necrosis_factor_receptor", 0.3466], ["immunoglobulin_heavy-chain_enhancer_mu_E1_site", 0.3466], ["AP-1_activation_pathway", 0.3466], ["IL-4/IL-13-induced_STAT6_activity", 0.3465], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_promoter", 0.3465], ["T-cell-mediated_immunity", 0.3465], ["Notch_signaling_pathway", 0.3465], ["TNF-alpha_transcription", 0.3465], ["kappa_B_enhancer", 0.3465], ["cytoplasmic_transcription_factor", 0.3464], ["T-cell-specific_expression", 0.3463], ["CD5+)_B_cell", 0.3463], ["hematopoietic_growth_factor-dependent_cell_line", 0.3462], ["inflammatory_cell", 0.3462], ["activated_neutrophil", 0.3461], ["proximal_IL-4_promoter", 0.3461], ["endothelial-leukocyte_adhesion_molecule_1", 0.3461], ["interleukin-10_receptor_intracellular_domain", 0.3461], ["TNF_receptor_system", 0.3461], ["55_kD_TNF_receptor", 0.3461], ["NF-AT_protein_expression", 0.346], ["serine_protease_factor_VIIa", 0.346], ["cytokine_dysregulation", 0.3459], ["TCR-stimulated_T_cell", 0.3459], ["tumor-specific_immune_response", 0.3459], ["serine-specific_protein_kinase", 0.3459], ["pleiotropic_immunomodulatory_molecule", 0.3458], ["multicomponent_cytokine_receptor", 0.3458], ["active_transcription_factor_CREB", 0.3458], ["EBNA2_mediated_transactivation", 0.3458], ["cytokine_receptor_gamma_chain_(gamma_c)_gene", 0.3458], ["cytokine_repertoire", 0.3457], ["human_interleukin-2_gene", 0.3457], ["proximal_IL-5_promoter", 0.3457], ["serine/threonine_protein_kinase_C", 0.3457], ["G_protein-coupled_transcription_factor_activation", 0.3457], ["interleukin-1_gene", 0.3456], ["TNF_receptor_1", 0.3456], ["T_cell_transcriptional_event", 0.3455], ["IL-2_regulation", 0.3454], ["NF-kappa_B-independent_suppression", 0.3454], ["IL-5-producing_T-cell_clone", 0.3454], ["monocyte_gene_expression", 0.3454], ["endogenous_cytokine_gene", 0.3454], ["IL2R_alpha_expression", 0.3453], ["activation-dependent_transcriptional_regulation", 0.3452], ["dephosphorylated_(activated)_pRB", 0.3452], ["staurosporine-sensitive_kinase", 0.3452], ["protein_kinase_inhibitor", 0.3451], ["TNF_stimulated_expression", 0.3451], ["CD4+_T_cell", 0.3451], ["T_cell_repertoire_development", 0.3451], ["LPS-stimulated_TNF-alpha_production", 0.345], ["B-cell-and_monocyte/macrophage-differentiation_lineage", 0.345], ["Intercellular_adhesion_molecule_1", 0.345], ["intercellular_adhesion_molecule_1", 0.345], ["Src_family_tyrosine_kinase", 0.345], ["anti-CD3_monoclonal_antibody", 0.345], ["cell_cycle_regulating_proteins", 0.3449], ["NF-kappaB_motif", 0.3449], ["tumor_necrosis_factor_(TNF)alpha", 0.3449], ["IL4_enhancer", 0.3449], ["specific_kappa_B_motif", 0.3449], ["IL-4_gene", 0.3448], ["cytokine-specific_mRNA", 0.3448], ["IL-2Rbeta_promoter", 0.3448], ["type_I_interleukin-1_receptor", 0.3448], ["cell_type-specific_reporter_gene_expression", 0.3447], ["I_kappa_B_alpha/MAD-3_gene_transcriptio", 0.3447], ["potentiates_immunological_function", 0.3447], ["active_death_effector_protease", 0.3447], ["vivo_transactivation_activity", 0.3447], ["P/I-inducible_fas_promoter_activation", 0.3447], ["T-cell-specific_Ets_protein", 0.3446], ["anti-CD3-activated_human_T_lymphocyte", 0.3446], ["transient_NF-kappa_B-DNA_interaction", 0.3445], ["TCR_signaling_cascade", 0.3445], ["IL-5_gene_segment", 0.3444], ["ligand-induced,_tyrosine-phosphorylated_docking_site", 0.3444], ["potential_nuclear_factor_(NF)-kappaB_binding_site", 0.3444], ["human_T_cell-specific_transcription_factor", 0.3444], ["monocyte_colony-stimulating_factor", 0.3443], ["platelet_endothelial_cell_adhesion_molecule", 0.3443], ["protein_kinase_C_(PKC)_inhibitor", 0.3443], ["tumor_necrosis_factor_(TNF)-alpha", 0.3443], ["Tumor_necrosis_factor_(TNF)-alpha", 0.3443], ["monocyte-macrophage_lineage-associated_surface_antigen", 0.3443], ["IL-1_receptor", 0.3442], ["STAT_transcription_factor_(STAT5)_pathway", 0.3442], ["cytokine_cooperativity", 0.3442], ["CD27/CD70_interaction", 0.3442], ["MHC_class_II_gene_activation", 0.3442], ["efficient_phosphorylation", 0.3441], ["CD4+_T-lymphocyte", 0.3441], ["immuno-cytochemistry", 0.3441], ["FK506_binding_protein", 0.3441], ["phosphatidic_acid_dependent_signalling", 0.3441], ["IL-6_mRNA_stability", 0.344], ["T_cell_immunity", 0.344], ["kappaB_enhancer", 0.344], ["interleukin_1beta", 0.3439], ["antigen-presenting_cells_to_CD4(+)_T_cell", 0.3439], ["B_cell-specifically_expressed", 0.3439], ["IL-2-induced_beta-casein", 0.3439], ["hGATA-3_transcriptional_activation_domain", 0.3439], ["activated_activator_protein-1_transcriptional_activity", 0.3438], ["kappa_immunoglobulin_germline_promoter", 0.3438], ["D1/CDR2-loop_ligand", 0.3438], ["myelomonocytic_lineage-specific_expression", 0.3437], ["PMA/A23187-induced_NF-AT", 0.3437], ["CCAAT_enhancer_binding_protein", 0.3436], ["E2F-mediated_transcription", 0.3435], ["IL-12R_beta_2_expression", 0.3435], ["IL-13-induced_response", 0.3435], ["IL1B_promoter_fragment", 0.3434], ["protein_kinase_A_expression_vector", 0.3434], ["CD3/CD28", 0.3434], ["inflammatory_gene", 0.3434], ["molecular_pathway", 0.3434], ["SEK/JNK/c-Jun/AP-1_pathway", 0.3433], ["T_cell-specific_expression", 0.3433], ["intracellular_peroxide_level", 0.3433], ["TNF-alpha_gene_transcription", 0.3432], ["inflammatory_cell_infiltration", 0.3432], ["STAT2_signaling_complex", 0.3432], ["variable_region_beta_chain_of_(V_beta)_T-cell_receptor", 0.3432], ["Fc_gamma_RIIA_stimulated_cell", 0.3431], ["post-transcriptional_regulation", 0.3431], ["CD8+_cytotoxic_T_lymphocyte_(CTL)_repertoire", 0.343], ["endothelial_cell_(EC)_activation", 0.343], ["human_platelet/endothelial_cell_adhesion_molecule-1_promoter", 0.343], ["neutrophil-specific_gene_expression", 0.343], ["novel_ets_transcription_factor", 0.343], ["basic_helix-loop-helix_protein-mediated_regulation", 0.343], ["Ag-induced_T_cell_activation", 0.343], ["human_T_cell_receptor_gamma_enhancer", 0.343], ["granulocyte_colony-stimulating_factor_receptor_promoter", 0.3429], ["immunosuppressive_activity", 0.3428], ["NF-kB_DNA_binding_activity", 0.3428], ["NK_cell-mediated_clearance", 0.3428], ["E2F-dependent_thymidine_kinase_regulation", 0.3427], ["anti-CD40_monoclonal_antibody", 0.3427], ["interleukin-1beta_mRNA", 0.3427], ["ROI-_and_5-LOX-independent_pathway", 0.3427], ["ionomycin-stimulated,_70Z/3-mediated_NFAT_activation", 0.3427], ["TK_inhibitor", 0.3427], ["T-cell_receptor_(TcR)_stimulation", 0.3426], ["Jun_NH(2)-terminal_kinase", 0.3426], ["c-sis/PDGF-B_promoter", 0.3426], ["human_CD34(+)_bone_marrow_cell", 0.3425], ["apoptosis_effector", 0.3425], ["TGF-beta_promoter", 0.3425], ["IL-4_mRNA", 0.3424], ["IL-10_receptor_site", 0.3424], ["CD4-CD8-_T_lymphocyte", 0.3423], ["mitogen-stimulated_cell", 0.3423], ["nuclear_factor_of_activated_cell", 0.3423], ["tumor_necrosis_factor-alpha_promoter", 0.3423], ["octamer-dependent_enhancer_activity", 0.3422], ["reactive_oxygen_intermediate_release", 0.3422], ["c-fos_mRNA_induction", 0.3422], ["I_kappa_B_alpha_(MAD3)-NF-kappa_B_dissociation", 0.3422], ["mitotic_signaling", 0.3422], ["lipopolysaccharide-induced_tyrosine_kinase_activation", 0.3422], ["CD8+_cell-derived_supernatant", 0.3422], ["activation_protein_1", 0.3421], ["lymphocyte_activation", 0.3421], ["IL-1ra_mRNA_expression", 0.3421], ["tyrosyl_phosphorylation", 0.342], ["dysregulated_cytokine_expression", 0.342], ["DNA_binding_NF-kappa_B_dimer", 0.342], ["cellular_DNA-binding_transcription_factor", 0.342], ["human_monocyte_PDGF(B)_mRNA", 0.3419], ["phosphatidyl_inositol_3-kinase", 0.3419], ["TCR-induced_apoptosis", 0.3419], ["multiple_signal_transduction_pathway", 0.3418], ["nuclear_factor-kappa_B_binding", 0.3418], ["tumor_necrosis_factor_receptor-associated_factor_6", 0.3418], ["myeloid_cell-derived_cytokine", 0.3418], ["interleukin_10", 0.3417], ["cell_cycle_regulator", 0.3417], ["Human_T_cell_activation", 0.3417], ["human_T_cell_activation", 0.3417], ["B-cell-specific_activator_protein-binding_site", 0.3417], ["transcription-enhancing_activity", 0.3416], ["leukocytes_gene_expression", 0.3416], ["thrombin-induced_tyrosine_phosphorylation", 0.3415], ["PCL_gamma_1_tyrosine_phosphorylation", 0.3415], ["human_T-cell_receptor_beta-chain_core_promoter", 0.3415], ["beta-chemokine_family", 0.3414], ["Fc_gamma_RII-mediated_antigen_presentation", 0.3414], ["Intrahepatic_lymphoid_follicle_(ILF)_formation", 0.3413], ["myeloid_lineage-associated_cytokine_receptor", 0.3413], ["IL-7R_alpha_chain", 0.3413], ["cyclin_E-dependent_kinase", 0.3412], ["immunoglobulin_heavy_chain_(IgH)_promoter", 0.3411], ["mechanism_of_activation", 0.3411], ["CD4_promoter_transactivation", 0.3411], ["endothelial_adhesion_molecule_induction", 0.341], ["oncogenic_Ets_transcription_factor", 0.341], ["M-CSF-induced_blood_monocyte", 0.341], ["myeloid-cell-specific_expression", 0.341], ["ligand-binding_activity", 0.341], ["NF-kappaB-DNA_binding", 0.3409], ["stem_cell_factor_(SCF)_receptor", 0.3409], ["phosphorylated_(inactivated)_pRB", 0.3409], ["tumor_necrosis_factor_(TNF)-alpha-induced_HIV-1_replication", 0.3409], ["reactive_oxygen_intermediate-release", 0.3408], ["kappa_B-driven_gene", 0.3408], ["c-myb_in_activated_T_cell", 0.3408], ["nonstimulating_CD28_mAb_9.3", 0.3408], ["anti-tumor_immune_response", 0.3408], ["anti-CD14_monoclonal_antibody", 0.3407], ["B-cell-specific_activator_protein", 0.3407], ["activated_HT-2_cell", 0.3407], ["cellular_transcription_factor", 0.3407], ["mouse_interleukin-2_receptor_alpha_gene", 0.3406], ["CD40_molecule", 0.3406], ["Janus_kinase/signal_transducer_and_activator_of_transcription", 0.3406], ["T-cell_clonal_expansion", 0.3406], ["human_granulocyte_macrophage-colony_stimulating_factor_promoter", 0.3405], ["CD33+,_CD56+,_CD16-_acute_leukemia", 0.3405], ["in_vitro_transcription_activity", 0.3405], ["tumor_necrosis_factor_alpha-induced_degradation", 0.3405], ["C5a-induced_reporter_gene_expression", 0.3405], ["Th2-type_lymphokine", 0.3404], ["signaling_intermediate", 0.3404], ["B-lymphocyte_activation", 0.3404], ["CD34(+)_cell", 0.3404], ["granulocyte-macrophage_colony_stimulating_factor", 0.3404], ["red_cell-specific_transcriptional_activator", 0.3403], ["mitogen-activated_T_lymphocyte", 0.3403], ["human_purified_CD34+_cell", 0.3403], ["HIV-1-induced_cell_fusion", 0.3403], ["kappa_E3'_enhancer", 0.3403], ["CD16_ligands", 0.3403], ["M-CSF_receptor_promoter", 0.3403], ["novel_B_cell-restricted_activity", 0.3402], ["STAT_protein_phosphorylation", 0.3402], ["phorbol_ester/ionomycin-induced_activation", 0.3402], ["antitumor_immune_response", 0.3402], ["cell_activation_signal", 0.3401], ["TNF_mRNA_accumulation", 0.3401], ["oxidative_signalling", 0.34], ["kappa_B_regulatory_element", 0.34], ["oxidant-regulation", 0.34], ["TGF-beta1_signaling", 0.34], ["cellular_protein_synthesis", 0.3399], ["cell_autonomous_coregulation", 0.3398], ["factor-kappa_B_(NF-kappa_B)_moiety", 0.3398], ["lymphocyte_transcriptional_activator", 0.3398], ["tumor_necrosis_factor_production", 0.3398], ["MAPK_kinase_1", 0.3398], ["TGF-beta_2", 0.3398], ["single_CD34+Thy-1+_cell", 0.3398], ["human_antigen-specific_CD4+_T-cell_line", 0.3398], ["TH2-regulated_response", 0.3398], ["CD4+_T_lymphocyte", 0.3398], ["E2F_transcriptional_activity", 0.3397], ["CD30+_cell", 0.3397], ["nuclear_transcription_factor_kB", 0.3397], ["cytokine_promoter_region", 0.3397], ["coagulation_protease_cascade", 0.3397], ["gamma_3_ECS-dependent_luciferase_reporter_gene_activation", 0.3396], ["PI_3-kinase)-induced_signaling_pathway", 0.3396], ["candidate_oncoprotein_Bcl-3", 0.3396], ["thrombin_receptor_mRNA_expression", 0.3396], ["hGM-CSF-mediated_cell_growth", 0.3396], ["CD40_cytoplasmic_domain_truncation", 0.3396], ["CD8+_cytotoxic_T_lymphocyte", 0.3395], ["SEA-activated_CD4+_spleen_T_cell", 0.3395], ["granulocyte_macrophage-colony_stimulating_factor", 0.3395], ["human_interleukin_(IL)-1_receptor", 0.3395], ["activated_tumorigenic_T_cell_line", 0.3394], ["IL-2R_alpha_promoter_construct", 0.3394], ["immunoregulatory_molecule", 0.3394], ["Lef/Tcf_transcription_factor_family", 0.3393], ["enhanced_gene_expression", 0.3393], ["cell_surface_PAF_receptor", 0.3393], ["NF_kappa_B_motif", 0.3393], ["purine-rich_IL-2_promoter_element", 0.3392], ["immunophilin_FKBP51", 0.3392], ["Th1-dominated_chronic_(auto)immune_inflammation", 0.3392], ["NF-IL-6_activity", 0.3391], ["E2A-HLF_chimaeric_transcription_factor", 0.3391], ["tyrosine-phosphorylated_motif", 0.339], ["cell_surface_mu/kappa", 0.339], ["Stat3-independent_BCL2_downregulation", 0.339], ["human_IL-5_gene_promoter", 0.339], ["tetracycline_trans-activator_protein", 0.339], ["endothelial_ICAM-1_expression", 0.3389], ["critical_regulatory_mechanism", 0.3389], ["enzyme-linked_immunosorbent_assay_procedure", 0.3389], ["vascular_cell_adhesion_molecule-1_(VCAM-1)_expression", 0.3389], ["natural_killer_(NK)_cell_activity", 0.3389], ["immunoglobulin_promoter_activity", 0.3389], ["Janus_kinase_3_tyrosine_kinase", 0.3389], ["Inhibitor_(IK)_of_IFN-gamma", 0.3389], ["antibody_to_CD3", 0.3387], ["interleukin_10_(IL-10)_receptor", 0.3387], ["tumor_necrosis_factor-alpha_production", 0.3387], ["nuclear_factor_kappa_B_binding", 0.3386], ["IL-2R_beta", 0.3386], ["BA-induced_cell_growth_inhibition", 0.3386], ["atherosclerosis-promoting_effect", 0.3386], ["TCR-mediated_apoptosis", 0.3386], ["peptide-loaded_dendritic_cell", 0.3386], ["immunosuppression", 0.3386], ["Immunosuppression", 0.3386], ["basic_helix_loop_helix_(bHLH)_transcription_factor", 0.3385], ["resting_B-cell_preparation", 0.3385], ["LPS-induced_activation", 0.3385], ["Wnt_signal_transduction_pathway", 0.3385], ["tyrosine_kinase_p56(lck)", 0.3385], ["IL-4_down-regulatory_effect", 0.3384], ["IL-5_synthesis", 0.3384], ["cytotoxic_effector_function", 0.3384], ["nuclear_factor-kappa_B/Rel_nuclear_activity", 0.3384], ["parental_granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)-dependent_cell_line", 0.3384], ["c-Myb_transcription_factor", 0.3384], ["immunosuppressant_action", 0.3384], ["Activated_mononuclear_cell", 0.3383], ["tumor_necrosis_factor-alpha_mRNA_accumulation", 0.3383], ["RNA_polymerase_III-dependent_gene_expression", 0.3383], ["LPS-induced_TNF-alpha_factor", 0.3383], ["secondary_response_pathway", 0.3383], ["C/EBPalpha-deficient_hematopoietic_cell", 0.3383], ["exogenous_IL-2", 0.3382], ["kappaB_regulatory_element", 0.3382], ["CES-2_cell-death_specification_protein", 0.3382], ["IL-4-induced_DNA_synthesis", 0.3381], ["phosphatidyl_inositol_3_kinase", 0.3381], ["CD1a+_cell", 0.338], ["immunoglobulin_kappa_light_chain_gene", 0.338], ["IL-2_promoter", 0.338], ["mouse_macrophage_inflammatory_protein-1alpha", 0.338], ["upstream_kinase", 0.3379], ["3,21-diacetoxy-5_beta,19-cyclopregn-5-ene-4,20-dione", 0.3379], ["natural_killer_(NK)_minus_T_cell_subtractive_library", 0.3379], ["IL-5_proximal_promoter_region", 0.3379], ["vascular_cell_adhesion_molecule_1", 0.3379], ["CD8(+)-T-cell_target", 0.3378], ["platelet-activating_factor_(PAF)-_receptor_antagonist", 0.3378], ["anti-onco-genic_transcription_factor", 0.3378], ["tumor_necrosis_factor-alpha_(TNF_alpha)_gene", 0.3378], ["human_granulocyte-macrophage_colony-stimulating_factor_gene_promoter", 0.3378], ["IFN-induced_tyrosine_phosphorylation", 0.3377], ["lck_gene_expression", 0.3377], ["serine/threonine_kinase_Akt/PKB", 0.3377], ["IL-5_gene", 0.3377], ["PKC_protein_expression", 0.3377], ["CREB/activating_transcription_factor_(ATF)_family", 0.3377], ["tumor_necrosis_factor-alpha_mRNA_level", 0.3377], ["T-cell-specific_promoter_sequence", 0.3377], ["TCR/CD3_ligation", 0.3377], ["cytoplasmic_IkappaB_inhibitor", 0.3377], ["cyclic_nucleotide-dependent_protein_kinase_inhibitor", 0.3376], ["nuclear_factor-kappa_B_subunit_p65", 0.3376], ["protein_kinase_C_(PKC)_dependent", 0.3376], ["human_monocyte_IL-1_receptor_antagonist", 0.3376], ["CD45_tyrosine_phosphatase", 0.3375], ["B_cell_receptor_coengagement", 0.3375], ["cyclin-dependent_kinase_4", 0.3375], ["IL-2_enhancer_construct", 0.3375], ["human_CD34+_hematopoietic_stem_cell", 0.3374], ["B-cell-specific_expression", 0.3374], ["cytokine_production_profile", 0.3374], ["cyclin-dependent_kinase_inhibitor", 0.3374], ["kinase_domain", 0.3374], ["sibling_CD34(+)CD38(-)_cell", 0.3374], ["human_monocyte_monokine_synthesis", 0.3372], ["immunoglobulin_gene_expression", 0.3372], ["I_kappa_B-alpha_mRNA", 0.3372], ["CD4+_T-cell", 0.3371], ["murine_pro-B_cell_line_BAF3", 0.3371], ["primary_human_lymphocyte_activation", 0.3371], ["TCR/CD3_stimulation", 0.3371], ["reactive_oxygen_intermediate_production", 0.3371], ["inflammatory_mediator", 0.337], ["eosinophil_specific_beta-chemokine", 0.337], ["ligand-receptor_interaction", 0.337], ["suppressor_of_immune_response_gene", 0.337], ["NF-AT/AP-1_transcription_factor", 0.337], ["IL-4R_alpha_chain", 0.337], ["ERK_pathway-specific_inhibitor", 0.3369], ["TNFR1_signaling", 0.3369], ["inhibitor_protein_I-kB", 0.3368], ["cyclosporin_A-sensitive_tumor_necrosis_factor", 0.3368], ["inhibitory_kappaB-alpha", 0.3368], ["gp41-induced_IL-10_up-regulation", 0.3368], ["promyelocytic/retinoic_acid_receptor_alpha_(RAR_alpha)_fusion_transcript", 0.3367], ["NF-AT-regulated_gene", 0.3367], ["CD11b+_bone_marrow_cell", 0.3366], ["interferon_beta_(IFN-beta)_promoter", 0.3366], ["HS-40_enhancer-mediated_activity", 0.3366], ["75_kd_TNF_receptor_(TR75)_expression", 0.3366], ["kappa_intron_enhancer", 0.3366], ["protein_kinase_A_site", 0.3366], ["IL-18_receptor", 0.3366], ["plasma_interleukin-1", 0.3365], ["p56lck-independent_pathway", 0.3365], ["granulocyte-macrophage_colony-stimulating_factor_gene", 0.3364], ["leukocyte_activation", 0.3364], ["proliferation-specific_transcription_factor_E2F1", 0.3364], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_receptor_alpha_gene", 0.3363], ["cAMP-dependent_protein_kinase", 0.3363], ["CD8(+)_T_cell", 0.3363], ["B_cell-specific_cell_surface_molecule", 0.3363], ["THP-1_mature_monocytic_cell_line", 0.3363], ["CD8(+)-T-cell_response", 0.3363], ["interleukin-1beta_(IL-1beta)_gene", 0.3363], ["Ras-dependent_signaling_pathways", 0.3362], ["activating_transcription_factor/cAMP_response_element_binding", 0.3362], ["mouse_IL-4_promoter", 0.3362], ["NF-kappa_B-binding_activity", 0.3362], ["immunomodulatory_agent", 0.3362], ["p38_MAP_kinase", 0.3362], ["Granulocyte-macrophage_colony-stimulating_factor", 0.3361], ["granulocyte-macrophage_colony-stimulating_factor", 0.3361], ["p21-activated_protein_kinase_1", 0.3361], ["TRAF3-mediated_signal_transduction", 0.3361], ["PWM-generated_B-cell_mitogenesis", 0.3361], ["TNF-treated_T_cell", 0.336], ["CD20/B1_antigen", 0.336], ["peptide-specific_T-cell_line", 0.3359], ["IL-10_inhibition", 0.3359], ["receptor-ligand_interactions", 0.3359], ["hematopoietic_cytokine", 0.3358], ["STAT-1_phosphorylation", 0.3358], ["TGF-beta1-transcribing_macrophage", 0.3358], ["c-fos_sense_mRNA_expression", 0.3358], ["intercellular_adhesion_molecule-1_(ICAM-1)_promoter", 0.3358], ["cell_effector_function", 0.3358], ["tumor_necrosis_factor_(TNF)-alpha_gene", 0.3358], ["HIV_type_1_protease_activation", 0.3357], ["IL-8_messenger_RNA", 0.3357], ["cellular_I_kappa_B-alpha_pool", 0.3357], ["NF-kappa_B-DNA_complex", 0.3357], ["human_tumor_necrosis_factor_alpha_promoter_region", 0.3357], ["cytokine_profile", 0.3356], ["cell-surface_IFNgamma_receptor", 0.3356], ["nuclear_factor-IL-6beta", 0.3356], ["IL-1_converting_enzyme", 0.3355], ["27-amino_acid_regulatory_motif", 0.3355], ["cellular_mechanism", 0.3355], ["tumor_necrosis_factor_receptor-associated_factor", 0.3355], ["TF_gene_expression", 0.3354], ["NF-AT1_transcription_factor_complex", 0.3354], ["transcription_factor_activity", 0.3354], ["nuclear_factor-kappa_B/Rel_induction", 0.3353], ["cytokine_secretion_profile", 0.3353], ["heterologous_promoter_(herpes_thymidine_kinase)_construct", 0.3353], ["triiodothyronine_(T3)_mononuclear_leukocyte_receptor_kinetics", 0.3352], ["HIV-mediated_mechanism", 0.3352], ["redox-sensitive_transcription_factor", 0.3352], ["intracellular_phosphorylated_STAT-1", 0.3351], ["PMA-induced_HIV-1_p24_antigen_production", 0.3351], ["erythroleukemic_cell_line_K562", 0.3351], ["TNF-mediated_induction", 0.3351], ["IL-13R_alpha1-positive_THP-1_cell", 0.3351], ["granulocyte-_macrophage_colony-stimulating_factor", 0.3349], ["Th1_cytokine", 0.3349], ["I_kappa_B_mRNA", 0.3349], ["C3a-mediated_enhancement", 0.3349], ["RelA_containing_nuclear_factor_kappaB_(NFkappaB)_complex", 0.3349], ["NF-kappa_B/I_kappa_B_dissociation", 0.3348], ["CD3_ligation", 0.3348], ["activated_Stat-3_protein", 0.3348], ["CD4+/CD45RO_T_cell", 0.3348], ["JAK3-deficient_severe_combined_immunodeficiency_lymphocyte", 0.3347], ["complex_regulatory_mechanism", 0.3347], ["nuclear_factor_(NK)-_kappa_B", 0.3346], ["Syk_kinase", 0.3346], ["CCAAT/enhancer-binding_protein", 0.3345], ["macrophage-lymphocyte_interaction", 0.3345], ["NK_cell-mediated_lysis", 0.3345], ["interferon_regulatory_factor_1", 0.3344], ["hGM-CSF-dependent_cell_proliferation", 0.3344], ["T-cell_oncogenic_protein_HOX11", 0.3344], ["granulocyte/macrophage_colony_stimulating_factor", 0.3344], ["tyrosine_phosphorylation", 0.3344], ["human_IL-5_synthesis", 0.3343], ["lymphotoxin_(LT;_TNF-beta)_gene", 0.3343], ["cAMP-dependent_intracellular_signaling_pathway", 0.3343], ["cell-specific_expression", 0.3342], ["G(Anh)MTetra-induced_IL-6_mRNA_expression", 0.3342], ["CD2_antigen", 0.3342], ["IL-13-treated_human_peripheral_monocyte_nuclear_extract", 0.3342], ["CCAAT/enhancer_binding_protein", 0.3342], ["gp160-induced_NF-kappa_B_complex", 0.3342], ["regulators_of_transcription", 0.3342], ["tissue-specific_primary_transcriptional_response", 0.3342], ["steroid-regulated_expression", 0.3342], ["tumor_necrosis_factor-alpha_(TNF-alpha)_gene", 0.3342], ["host_natural_killer_(NK)_cell_response", 0.3342], ["phosphatidylinositol_3-kinase_inhibitor", 0.3341], ["cyclooxygenase-2", 0.3341], ["MZF-1_transcriptional_regulation", 0.3341], ["cytokine_treatment", 0.3341], ["TcR_delta_gene_expression", 0.3341], ["phosphorylations", 0.334], ["anti-CD2_receptor_antibody", 0.334], ["ATP-dependent_26_S_multicatalytic_protease", 0.3339], ["TCR-inducible_gene_expression", 0.3338], ["B-cell-specific_transcription", 0.3338], ["TGF-beta_gene_promoter", 0.3338], ["Tcf-dependent_transcription", 0.3338], ["IL-2_promoter_region", 0.3338], ["cAMP_response_element-binding_protein/activation_transcription_factor", 0.3337], ["T_effector_cell", 0.3337], ["Ras/protein_kinase_C_and_calcium_pathway", 0.3337], ["3,21-diacetoxy-5_beta,19-cyclopregna-2,9(11)-diene-4,20-dione", 0.3337], ["I_kappaB_molecule", 0.3336], ["c-Jun_phosphorylation", 0.3336], ["phosphatidylinositol-3-kinase", 0.3336], ["kinase_inhibitor_H-89", 0.3336], ["IL-1alpha_gene", 0.3335], ["T_cell_receptor_stimulation", 0.3335], ["multipotential_cytokine", 0.3335], ["allogen-specific_human_CD4+_T_cell_line", 0.3335], ["IL-4-driven_germline_C_epsilon_transcription", 0.3335], ["TNF_receptor-associated_factor_6", 0.3335], ["NF_kappa_B_binding_complex", 0.3335], ["granulocyte/macrophage_colony-stimulating_factor", 0.3335], ["inflammation", 0.3335], ["TNF-alpha_mRNA_transcript", 0.3335], ["immunohistochemical_study", 0.3334], ["CD8+_T_cell_clone", 0.3334], ["biochemical_pathway", 0.3333], ["lymphoid-specific_octamer-binding_factor", 0.3333], ["T-cell_antigen_receptor_function", 0.3333], ["T-_cell_mitogen", 0.3333], ["inflammatory_response", 0.3333], ["inducible_N-terminal_transactivation_domain", 0.3333], ["granulocyte_macrophage_colony-stimulating_factor", 0.3333], ["heterologous_herpes_thymidine_kinase_(TK)_promoter", 0.3333], ["cDNA_fusion_protein", 0.3332], ["T-cell_receptor_loci", 0.3332], ["p65-containing_NF-kappa_B", 0.3332], ["protein_kinase_inhibitor_H-7", 0.3332], ["human_interleukin-2_receptor_alpha_gene", 0.3332], ["platelet-endothelial_cell_adhesion_molecule-1", 0.3332], ["CCAAT/enhancer-binding_protein-beta_(C/EBP-beta)_binding_site", 0.3331], ["nuclear_factor-kappaB_(NF-kappaB)/Rel_family_member", 0.3331], ["peripheral_blood_T_cell_proliferation", 0.3331], ["neutralizing_anti-TNF_alpha_monoclonal_antibody", 0.3331], ["protein_kinase_C_(PKC)_isoenzyme", 0.333], ["human_IL-4_receptor_alpha-chain", 0.333], ["signal-transduction_pathway", 0.333], ["CD14_gene", 0.333], ["RelA/NF-kappaB1_binding_complex", 0.333], ["MAPk_kinase", 0.3329], ["p70(S6)-kinase_activation", 0.3329], ["T_cell_receptor_cross-linking", 0.3329], ["CD4_gene_transcription", 0.3328], ["protein_kinase_A-independent", 0.3328], ["regulatory_(B)_subunit", 0.3328], ["dexamethasone-induced_transcriptional_activation", 0.3328], ["IL-5_induced_signal", 0.3328], ["transcription_mechanism", 0.3327], ["H-7-sensitive_kinase_pathway", 0.3327], ["LPS_signaling_receptor", 0.3327], ["IL-1RI_and_IL-1RII_mRNA_level", 0.3327], ["TGF-beta1_mRNA_synthesis", 0.3327], ["murine_cyclin-dependent_kinase_inhibitor_gene", 0.3326], ["T_lymphocyte_growth_factor", 0.3326], ["gene_regulatory_activity", 0.3326], ["tyrosine_kinase-linked_receptor_agonist", 0.3325], ["effector_T_cell", 0.3325], ["putative_transcriptional_regulator", 0.3325], ["IL-13_mRNA_expression", 0.3324], ["immunoglobulin_enhancer", 0.3324], ["nonspecific_protein_kinase_inhibition", 0.3324], ["activation-induced_p65/p50", 0.3323], ["NF-kappa_B_binding_activity", 0.3323], ["NF-kappa_B1_promoter", 0.3322], ["IL-2_promoter-reporter", 0.3322], ["interleukin-10_(IL-10)_receptor", 0.3322], ["T-cell_signal_transduction", 0.3322], ["nuclear_NF-kappaB_activity", 0.3322], ["PKB/PI3-kinase_activity", 0.3321], ["nuclear_factor-kappaB-mediated_phenomenon", 0.3321], ["ERK_kinase", 0.3321], ["NF-chi_B_enhancer", 0.3321], ["monocyte_chemoattractant_protein-1_secretion", 0.332], ["IL-5_mRNA", 0.332], ["IL-1_signal_transduction", 0.3319], ["transcription_factor,_activated_protein-1", 0.3319], ["kappa_B_DNA_motif", 0.3318], ["stromal-derived_cytokine", 0.3318], ["nuclear_factor-IL6_motif", 0.3318], ["LPS-stimulated_TNF_production", 0.3318], ["Interleukin-9_receptor_(IL-9R)_complex", 0.3318], ["nuclear_factor-kappaB_(NF-kappaB)_complex", 0.3318], ["immunocytochemical_analysis", 0.3318], ["stromal_cell-mediated_Tcell_rescue", 0.3318], ["phosphatidylinositol_3-kinase_(PI_3-kinase)_activity", 0.3317], ["human_IL-5_(hIL-5)_promoter", 0.3317], ["endothelial_leukocyte_adhesion_molecule", 0.3317], ["STAT1_phosphorylation", 0.3317], ["CD41_immunofluorescence", 0.3316], ["E2A-HLF_(hepatic_leukemia_factor)_oncoprotein", 0.3316], ["CD4+_T-cell_subset", 0.3315], ["phosphatidylinositol_3-kinase", 0.3315], ["Phosphatidylinositol_3-kinase", 0.3315], ["nuclear_factor_kappaB_(NF-kappaB)_system", 0.3315], ["tyrosine_phosphorylated_Jak1", 0.3315], ["signal_transduction_pathway", 0.3314], ["interleukin-10", 0.3314], ["Interleukin-10", 0.3314], ["TCR-mediated_gene_transcription", 0.3314], ["inducible_phosphorylation", 0.3314], ["PKC-dependent_signaling_system", 0.3313], ["cyclooxygenase/5-lipoxygenase_anti-inflammatory_compound", 0.3313], ["polymerized_mutated_NF-kappaB_binding_sequence", 0.3313], ["intracellular_prooxidant_state", 0.3313], ["human_T_cell_transcription_factor", 0.3313], ["proto-oncogene_activation", 0.3313], ["extra_C-terminal_peptide", 0.3312], ["PI_3-kinase-induced_pathway", 0.3312], ["antagonistic_anti-TR55_antibody", 0.3312], ["STAT5_phosphorylation", 0.3311], ["cellular_oxidant_stress", 0.3311], ["cell_cycle_activation_program", 0.3311], ["antioxidant_mechanism", 0.3311], ["transcriptional_regulatory_factor", 0.331], ["cytoplasmic_effector_protein", 0.331], ["TPA-treated_HL-60_cell", 0.331], ["peroxisomal_proliferator-activated_receptor_gamma", 0.3309], ["IL-1_receptor_complex", 0.3309], ["B_cell-specific_transcription", 0.3308], ["IL-4_synthesis", 0.3308], ["TLR-dependent_transcription", 0.3308], ["NF-IL-6_binding_activity", 0.3307], ["human_PAF_receptor_transcript_1", 0.3307], ["B7-negative_(endothelial)_accessory_cell", 0.3307], ["context-dependent_transcriptional_activation", 0.3307], ["interleukin-15", 0.3306], ["CIITA_B-cell-specific_promoter_suppression", 0.3306], ["cell_cycle-dependent_initiation", 0.3306], ["IL-1_receptor_antagonist", 0.3305], ["G(Anh)MTetra-induced_IL-1_beta_mRNA_accumulation", 0.3305], ["cellular_immune_response", 0.3305], ["T-cell_cycle_progression", 0.3305], ["CD4_receptor", 0.3305], ["murine_p105_NF-kappa_B_gene", 0.3305], ["anti-pml/RAR-alpha_CD4(+)_T-cell_clone", 0.3305], ["intrinsic_kinase_domain", 0.3304], ["cytokine_mobilized_peripheral_blood", 0.3304], ["cord_blood_CD4+_T_cell", 0.3304], ["phosphorylationdependent", 0.3304], ["multiple_signaling_protein", 0.3304], ["transcriptional_regulatory_protein", 0.3304], ["cell-specific_gene_transcription", 0.3303], ["CD3+_cell", 0.3302], ["transcription_activation", 0.3302], ["T-cell_oncogene", 0.3302], ["tumor_necrosis_factor-alpha_generation", 0.3302], ["BCR-mediated_signal_transduction", 0.3302], ["constitutively_expressed_transcription_factor", 0.3301], ["murine_B_cell_line_K46", 0.3301], ["T-cell_mitogen", 0.33], ["CD4+_T_cell_subset", 0.33], ["viral_gene_regulatory_mechanism", 0.3299], ["JAK-STAT_signaling", 0.3299], ["cytokine_profiles", 0.3299], ["SN50-mediated_apoptosis", 0.3298], ["nuclear_factor_of_activated_T_cells_(NFAT)_group", 0.3298], ["rapid_Ca2+-mediated_activation", 0.3298], ["phorbol_ester-inducible_transcription_factor_AP1", 0.3297], ["Anti-TR55_antibody_cross-linking", 0.3297], ["B_cell_restricted_coactivator", 0.3297], ["interferon_regulatory_factor_(IRF)_family", 0.3296], ["nuclear_factor_of_activated_T_cells_(NFAT)_element", 0.3296], ["T-cell_activation_response_element", 0.3296], ["human_CD3-CD16+_natural_killer_cell", 0.3296], ["murine_macrophage_cell_line_RAW_264.7", 0.3296], ["mature_T-cell_proliferation", 0.3296], ["B_cell_lineage-specific_activator_protein_(BSAP)_site", 0.3295], ["T_helper_1-type_cytokine", 0.3295], ["global_TCR/CD3-signaling_defect", 0.3295], ["costimulated_CD4+_T_cell", 0.3295], ["transcriptional_activation", 0.3294], ["TCL1_protein_expression", 0.3294], ["intrinsic_transcriptional_activation_motif", 0.3294], ["IL-3_promoter", 0.3294], ["STAT-mediated_transcription", 0.3293], ["12-O-tetradecanoylphorbol-13-acetate_induced_hemopoietic_differentiation", 0.3293], ["receptor-effector_mechanism", 0.3293], ["T_cell_receptor_beta_gene", 0.3293], ["tumor_necrosis_factor-alpha_secretion", 0.3293], ["death-inducing_ligand", 0.3293], ["erythroid_cell_transcription_factor", 0.3293], ["Janus_kinase_3_(JAK3)_activity", 0.3293], ["cytotoxic_T_cell_response", 0.3292], ["T_cell-receptor-induced_FasL_upregulation", 0.3292], ["endothelial_leukocyte_adhesion_molecule-1", 0.3291], ["IL-1-dependent_NFkappaB_activity", 0.3291], ["CD40_ligand+_hyper_IgM_syndrome", 0.3291], ["protein_tyrosine_phosphatase_(PTPase)_inhibitor", 0.3291], ["Ipr_CD4-8-_T_cell", 0.3291], ["oxidative_stress-inducing_signal", 0.3291], ["novel_B-cell", 0.329], ["TCRalpha_beta_cell", 0.329], ["immunologically_related_octamer-binding_protein", 0.3289], ["immune_cell_function", 0.3289], ["TNF-alpha-mediated_induction", 0.3289], ["interleukin-10_receptor", 0.3289], ["nuclear_kappaB_DNA-binding_activity", 0.3289], ["immunoperoxidase", 0.3289], ["PKA_transduction_pathway", 0.3289], ["TGF-beta2", 0.3288], ["filarial_antigen_stimulated_T-cell", 0.3288], ["anti-inflammatory", 0.3288], ["TNF_receptor_family_member", 0.3287], ["NF-kappa_B_activity", 0.3287], ["lipopolysaccharide_(LPS)-induced_TF_expression", 0.3287], ["p56_Src_family_non-receptor_tyrosine_kinase", 0.3286], ["N-terminal_(1-60)_peptide", 0.3286], ["anti-inflammatory_potency", 0.3286], ["PKC-depleted_T_cell", 0.3286], ["type_2_cytokine", 0.3286], ["recombinant_vascular-cell_adhesion_molecule-1", 0.3285], ["two-color_immunohistochemistry", 0.3285], ["THP-1_macrophage_cell_line", 0.3285], ["Rel_transcription_factor_family", 0.3285], ["human_type_II_interleukin-1", 0.3285], ["IL-1_receptor_antagonist_(IL1-RA)_gene", 0.3284], ["alpha_beta_T_cell_development", 0.3284], ["T_cell_functional_phenotype", 0.3284], ["Th1_cell_development", 0.3283], ["IL-4Ralpha_chain", 0.3283], ["CD14_mRNA", 0.3283], ["SN50-induced_apoptosis", 0.3283], ["granulocyte/_macrophage_colony-stimulating_factor", 0.3283], ["IkappaB_cytoplasmic_inhibitor", 0.3283], ["phorbol_ester-induced_monocytic_differentiation", 0.3282], ["NF-_(kappa)B_activity", 0.3282], ["gamma_interferon_(IFN-gamma)-induced_HLA-DR_expression", 0.3281], ["interferon_(IFN)_regulatory_factor", 0.3281], ["enhancer_activation", 0.3281], ["T-cell_receptor_(TcR)_gene", 0.3281], ["chemical-induced_erythroleukemia_cell_line", 0.328], ["immunosuppressive_agents", 0.3279], ["T-cell_costimulation", 0.3279], ["ubiquitin-proteasome_pathway", 0.3279], ["bcl-xL_gene_expression", 0.3278], ["TNF-alpha-activity_neutralizing_antibodie", 0.3278], ["primary_physiological_regulator", 0.3278], ["IL2R_gamma", 0.3278], ["TNF-alpha_receptor", 0.3277], ["I_kappa_B_alpha/MAD-3_mRNA_level", 0.3277], ["exogenous_IL-2_growth_factor", 0.3277], ["IL_6-induced_differentiation", 0.3277], ["activated_blood_mononuclear_cell", 0.3276], ["CD44-CD25+,_CD4-CD8-_double-negative_stage", 0.3276], ["pharmacokinetic_mechanism", 0.3276], ["cytotoxic_cytokine", 0.3275], ["CD19_cross-linked_BLIN-1_cell", 0.3275], ["activator_protein_1-mediated_transcription", 0.3275], ["mammalian_NF-kappaB", 0.3275], ["CD45RO+_(memory)_T_lymphocyte", 0.3275], ["T_cell_receptor-beta", 0.3274], ["nuclear_factor_kappa_B_(NF-kappaB)_site", 0.3274], ["rapid_phosphorylation", 0.3274], ["intracellular_reactive_oxygen_species", 0.3274], ["cytokine-induced_VCAM-1_expression", 0.3273], ["Jun_N-terminal_kinase", 0.3273], ["pro-B-cell_development", 0.3273], ["apoptosis-mediating_receptor", 0.3273], ["TNF_receptor", 0.3273], ["IL-2-inducible_component", 0.3272], ["human_IL4_transcription", 0.3272], ["TCRalpha_enhancer_function", 0.3272], ["nuclear_factor-mu_negative_regulator_(NF-muNR)_enhancer_repressor_overlap_nuclear_matrix_attachment_regions", 0.3271], ["transcriptional_regulation", 0.3271], ["biological_oxidation", 0.3271], ["Janus_kinase/STAT_signaling_pathway", 0.3271], ["nuclear_factor_kappa_B/Rel_nuclear_activity", 0.3271], ["bound_kinase", 0.3271], ["nuclear_NF-kappa_B_expression", 0.327], ["immunoglobulin_heavy-chain_promoter", 0.327], ["TPA-activated_cell", 0.327], ["T-cell_inhibitory_effect", 0.327], ["anti-CD2_mAb", 0.327], ["IL-5-nonproducing_T-cell_clone", 0.327], ["CD69_promoter-based_reporter_gene_construct", 0.327], ["intracellular_signal-transducing_protein_Stat6", 0.3269], ["lymphoid-specific_transcription_complex", 0.3269], ["NF-kappa_B/I_kappa_B_component", 0.3269], ["anti-inflammatory_drug", 0.3269], ["agonist-dependent_phosphorylation", 0.3268], ["mouse_granulocyte/macrophage_colony-stimulating_factor", 0.3268], ["interferon_regulatory_factor-1", 0.3268], ["NK_cell-induced_HLA-DR_alpha_mRNA_expression", 0.3268], ["cytokine_imbalance", 0.3268], ["IL-6_stimulation", 0.3268], ["lipopolysaccharide_(LPS)-dependent_cell-free_activation_system", 0.3268], ["beta_interferon_promoter", 0.3268], ["combined_immunochemistry_in_situ_hybridization_histochemistry_techniquep", 0.3267], ["p65-RelA_protein_expression", 0.3267], ["CD4(+)_human_T_cell", 0.3267], ["T_cell_antigen_receptor-induced_protein", 0.3267], ["activated_B_cell", 0.3266], ["TCR-stimulated_protein", 0.3266], ["lesion-derived_CD4+_T-cell_clone", 0.3266], ["interferon-regulated_gene", 0.3266], ["IFN-gamma-producing_T_helper_1_(Th1)_cell", 0.3266], ["cellular_regulation", 0.3265], ["nuclear_factor_kappa_B_subunit_p65", 0.3265], ["murine_macrophage_12/15-lipoxygenase_activity", 0.3265], ["granulocyte/macrophage-colony-stimulating_factor", 0.3265], ["CHO-CD14_cell", 0.3265], ["T_cell_growth_factor", 0.3264], ["tumor_necrosis_factor_receptor-1", 0.3264], ["transcription_factor_NFkappaB", 0.3263], ["CD26_expression", 0.3263], ["mouse_granulocyte/macrophage_colony-stimulating_factor_gene", 0.3263], ["physiological_regulation", 0.3263], ["signal-induced_phosphorylation", 0.3263], ["transcriptional_mechanism", 0.3263], ["transcriptionally_active_factor", 0.3263], ["tyrosine-phosphorylated_peptide", 0.3263], ["LPS-induced_TK_activity", 0.3262], ["vascular-specific_gene_expression", 0.3262], ["IL-2R_alpha_activaiton", 0.3262], ["lymphoid_src_kinase", 0.3262], ["JAK2_Janus_kinase", 0.3261], ["Ras/protein_kinase_C", 0.3261], ["naive_CD4+_T_cell", 0.3261], ["normal_CD56+,_CD33+,_CD16-_counterpart_cell", 0.3261], ["negative_regulatory_pathway", 0.3261], ["c-Jun_amino-terminal_kinase", 0.326], ["E2A-HLF_(for_hepatic_leukaemia_factor)_fusion_gene", 0.326], ["MAP_kinase_p38", 0.326], ["ligand-specific_alpha_chain", 0.326], ["human_IL-2R_beta", 0.326], ["vivo_generated_LAK_cell-mediated_lysis", 0.326], ["nuclear_factor_(NF-kappa_B)_target_sequence", 0.326], ["immunoregulatory_function", 0.326], ["IL-10_receptor", 0.3259], ["IL-6_neutralizing_antibody", 0.3259], ["IL-2R_alpha", 0.3259], ["cell_gene_CD21", 0.3259], ["beta-globin-expressing_murine_erythroid_leukemia_cell", 0.3259], ["MRL-Ipr/Ipr_(Ipr)_peripheral_CD4-CD8-_(CD4-8-)_T_cell", 0.3258], ["TF_gene_transcription", 0.3258], ["cytokine_gene_cluster", 0.3258], ["IL-1R_gene", 0.3258], ["B_cell_activation_event", 0.3257], ["IFN-gamma-induced_tyrosine_phosphorylation", 0.3257], ["Jun_NH2-terminal_kinase", 0.3257], ["immunoglobulin_(Ig)_expressing_B_cell", 0.3257], ["human_leukemic_CD4+_T-lymphocyte_cell_line", 0.3257], ["NF-kappa_B_suppression", 0.3256], ["oncogenic_E2A-HLF_fusion_protein", 0.3256], ["human_interferon_regulatory_factor_2_gene", 0.3256], ["cAMP_signaling_pathway", 0.3256], ["T_cell_activating_signal", 0.3256], ["monocytic_cell_lineage", 0.3255], ["human_tumor_necrosis_factor_alpha_(TNF-alpha)_gene", 0.3255], ["phosphorylation", 0.3255], ["T-cell_receptor_stimulation", 0.3255], ["PI3-kinase_pathway", 0.3255], ["immunosuppressive_agent", 0.3255], ["IFN-stimulated_gene_expression", 0.3255], ["essential_transcription_factor", 0.3255], ["endothelial_expression", 0.3254], ["SCF_+_Epo-induced_erythroid_colony_growth", 0.3254], ["cellularly_encoded_transcription_factor", 0.3253], ["NF-kappaB_action", 0.3253], ["cell_type-specific_gene_expression", 0.3253], ["IL-6_luciferase_activity", 0.3253], ["interleukin_16", 0.3253], ["leukemic_cell_line_K562", 0.3253], ["IL-1_stimulation", 0.3253], ["transduction/transcription_factor", 0.3252], ["immunoglobulin_heavy_chain_(IgH)_gene_rearrangement", 0.3252], ["human_CD34+_erythroid_progenitor_cell", 0.3252], ["STAT6_phosphorylation", 0.3251], ["IL-2R_alpha_expression", 0.3251], ["cytoplasmic_inhibitory_IkBalpha_protein_degradation", 0.3251], ["cell_death_specification_protein", 0.3251], ["T-helper_lymphocyte_2_(Th2)_phenotype", 0.3251], ["IL-4_stimulation", 0.325], ["IL-1beta_protein", 0.325], ["FGF_receptor-bearing_Jurkat_T_cell", 0.3249], ["PWM-generated_B-cell_proliferation", 0.3249], ["transcription_factor_Oct-2A", 0.3249], ["human_CD34+_cord_blood_cell_(CB)_subset", 0.3249], ["endothelial_cell_surface_adhesion_molecule", 0.3249], ["human_T-cell_leukemia_virus_I_transactivating_protein", 0.3249], ["-independent_pathway", 0.3249], ["CD28_response_element", 0.3248], ["T_helper_cell_differentiation_system", 0.3248], ["murine_basic_helix-loop-helix_transcription_factor_gene", 0.3248], ["multiple_effector_pathway", 0.3248], ["serine/threonine_protein_kinase", 0.3247], ["IL-10-induced_modulation", 0.3246], ["Ras_signaling_pathway", 0.3246], ["platelet/endothelial_cell_adhesion_molecule-1", 0.3246], ["C-terminal_peptide", 0.3245], ["serine/threonine_kinase", 0.3245], ["IL2_expression", 0.3245], ["PKC_inhibitor_H7", 0.3245], ["lymphocyte-specific_gene_expression", 0.3244], ["human_CD36_gene_promoter", 0.3244], ["murine_macrophage_12-lipoxygenase", 0.3244], ["IL-2mRNA", 0.3244], ["TNF-alpha-inuced_apoptosis", 0.3244], ["LPS-stimulated_monocyte", 0.3244], ["plasma_membrane_CD14", 0.3244], ["NF-kappaB_binding_complex", 0.3244], ["TNF-alpha_protein", 0.3243], ["timulus-dependent_CD44_transcription", 0.3243], ["pleiotropic_cytokine", 0.3243], ["CD4_positive_T_cell", 0.3243], ["activation-dependent_cell_surface_marker", 0.3242], ["TPA-dependent_activation", 0.3242], ["hematopoietin/cytokine_receptor_superfamily", 0.3242], ["CD8_molecule", 0.3241], ["immuno-histochemical_analysis", 0.3241], ["HIV-1_gp41-induced_IL-10_up-regulation", 0.3241], ["endothelial-leukocyte_adhesion_molecule-1", 0.3241], ["CD45R0_T_cell", 0.324], ["CD3-epsilon_gene_expression", 0.324], ["globin_gene_activation", 0.324], ["activation-inducible_enhancer_element", 0.3239], ["endothelial-RAW264.7_coculture_system", 0.3239], ["c-fos_mRNA_level", 0.3239], ["RNA_polymerase_II_transcription_system", 0.3239], ["heterodimeric_NFKB2(p49)/RelA(p65)_protein", 0.3238], ["intrafollicular_T-cell", 0.3238], ["chimeric_cytokine_receptor", 0.3238], ["B_cell_specific_expression", 0.3238], ["in_vitro_monocyte-derived_macrophage", 0.3238], ["proinflammatory_cytokine_gene", 0.3237], ["leukocyte_clearance_mechanism", 0.3237], ["erythroleukemia_cell_line_K562", 0.3237], ["CD14_antigen", 0.3237], ["JAK2/STAT5_activation", 0.3237], ["EBV_nuclear_protein_2_(EBNA-2)_transactivator", 0.3237], ["intracellular_adhesion_molecule_(ICAM)-1", 0.3237], ["bipartite_human_interleukin-4_(IL-4)_receptor", 0.3236], ["immunosuppressive_compound", 0.3236], ["alpha-globin_HS-40_enhancer", 0.3236], ["anti-CD2_antibody", 0.3235], ["serine_phosphorylation", 0.3234], ["CD45RA+_(naive)_T_lymphocyte", 0.3234], ["ex_vivo_HIV-1_expression", 0.3234], ["T-cell_functional_region", 0.3234], ["calmodulin-regulated_kinase", 0.3233], ["CD4(+)_T_cell", 0.3232], ["transcriptional_regulating_protein", 0.3232], ["TCRalpha_enhancer", 0.3232], ["pyruvate_kinase_erythroid-specific_promoter", 0.3232], ["IL_6-induced_IgM_production", 0.3232], ["human_interleukin-4_(IL-4)_gene", 0.3231], ["IL-5-nonproducing_T_cell_clone", 0.3231], ["caspase-3_inhibitor", 0.323], ["immunosuppressant_binding_protein", 0.3229], ["TNF-alpha-treated_T_lymphocyte", 0.3229], ["activating_transcription_factor/cAMP_response_element_binding_(ATF/CREB)_binding_site", 0.3229], ["IL-1_gene", 0.3229], ["biochemical_mechanism", 0.3229], ["I_kappa_B_alpha_subunit", 0.3229], ["upstream_nuclear_factor-kappa_B_(NF-kappa_B)_site", 0.3228], ["proteasome_activation", 0.3228], ["I_kappa_B-like_protein", 0.3228], ["activated_peripheral_T_lymphocyte", 0.3228], ["intracellular_response", 0.3228], ["normal_activated_B_cell", 0.3227], ["prolonged_immunosuppression", 0.3227], ["ligandactivated", 0.3227], ["cAMP-dependent_signaling_pathway", 0.3227], ["polyomavirus_enhancer-binding_protein_2/core-binding_factor_(PEBP2/CBF)_family", 0.3226], ["receptor_tyrosine_phosphorylation", 0.3226], ["AML/PEBP2/CBF_family_of_transcription_factor", 0.3226], ["serine/threonine_protein_kinase_inhibitor_H-7", 0.3226], ["transcription_factor_NF-E2", 0.3226], ["NF-kappa_B-related_moiety", 0.3225], ["T_cell_precursor", 0.3225], ["IL-8_antigen", 0.3225], ["GM-CSF_gene_activation", 0.3225], ["jun/fos_early_response_gene_expression", 0.3225], ["c-Jun_N-terminal_transactivation_domain", 0.3225], ["T_cell_costimulation", 0.3224], ["Duffy_antigen/chemokine_receptor_gene", 0.3224], ["mouse_IL-2R_alpha_gene", 0.3224], ["pro-inflammatory_stimulus", 0.3224], ["tumor_metastasis_regulation", 0.3224], ["phorbol_12-myristate_13-acetate_(PMA)/alpha-CD28_stimulation", 0.3224], ["CD56+_cell", 0.3224], ["nuclear_factor_(NF)-kappa_B", 0.3223], ["resting_CD4+_memory_T_cell", 0.3223], ["Rel-related_transcription_factor", 0.3223], ["cdc2_mRNA_transcript", 0.3223], ["Wnt_signaling_pathway", 0.3222], ["nuclear_receptor_peroxisome_proliferator-activated_receptor_gamma", 0.3222], ["de_novo_macromolecule_synthesis", 0.3222], ["CD57+_cell", 0.3222], ["PKB/PI3-kinase", 0.3222], ["H-7-sensitive_kinase", 0.3221], ["cytokine_pleiotropy", 0.3221], ["(NF)-kappa_B/Rel_nuclear_activity", 0.3221], ["IL-2R_gamma", 0.3221], ["TCR_beta_enhancer", 0.3221], ["mouse_macrophage_inflammatory_protein-1alpha_(MIP-1alpha)_receptor_gene", 0.3221], ["T-cell_apoptosis", 0.3221], ["anti-HRBC_antibody_production", 0.322], ["ICR27TK.3_cell", 0.322], ["N-terminal_peptide", 0.322], ["HIV-2_transcriptional_enhancer", 0.322], ["Duffy_antigen/chemokine_receptor", 0.3219], ["leukocyte-endothelium_interaction", 0.3219], ["agonist-induced_phosphorylation", 0.3219], ["IgG_Fc_receptor_type_IC_gene", 0.3219], ["IL-11_mRNA", 0.3219], ["RAW264.7_macrophage_cell", 0.3218], ["cyclosporin_A-insensitive_pathway", 0.3218], ["IL-2R_alpha_kappa_B_site", 0.3218], ["SCF-mediated_ligation", 0.3217], ["anti-IL-1_beta_antibody", 0.3217], ["CD40_cytoplasmic_domain", 0.3217], ["NF-kappaB_enhancer_element", 0.3217], ["T_cell_apoptosis", 0.3217], ["CD3-CD16+_cell", 0.3217], ["endothelial_cell_adhesion_molecule", 0.3217], ["IFN_primed,_cycloheximide/polyinosinic-polycytidylic_acid_treated_HeLa_S3_cell", 0.3216], ["tyrosine-phosphorylated_substrate", 0.3216], ["CD23_receptor", 0.3216], ["oxidative_stress-induced_signal", 0.3216], ["T_cell-specific_protein", 0.3215], ["AP-1_independent_PMA-mediated_transactivation", 0.3215], ["CD5_structural_gene", 0.3214], ["E2-stimulated_ER+_cell", 0.3214], ["differential_phosphorylation", 0.3214], ["stimulated_human_endothelial_cell", 0.3214], ["lymphoid-specific_enhancer_element", 0.3213], ["octamer-binding_transcription_factor", 0.3213], ["cAMP_signal_transduction_pathway", 0.3213], ["IL3_promoter", 0.3212], ["immunosuppressive_effect", 0.3212], ["STAT-mediated_gene_transcription", 0.3212], ["inducer-mediated_degradation", 0.3211], ["lymphokine-activated_killer_(LAK)_activity", 0.3211], ["inducible_transcription_factor", 0.3211], ["murine_IL-2_mRNA", 0.3211], ["potential_transcriptional_regulator", 0.3211], ["PMA-induced_JNK_activation", 0.3211], ["HIV-protease_expressing_cell", 0.321], ["human_I_kappa_B_alpha_protein", 0.321], ["molecular_pathogenesis", 0.3209], ["36-kDa_transcription_factor", 0.3209], ["putative_intracellular_receptor", 0.3208], ["activated_monocyte", 0.3208], ["transcriptional_transactivation", 0.3208], ["immunoglobulin_heavy-chain_(IgH)_gene_rearrangement", 0.3208], ["lymphoid_specific_gene_expression", 0.3207], ["phosphatidylinositol_3-kinase_(PI3-K)_binding_site", 0.3207], ["peroxisome_proliferator-activated_receptor_gamma", 0.3207], ["octamer_binding_transcription_factor", 0.3207], ["T-cell_activator", 0.3207], ["Megakaryocyte/Platelet-specific_enhancer", 0.3207], ["CD95_(Fas)_ligand", 0.3207], ["Epo_signaling_mechanism", 0.3206], ["BHLF1/NotI_oligoprobe", 0.3206], ["T-cell_expression", 0.3206], ["human_IL-4_promoter", 0.3205], ["Jak3/Stat_activation", 0.3205], ["PML-RAR_alpha_fusion_oncoprotein", 0.3204], ["NF-kappaB_p50-p65_recruitment", 0.3204], ["thymidine_kinase_mRNA_expression", 0.3203], ["C/EBP_(CCAAT/enhancer-binding_protein)_consensus_binding_site", 0.3203], ["cytokine_message_induction", 0.3203], ["nuclear_factor_kappa_B_(NF_kappa_B)_site", 0.3203], ["immunosuppressive_factor", 0.3202], ["NF-kappa_B_p65_mutant", 0.3202], ["IL-1beta_mRNA", 0.3202], ["granulocyte_colony-stimulating_factor_receptor", 0.3202], ["CD40_antigen", 0.3201], ["antibodies_to_IL-4_Stat", 0.3201], ["CD34+/CD38(2+)", 0.3201], ["in_vitro_transcription_assay", 0.3201], ["regulatory_mechanism", 0.3201], ["cyclosporin_A-sensitive_tumor_necrosis_factor-alpha_gene", 0.3201], ["gamma-globin-expressing_K562_cell", 0.32], ["Rel/NF-kappa_B_activity", 0.32], ["host-cell_transcription_factor", 0.32], ["protein_kinase_C-zeta", 0.32], ["Duffy_chemokine_receptor_gene", 0.32], ["cytokine_network", 0.32], ["signal_transducers_and_activators_of_transcription_(STAT)_factor", 0.32], ["functional_1,25(OH)2D3_receptor", 0.32], ["B-cell_precursor", 0.3199], ["PL/IM_430_monoclonal_antibody", 0.3199], ["type_1_tumor_necrosis_factor_receptor", 0.3199], ["Th_cell_development", 0.3198], ["TLCK_inhibited_LPS_induction", 0.3198], ["oncogene_expressing_sensitive_target_fibroblast", 0.3198], ["catalytic_sub-unit_of_DNA-protein_kinase", 0.3198], ["monoclonal_antibody_(MAb)_13B8-2", 0.3197], ["c-sis/PDGF-B_proto-oncogene", 0.3197], ["NF-AT_transcription_factor", 0.3197], ["NF-kappa_B_accumulation", 0.3196], ["cell-free_RNA_transcription_assay", 0.3196], ["B_cell-associated_surface_molecule", 0.3196], ["immunoglobulin_beta-chain", 0.3196], ["human_CD4+_T_cell", 0.3196], ["upstream_signaling_molecule", 0.3195], ["B_cell-specific_expression", 0.3195], ["B-cell_growth_and_differentiation_factor", 0.3194], ["AP-1_enhancer_factor_activity", 0.3194], ["human_dendritic_cell-based_assay", 0.3194], ["intracellular_action", 0.3194], ["immunohistochemical", 0.3194], ["MAPK_kinase-1", 0.3194], ["B-cell_Fc_gamma_RII", 0.3193], ["endothelial_cell-monocyte_(EC-Mn)_adhesion", 0.3193], ["C/EBPalpha_mRNA", 0.3193], ["CD34_expression", 0.3193], ["MAP_kinase", 0.3193], ["JunB_phosphorylation", 0.3193], ["Raf1/MEK1/ERK1/2_pathway", 0.3192], ["OTF-1_activation", 0.3192], ["c-fos_and_c-jun_protein", 0.3192], ["intercellular_adhesion_molecule-1", 0.3192], ["TNF_translational_regulation", 0.3192], ["Janus_kinase_3_(JAK3)", 0.3191], ["B_cell_110-kDa_nuclear_protein", 0.3191], ["tissue-specific_regulation", 0.3191], ["NF-kappa_B/Rel_factor", 0.3191], ["myocyte-enhancer_factor_2_(MEF2)_group", 0.3191], ["immunocytochemical_method", 0.3191], ["IL-2-dependent_transformation_step", 0.3191], ["PMA-induced_superoxide_release", 0.319], ["cell_growth_inhibitor", 0.319], ["basic_helix-loop-helix_(bHLH)_transcription_factor", 0.319], ["leukocyte_signal_transduction", 0.319], ["C-C_chemokine_receptor-like_gene", 0.3189], ["anti-STAT_(signal_transducers_and_activators_of_transcription)_6", 0.3189], ["IL-1RII_mRNA_level", 0.3189], ["human_interleukin_4_gene", 0.3189], ["nuclear_NF-kB_binding_protein", 0.3189], ["major_I_gamma_3_transcription_initiation_site", 0.3188], ["cytolytic_effector_molecule", 0.3188], ["chemotherapy_(paclitaxel)-induced_expression", 0.3188], ["human_CD4(+)_T_cell", 0.3188], ["human_immunodeficiency_virus_1_enhancer-dependent_transcription", 0.3187], ["CD23_mRNA_transcription", 0.3187], ["CD95_receptor", 0.3187], ["Rel-/-_splenic_T_cell_culture", 0.3187], ["nuclear_factor-kappaB-dependent_induction", 0.3187], ["GC-induced_monocyte_apoptosis", 0.3186], ["monocytic_cell_line_THP-1", 0.3186], ["transduction_pathway", 0.3186], ["recombinant_human_IL-2", 0.3185], ["conserved_lymphokine_element", 0.3185], ["enzyme_linked_immunosorbent_assay", 0.3185], ["T_cell_receptor_(TCR)_repertoire", 0.3185], ["EBNA_2-dependent_enhancer", 0.3185], ["CD28RC", 0.3185], ["hIL-5_receptor_alpha-subunit_(hIL-5R_alpha)_cDNA-transfected_TF-1", 0.3184], ["neutrophilic_inflammation", 0.3184], ["interferon_alpha_regulated_nuclear_protein", 0.3184], ["mechanism_of_transactivation", 0.3184], ["PI3-kinase_activity", 0.3184], ["B_cell_adaptor_containing_SH2_domain", 0.3183], ["granulocyte-colony-stimulating_factor_receptor_mRNA", 0.3183], ["human_interleukin-9_receptor_alpha_chain", 0.3183], ["nuclear_factors_NF-IL6", 0.3183], ["MAPK_pathway", 0.3183], ["T_cell_expression", 0.3183], ["TNF-alpha_mRNA_level", 0.3183], ["NF-IL6_motif", 0.3183], ["NF-kappaB/Rel_factor", 0.3183], ["murine_FDC-P1-derived_cell_line", 0.3183], ["IMPDH_type_II_gene_expression", 0.3182], ["adhesion_molecule_expression", 0.3182], ["cell_specific_expression", 0.3182], ["Ca(2+)-regulated_kinase", 0.3182], ["clonal_immune_response", 0.3182], ["TSH_receptor_(TSHR)-specific_T_cell_line", 0.3182], ["neutrophil-endothelial_cell_adhesion", 0.3182], ["CD40_cell", 0.3182], ["CD38+_cell", 0.3182], ["CD8+CD18bright_T_cell", 0.3182], ["cyclic-AMP-responsive_element_binding_protein/activation_transcription_factor_family", 0.3182], ["signal_transducers_and_activators_of_transcription_(STAT)_protein", 0.3181], ["signal_transducers_and_activators_of_transcription_(Stat)_protein", 0.3181], ["interferon-stimulated_gene", 0.3181], ["c-erbA-dependent_activation", 0.3181], ["granulocyte-colony-stimulating_factor_receptor", 0.318], ["cell-cycle_progression.", 0.318], ["STAT-dependent_early_response_gene_expression", 0.318], ["whole_cell_dexamethasone_binding_assay", 0.318], ["IFN-gamma-induced_up-regulation", 0.318], ["NLS_peptide-mediated_disruption", 0.3179], ["Bruton's_agammaglobulinemia_tyrosine_kinase", 0.3179], ["I_kappa_B_alpha-/-_embryonic_fibroblast", 0.3179], ["GM-CSF-stimulated_HIV_expression", 0.3179], ["alphaIIbbeta3_activation", 0.3178], ["T_cell_mitogen", 0.3178], ["zymogen_plasma_factors_VII", 0.3178], ["lymphoid-specific_OTF-2_factor", 0.3178], ["cell_cycle-related_protein", 0.3177], ["differentiation_pathway", 0.3177], ["CD+8_T-cell", 0.3176], ["T_cell_restricted_cytoplasmic_factor", 0.3176], ["ligand-activated_IL-10_receptor", 0.3175], ["epithelial_cell_fusion_partner", 0.3175], ["proenkephalin_transcription", 0.3175], ["src-family_tyrosine_kinase_gene", 0.3175], ["CD95L_proximal_promoter_sequence", 0.3175], ["enhancer_positive_regulatory_element", 0.3174], ["GM-CSF_receptor_alpha_promoter_activity", 0.3173], ["myeloid-associated_growth_factor_receptor", 0.3173], ["IFN-mediated_regulation", 0.3173], ["signal_transducers_and_activators_of_transcription_(STAT)_6", 0.3173], ["p24_antigen_level", 0.3173], ["THP-1_monocyte/macrophage_cell", 0.3173], ["transcription_factor_IIA", 0.3172], ["THP-1_monocytic_cell_line", 0.3172], ["TPA-induced_expression", 0.3172], ["whole-cell_binding_assay", 0.3172], ["autocrine_regulatory_mechanism", 0.3172], ["cell-type-specific_trans-acting_factor", 0.3172], ["CD30_coengagement", 0.3172], ["T-cell_receptor_gene_rearrangement", 0.3172], ["CD40_agonist", 0.3172], ["phorbol_ester-treated_Jurkat_cell", 0.3171], ["cell_surface_activation_marker", 0.3171], ["transcription_factor_jun-B", 0.3171], ["tumor_proliferative_activity", 0.3171], ["p38-catalysed_phosphorylation", 0.3171], ["47_kDa_sterol_regulatory_element_binding_factor", 0.3171], ["IL2R_alpha", 0.317], ["CD8+_cell", 0.317], ["I_kappa_B_subunit", 0.317], ["Janus_kinase-STAT_pathway", 0.317], ["DNA_binding_protein_NF-kB", 0.3169], ["chimeric_CD8alpha/IL-4Ralpha_receptor", 0.3168], ["IkappaB-alpha_mRNA_transcript", 0.3168], ["peroxisome-proliferator_activated_receptor_gamma", 0.3168], ["TGF-beta_mRNA", 0.3168], ["myeloid-cell-specific_gene_expression", 0.3168], ["thymocyte-specific_gene_expression", 0.3168], ["CAML_(calcium-modulator_and_cyclophilin_ligand)_protein", 0.3168], ["apoptosis-associated_protein", 0.3167], ["early_G1_cell_cycle_regulatory_function", 0.3167], ["IL-4-inducible_reporter", 0.3166], ["common_B_cell/monocyte_surface_antigen", 0.3166], ["retinoid-dependent_granulocytic_markers_expression", 0.3166], ["DQ3.2-peptide_complex", 0.3166], ["cytokineinduced", 0.3166], ["nonexpressing_erythroleukemia_cell_line", 0.3165], ["bHLH_transcription_factor", 0.3165], ["N_terminal_transactivation_domain", 0.3165], ["PHA-activated_T_cell", 0.3165], ["NF-kappaB_suppression", 0.3165], ["interleukin-13", 0.3165], ["preactivated_primary_NK_cell", 0.3164], ["BCL-2-deficient_T_cell", 0.3164], ["p42/44_(ERK)_MAPk_activation", 0.3164], ["N-terminal_regulatory_region", 0.3164], ["MS2-HBx_fusion_protein", 0.3164], ["TNF-alpha-mediated_degradation", 0.3163], ["activator_protein-1-responsive_gene_activation", 0.3163], ["c-fos_mRNA", 0.3163], ["eukaryotic_transcription_factor", 0.3163], ["V_beta_11+/CD4+_T_lymphocyte", 0.3163], ["IL-13_gene_5'_flank_region", 0.3162], ["human_CD36-specific_antibody", 0.3162], ["pro-B_cell_stage", 0.3161], ["transcriptionally_active_human_TATA_binding_factor", 0.3161], ["granulocyte_colony-stimulating_factor_(G-CSF)_receptor_mRNA", 0.3161], ["chemokine_receptor", 0.3161], ["intracellular_biochemical_event", 0.316], ["peroxisome_proliferator-activated_receptor_activator", 0.316], ["NF_kappa_B2_effect", 0.316], ["cd28", 0.316], ["CD28", 0.316], ["endothelial_production", 0.316], ["endothelial-RAW264.7", 0.316], ["T_cell_receptor_alpha", 0.316], ["27-kDa_unphosphorylated_form", 0.316], ["intracellular_redox_status", 0.3159], ["IFN-gamma-stimulated_monocyte", 0.3158], ["cellular_immunity", 0.3158], ["CD34+Thy-1-CD45RA-_subset", 0.3158], ["LPS-induced_monocyte_cytotoxicity", 0.3158], ["activated_endothelium", 0.3158], ["kappa_B_enhancer_element", 0.3158], ["natural_killer_cell_activity", 0.3158], ["NF_kappa_B-I_kappa_B_complex", 0.3157], ["C-C_chemokine", 0.3157], ["activated_t_cell", 0.3157], ["activated_T_cell", 0.3157], ["GM-kappa_B_motif", 0.3157], ["novel_T_lymphocyte_protein", 0.3156], ["PI-3_kinase", 0.3156], ["dose-dependent_tyrosine_phosphorylation", 0.3156], ["NFAT_transcriptional_activation", 0.3156], ["exogenous_tumor_necrosis_factor", 0.3156], ["Fas_ligand_(fasL)_promoter", 0.3156], ["peripheral_CD8_T_lymphocyte", 0.3156], ["IFN-stimulated_gene_factor_3", 0.3155], ["eosinophil_granule_major_basic_protein_promoter", 0.3155], ["endotoxin-stimulated_cell", 0.3155], ["MHC_class_II_gene_regulatory_factor", 0.3155], ["immunoglobulin_gene_promoter", 0.3155], ["PMA-stimulated_T_cell", 0.3155], ["IRF-1-dependent_pathway", 0.3154], ["Fas_ligand_expression", 0.3154], ["immunosuppressive_reagent", 0.3154], ["LPS-induced_endothelial_cell_adhesiveness", 0.3154], ["extravascular_inflammation", 0.3153], ["nuclear_factor_(NF)_kappa_B", 0.3153], ["Ig_kappa_3'_enhancer", 0.3153], ["B-cell_proliferation", 0.3153], ["DNA-binding_eukaryotic_transcription_factor", 0.3153], ["NF-kappa_B_expression", 0.3153], ["ubiquitinylation_pathway", 0.3152], ["intracellular_level", 0.3152], ["hematopoietic_growth_factor_release", 0.3152], ["ICAM-1-dependent_endothelial_adhesivity", 0.3152], ["EBV-mediated_B_cell_transformation", 0.3152], ["erythroid-specific_transcription_factor", 0.3151], ["key_cell_cycle_regulator", 0.3151], ["transcription-regulating_protein", 0.315], ["bcl-2-transduced_cell", 0.315], ["Epo-induced_beta-globin_expression", 0.3149], ["TGF-beta_receptor_profile", 0.3149], ["kappaB-dependent_reporter_activity", 0.3149], ["beta-globin_reporter_gene_expression", 0.3149], ["oxygen_species-mediated_suppression", 0.3149], ["adult_CD34+_bone_marrow_cell", 0.3149], ["E2F-dependent_thymidine_kinase", 0.3148], ["tyrosine-phosphorylated_stat1_protein", 0.3148], ["Stat_(Signal_transducers_and_activators_of_transcription)_protein", 0.3148], ["STAT_(signal_transducers_and_activators_of_transcription)_protein", 0.3148], ["CD40_expression", 0.3147], ["peroxisome_proliferator-activated_receptor_alpha", 0.3147], ["latent_membrane_protein_1-driven_activation", 0.3147], ["immunopoiesis", 0.3147], ["heteromeric_kappa_B-binding_complex", 0.3147], ["platelet-derived_growth_factor_B_subunit", 0.3146], ["endothelial_leukocyte_adhesion_molecule_(ELAM)_mRNA", 0.3146], ["preactivated_NK_cell", 0.3146], ["lymphocyte-specific_negative_regulation", 0.3146], ["host_cell_gene_expression", 0.3145], ["TcR_gamma/delta+_T_lymphocyte", 0.3145], ["LPS-induced_TNF-alpha_production", 0.3145], ["IL-6/interferon-gamma_response_element", 0.3145], ["CD4-positive_lymphocyte_cell_line", 0.3145], ["anti-CD3_mAb", 0.3145], ["dominant_IkappaB_molecule", 0.3144], ["protein_phosphorylation_pattern", 0.3144], ["cis-acting_regulatory_sequence", 0.3144], ["thrombin-induced_[Ca2+]i_rise", 0.3144], ["monocytic_cell_line_MM6", 0.3144], ["interferon-gamma_activation", 0.3143], ["B_cell_proliferation", 0.3143], ["Stat5-mediated_gene_expression", 0.3143], ["PMA-induced_phosphorylation", 0.3143], ["TCR_alpha_enhancer_activity", 0.3143], ["cytokine_responsiveness", 0.3143], ["myeloid-cell-specific_c-fes_promoter", 0.3142], ["primary_B-lymphocyte_growth_transformation", 0.3142], ["organ_inflammation", 0.3142], ["pro-monocytic_cell_line", 0.3142], ["JAK/STAT_signaling", 0.3142], ["T-cell_trans-activator", 0.3142], ["native_human_erythrocyte_NDP_kinase_protein", 0.3141], ["ets_transcription_factor_family", 0.3141], ["Ets_transcription_factor_family", 0.3141], ["NK_cell_development", 0.3141], ["vascular-specific_expression", 0.3141], ["TGF-beta_1", 0.314], ["ligation-mediated_polymerase_chain_reaction_(LM-PCR)_technique", 0.314], ["inflammatory", 0.314], ["cell-cycle_motif", 0.314], ["murine_B-cell_cDNA-library", 0.314], ["human_macrophage_inflammatory_protein-1alpha", 0.314], ["proliferating_cell", 0.314], ["colony-stimulating_factor_receptor", 0.3139], ["myeloid-specific_promoter_activity", 0.3139], ["human_C-C_chemokine_receptor", 0.3139], ["recombinant_caspase_3", 0.3139], ["aberrant_CD4(-)CD8(-)_T_cell", 0.3138], ["cell_growth-related_gene", 0.3138], ["JNK_pathway", 0.3137], ["tumor_necrosis_factor-associated_factor_3", 0.3137], ["serine/threonine_protein_phosphorylation", 0.3137], ["interferon-gamma_activation_sequence", 0.3137], ["kappa_B-specific_binding_factor", 0.3137], ["(p65)-mediated_induction", 0.3137], ["human_myeloid_cell_nuclear_differentiation_antigen_gene_promoter", 0.3137], ["MEK1_kinase_activity", 0.3137], ["T-cell_homeostasis", 0.3137], ["12-lipoxygenase_activity", 0.3136], ["hematopoietic_gene_expression", 0.3136], ["cell_proliferation", 0.3135], ["T-cell_protein", 0.3135], ["immunostaining", 0.3135], ["proinflammatory_cytokine_gamma-IFN", 0.3135], ["Class_II_antigen_expressing_T-cell_line", 0.3135], ["common_T-cell_mitogen", 0.3135], ["IL-1ra_protein", 0.3135], ["cell_surface_T-cell_receptor", 0.3135], ["monocytic_HL60_cell", 0.3134], ["75_kd_TNF_receptor", 0.3134], ["specific_cell_fate_development", 0.3134], ["T-cell-activating_signal", 0.3134], ["E2F-dependent_activation", 0.3134], ["T-cell_growth", 0.3134], ["CD4+_CD8int/-_cell_population", 0.3133], ["GM-CSF_receptor_beta_common_subunit", 0.3133], ["NF-kappa_B-inducing_agent", 0.3132], ["NF_kappa_B_binding_sequence", 0.3132], ["early_T_cell_activation_event", 0.3132], ["NF-kappa_B/KBF1_p50", 0.3132], ["inducible_T-cell_gene", 0.3132], ["NK_cell_activity", 0.3131], ["C_terminal_peptide", 0.3131], ["transcription_factor_IFN_regulatory_factor-1", 0.3131], ["proto-oncoprotein_c-Rel", 0.3131], ["thrombogenesis", 0.3131], ["nuclear_factor_NF-kappa_B", 0.3131], ["HIV-inductive_cytokine", 0.3131], ["HIV_long_terminal_repeat_reporter_gene_construct", 0.3131], ["mature_B_cell_proliferation", 0.3131], ["STAT1_pathway", 0.313], ["500-bp_human_IL-5_gene_segment", 0.313], ["ets-related_transcription_factor", 0.313], ["Ets-related_transcription_factor", 0.313], ["Myb-Ets_oncoprotein", 0.313], ["anti-CD3_antibody", 0.313], ["T_cell_Ag_receptor_complex", 0.3129], ["HIV-1_LTR-mediated_reporter_gene_activity", 0.3129], ["manipulating_pathological_immune_response", 0.3129], ["GM-CSF_receptor_alpha_promote", 0.3129], ["leukemic_cell_transformation", 0.3129], ["nm23/NDP_kinase_protein", 0.3129], ["TGF_beta_2", 0.3129], ["JAK_(Janus_kinase)_family", 0.3128], ["proliferating_T_lymphocyte", 0.3128], ["TSC2_gene_expression", 0.3128], ["Raf-1_kinase_activity", 0.3127], ["intercellular_adhesion_molecule-1_(ICAM-1)_gene", 0.3127], ["constitutive_PI3-kinase/PKB/Akt_pathway", 0.3127], ["transcription_factor_recruitment", 0.3127], ["B_cell-expressed_gene", 0.3127], ["NF-kappa_B/Rel_nuclear_activity", 0.3127], ["Jurkat_CD4+_T_cell", 0.3126], ["signal_transducer_and_activator_of_transcription_(STAT)_protein", 0.3126], ["signal_transducer_and_activator_of_transcription_(Stat)_protein", 0.3126], ["neuroendocrine-immune_regulatory_interaction", 0.3126], ["proto-enhancer_activity", 0.3126], ["subcellular_mechanism", 0.3126], ["stimulated_T_lymphocyte", 0.3126], ["CREB_kinase", 0.3126], ["LPS-induced_mRNA_level", 0.3126], ["tissue-specific_transcription_factor", 0.3126], ["transcriptional_enhancement", 0.3125], ["human_interleukin-4_gene", 0.3125], ["NF-kappa_B_binding_sequence", 0.3125], ["inducible_gene_expression", 0.3124], ["transcriptional_regulator", 0.3124], ["signal_transducers_and_activators_of_transcription_(Stat)_family", 0.3124], ["signal_transducers_and_activators_of_transcription_(STAT)_family", 0.3124], ["T_cell_activator", 0.3124], ["chemoattractant_cytokine", 0.3124], ["NFAT-dependent_transcriptional_activation", 0.3124], ["IL-2-independent_growth", 0.3124], ["hCLEO_and_NF-kappa_B_region", 0.3124], ["murine_c-fos_promoter", 0.3123], ["immunoblotting_extract", 0.3123], ["signal_transducers_and_activators_of_transcription_(Stat)_binding_site", 0.3123], ["stimulated_T_cell", 0.3123], ["interfollicular_zone_cell", 0.3123], ["human_proximal_sequence_element-binding_transcription_factor", 0.3123], ["metabolized_transcription_factor_protein", 0.3122], ["immunopathogenesis", 0.3122], ["PDGF(B)_mRNA_accumulation", 0.3122], ["human_myeloid_cell_nuclear_differentiation_antigen_promoter", 0.3122], ["adult_T_cell_leukemia-derived_factor", 0.3121], ["intrafollicular_T_cell", 0.3121], ["p85_phosphoinositide_3-kinase", 0.3121], ["CD68+_cell", 0.312], ["hToll-induced_activation", 0.312], ["human_erythroleukemia_cell_line_K562", 0.312], ["human_granulocyte_macrophage-colony_stimulating_factor", 0.312], ["RANTES_Factor_of_Late_Activated_T_Lymphocytes-1", 0.3119], ["apoptosis_suppressor_protein", 0.3119], ["CBF_beta-MYH11_fusion_transcript", 0.3119], ["p75_tumor_necrosis_factor_receptor", 0.3118], ["redox_regulation", 0.3118], ["enhancer/promoter_interaction", 0.3117], ["T_cell_receptor_(TcR)_responsive_element", 0.3117], ["granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_gene", 0.3117], ["I(kappa)B_protease", 0.3116], ["signaling_complex", 0.3116], ["D3-induced_monocyte_differentiation", 0.3116], ["OKT8+_T_cell", 0.3116], ["in_situ_reverse_transcription_based_polymerase_chain_reaction", 0.3116], ["CD4_T_cell", 0.3116], ["TF_activation", 0.3115], ["gamma_interferon-induced_class_II_transactivator_expression", 0.3115], ["STAT3_phosphorylated", 0.3115], ["cell-type-specific_transcription", 0.3114], ["CD4_positive_T_cell_line", 0.3113], ["pathogenic_mechanism", 0.3113], ["signal_transducer_and_activator_of_transcription_(STAT)_factor", 0.3113], ["major_proinflammatory_cytokine", 0.3113], ["I_kappa_B_alpha/MAD-3_mRNA", 0.3113], ["NK_cell_cytolytic_program", 0.3112], ["Mac-1_cell_surface_antigen_expression", 0.3112], ["B-cell-specific_activity", 0.3112], ["early_inflammatory_response", 0.3112], ["STAT3_signaling", 0.3112], ["cyclic_AMP_signaling_pathway", 0.3112], ["THP-1_promonocytic_cell", 0.3111], ["NF-AT_activation", 0.3111], ["tumor_necrosis_factor-alpha_mRNA", 0.3111], ["nuclear_kinase", 0.3111], ["NF-kappa_B_complex", 0.3111], ["hGATA-1_transactivation", 0.3111], ["NFIL3/E4BP4_transcription_factor", 0.311], ["thrombin-induced_p65_homodimer", 0.3109], ["antigen_receptor_signaling", 0.3109], ["activation_antigen", 0.3109], ["2'-5'_oligoadenylate_synthetase_(OAS)_gene_expression", 0.3109], ["IL-2_octamer_motif", 0.3109], ["cytokine_production_deficiency", 0.3109], ["kappa_enhancer", 0.3109], ["potent_transcriptional_activator", 0.3108], ["functional_receptor-effector_system", 0.3108], ["T_cell-specific_factor", 0.3108], ["redox-dependent_gene_transcription", 0.3108], ["regulatory_protein", 0.3108], ["IL-5_stimulation", 0.3107], ["G-CSF_receptor_signaling", 0.3107], ["NF(kappa)B_expression", 0.3107], ["transcriptional_and_developmental_regulation", 0.3107], ["CD8_antigen", 0.3107], ["monoclonal_anti-endothelial_cell_antibody", 0.3107], ["anti-IL-6_monoclonal_antibody", 0.3107], ["nuclear_factor_(NF)-kappaB", 0.3106], ["Nuclear_factor_(NF)-kappaB", 0.3106], ["vascular_cell_adhesion_molecule-1", 0.3106], ["leukemia-associated_fusion_protein", 0.3106], ["chemokine_superfamily", 0.3106], ["nuclear_signaling_mechanism", 0.3106], ["steady-state_I_kappa_B_alpha/MAD-3_mRNA_level", 0.3105], ["NK_cell_inhibitory_receptor", 0.3105], ["cytokine_rescue", 0.3105], ["Ras-regulated_activation", 0.3105], ["STAT_(signal_transducers_and_activators_of_transcription)_6", 0.3104], ["1,24(OH)2-22-ene-24-cyclopropyl-vitamin_D3", 0.3104], ["non-lymphoid,_non-IL-5-producing_cell_line", 0.3104], ["immunoregulatory_effect", 0.3104], ["NF-kappa_B_prototypic_probe", 0.3104], ["NFkB-like_transcription_factor", 0.3104], ["human_granulocyte-macrophage_colony-stimulating_factor", 0.3104], ["human_cytokine_IL-4", 0.3103], ["activated_T_cell_lysate", 0.3103], ["CD40-dependent_signal", 0.3103], ["serine_727_phosphorylation", 0.3103], ["enzyme-linked_immunosorbent_assay", 0.3102], ["I_kappa_B-induced_nuclear_exclusion", 0.3102], ["I_kappa_B_gamma_isoform", 0.3102], ["HIV-1_long_terminal_repeat_(LTR)-driven_reporter_gene_activity", 0.3102], ["human_interferon_regulatory_factor_1", 0.3102], ["CD34_promoter", 0.3101], ["IL-2_binding", 0.3101], ["tyrosine-phosphorylated_protein", 0.3101], ["vascular_cell_adhesion_molecule", 0.3101], ["NF-kappaB_expression", 0.31], ["CD40_surface_expression", 0.31], ["transcription-dependent_surface_expression", 0.31], ["Nb2_T_cell", 0.31], ["JAK3_activation", 0.3099], ["activated_peripheral_blood_T_lymphocyte", 0.3099], ["tumour_associated_cell_surface_antigen", 0.3099], ["type_I_interferon_(IFN-alpha/beta)_to_specific_receptor", 0.3099], ["B-cell-specific_promoter", 0.3099], ["PKC-specific_inhibitor", 0.3099], ["Macrophage_migration_inhibitory_related_protein", 0.3098], ["NF-kappa_B_translocation_step", 0.3098], ["HS-40_enhancer_motif", 0.3098], ["PMA/ionomycin_inducible_factor", 0.3097], ["T_cell_surface_receptor", 0.3097], ["p60_phosphorylation", 0.3097], ["Janus_protein-_tyrosine_kinase_3", 0.3097], ["CD14_expression", 0.3096], ["Rel-deficient_T_cell", 0.3096], ["cis-activation", 0.3096], ["activation-dependent_expression", 0.3096], ["Naive_(CD45RA+)_T_lymphocyte", 0.3096], ["MHC_class_II_gene-specific_transcription_activator", 0.3096], ["KB-enhancer_target_sequence", 0.3095], ["phorbol_12-myristate_13-acetate_(PMA)-differentiated_THP-1_monocytic_cell", 0.3095], ["radiation-induced_signaling_cascade", 0.3095], ["agonist-induced_monocyte_adhesion", 0.3095], ["Src_family_kinase", 0.3095], ["polyomavirus_enhancer_binding-protein_2_(PEBP2)_transcription_factor", 0.3094], ["B_cell-specific_BLK_gene_promoter", 0.3094], ["JAK-1-deficient_HeLa_cell", 0.3094], ["CD4_gene_transcription_start_site", 0.3093], ["early_growth_response_1_gene_transcription", 0.3093], ["signal_transducer_and_activator_of_transcription_(STAT)_family", 0.3093], ["CD30_Hodgkin's_disease_marker", 0.3093], ["phorbol_ester/IL-2", 0.3093], ["in_vivo_modulation", 0.3092], ["IkappaB-alpha_proteolysis", 0.3092], ["platelet-induced_activation", 0.3092], ["phosphorylation_status", 0.3092], ["alpha_4_beta_1_ligation", 0.3091], ["IL-10-treated_cell", 0.3091], ["CD95_(APO-1/Fas)_ligand", 0.3091], ["IFN-gamma-induced_STAT_activation", 0.3091], ["immune-modulating_effects", 0.3091], ["NF-kappa_B_binding", 0.3091], ["GM-CSF-induced_peripheral_blood_polymorphonuclear_leukocyte", 0.3091], ["nonreceptor_protein_tyrosine_kinase", 0.309], ["B-cell_development", 0.309], ["K562_human_erythroleukemia_cell", 0.309], ["T_lymphocyte_proliferation", 0.309], ["40S_ribosomal_protein_S6_serine/threonine_kinase", 0.309], ["limiting-component_transcription_assay", 0.309], ["tissue-specific_mechanism", 0.309], ["proinflammatory_cytokine", 0.3089], ["ATL(Adult_T-cell_leukemia)-16T_expression_library", 0.3089], ["interferon-treated_cell", 0.3089], ["gene_activation", 0.3089], ["enhancer-binding_protein", 0.3089], ["NF-kappa_B/Rel_complex", 0.3088], ["tumor_necrosis_factor-alpha-induced_HIV-1_replication", 0.3088], ["microB-dependent_enhancer_activity", 0.3088], ["CHO/CD14_cell", 0.3088], ["gamma/delta_T_cell_receptor_positive_cell", 0.3088], ["adhesion_molecule-mediated_interaction", 0.3087], ["pleiotropic_transcription_factor", 0.3087], ["RAW264.7_macrophage-like_cell", 0.3087], ["src_homology_(SH)2_domain-containing_intracellular_molecule", 0.3087], ["retinoid_response_pathway", 0.3086], ["gene-proximal_regulatory_element", 0.3086], ["antibody_super-shift_reaction", 0.3086], ["proximal_sequence_element_(PSE)-binding_transcription_factor", 0.3086], ["naive_CD4(+)_T_cell", 0.3085], ["IkappaB-alpha_inhibitor_hydrolysis", 0.3085], ["monoclonal_antibody_KN_382/EC1", 0.3085], ["kappa_B_binding_complex", 0.3085], ["immunoglobulin_promoter", 0.3085], ["activator_protein-1_(AP-1)_activation", 0.3085], ["immunoglobulin_heavy_chain_constant_region", 0.3085], ["T-cell-specific_factor", 0.3085], ["PHA-stimulated_T_cell_line", 0.3085], ["central_nervous_system-enriched_kappa_B", 0.3084], ["Bcl-2_family_protein", 0.3084], ["intracellular_ROI", 0.3084], ["natural_killer_(NK)_cell_lineage", 0.3083], ["PHA-activated_peripheral_mononuclear_cell", 0.3083], ["1.4-kb_human_TNF-alpha_promoter", 0.3083], ["activated_T-lymphocyte", 0.3083], ["inducible_transcription_factor_binding_site", 0.3082], ["THP-1_monocytic_cell", 0.3081], ["T-cell_stimulation", 0.308], ["monocyte-binding_receptor", 0.308], ["v-abl_protein_tyrosine_kinase", 0.308], ["B_cell_receptor_stimulation", 0.308], ["IL-2_promoter_element", 0.3079], ["interferon_regulatory_factor-1_gene", 0.3079], ["leukocyte-specific_pp52_promoter", 0.3079], ["killer_(NK)_cell_activity", 0.3079], ["Raf_kinase", 0.3079], ["gp39-CD8_fusion_protein", 0.3078], ["activation-dependent_fas_promoter_induction", 0.3078], ["ubiquitous_cellular_transcription_factor", 0.3078], ["Lyn_tyrosine_kinase", 0.3078], ["lipid_oxidation", 0.3078], ["human_T-cell_leukemia_virus_type_I_Tax_activation", 0.3077], ["cell_surface_CD4(-)CD8(-)CD3(-)_cell", 0.3077], ["CD+8_T-cell_numbers", 0.3077], ["lymphokine_production", 0.3077], ["activated_T-cell", 0.3077], ["octamer-dependent_activation", 0.3077], ["transcriptional_enhancer", 0.3077], ["fas-ligand_expression", 0.3076], ["growth-factor-dependent_myeloid_cell_line", 0.3076], ["delayed_transcriptional_activation", 0.3076], ["in_vitro_acetylation", 0.3076], ["IL-3_CK-1/CK-2_element", 0.3075], ["LPS-treated_endothelial_cell", 0.3075], ["Th2_T_cell", 0.3074], ["early_growth_response-1_gene_expression", 0.3074], ["T_cell_homeostasis", 0.3074], ["enhanced_protein_secretion", 0.3073], ["TNFalpha-mediated_NFkappaB_activity", 0.3073], ["adhesion-dependent_pathway", 0.3073], ["reverse_transcription-polymerase_chain_reaction_(RT)_assay", 0.3073], ["signal_transducers_and_activators_of_transcription_(STAT)_family_member", 0.3072], ["mutant_signaling_molecule", 0.3072], ["heterodimeric_NF-kappa_B_complex", 0.3072], ["interferon_regulatory_factor-1_(IRF-1)_gene", 0.3072], ["T-cell_receptor_(TCR)-zeta", 0.3072], ["Rel/NF-kappaB-dependent_induction", 0.3071], ["Pb-induced_immunotoxicity", 0.3071], ["cellular_immunoreaction", 0.3071], ["40S_ribosomal_protein_S6_kinase", 0.3071], ["Fas_ligand_transcription", 0.3071], ["ligandbinding", 0.307], ["immunoglobulin_molecule", 0.307], ["T-cell_development", 0.3069], ["human_pro-interleukin_1beta", 0.3069], ["Y701_and_S727_STAT1_phosphorylation", 0.3069], ["lineage-specific_transcription_factor", 0.3069], ["antihuman_TNF-alpha-neutralizing_antibody", 0.3069], ["RelA-mediated_transcription", 0.3069], ["CD68+cell", 0.3068], ["IFN-gamma-induced_class_II_gene_expression", 0.3068], ["differentiation-dependent_peroxisomal_proliferator-activated_receptor_gamma(PPARgamma)_expression", 0.3068], ["Bcl-6_protein", 0.3067], ["bcl-6_protein", 0.3067], ["BCL-6_protein", 0.3067], ["Tpl-2-mediated_NFAT_activation", 0.3067], ["complex_regulatory_protein_network", 0.3067], ["erythroid-enriched_NF-E2_factor", 0.3067], ["consensus_kappaB_binding_motif", 0.3066], ["NK_cell-mediated_cytotoxicity", 0.3066], ["T_cell_growth", 0.3066], ["immune-mediated_lysis", 0.3066], ["lymphoid-specific_expression", 0.3066], ["NFAT_(nuclear_factor_of_activated_T_cells)_element", 0.3065], ["genomic_IL-4_region", 0.3065], ["intercellular", 0.3065], ["tegument-specific_CD4_T-cell_clone", 0.3065], ["HIV-2_gene_expression", 0.3065], ["ligand-activated_c-erbA/TR_accelerated_differentiation", 0.3065], ["cell_cycle_progression", 0.3064], ["Fc_gamma_RI_transcript_levels", 0.3064], ["in_vitro_binding_activity", 0.3064], ["GD3+_T_cell_proliferation", 0.3064], ["transcription_activator_protein-2_binding_site", 0.3063], ["T_cell_protein", 0.3062], ["peripheral_blood_mononuclear_cell_culture", 0.3061], ["receptor-negative_S49_murine_thymoma_cell", 0.3061], ["B-cell_lymphoma/leukemia-2_gene_product", 0.3061], ["B_cell-specific_promoter", 0.3061], ["in_vitro_binding_assay", 0.3061], ["concomitant_cell_proliferation", 0.306], ["NK_cell-derived_granule", 0.3059], ["human_Bruton's_agammaglobulinemia_tyrosine_kinase_gene", 0.3059], ["tissue_factor_(TF)_receptor", 0.3059], ["IkappaB-alpha_protein_levels", 0.3059], ["STAT_(signal_transducer_and_activator_of_transcription)_protein", 0.3059], ["redox-regulated_enzyme", 0.3059], ["DNA-PK(CS)_mRNA_level", 0.3058], ["regulatory_gene_BZLF_1", 0.3058], ["antitumor_immunity", 0.3058], ["erythroleukemia_K562_cell", 0.3058], ["low_density_lipoprotein-induced_inflammatory_response", 0.3058], ["beta-promoter_activity", 0.3058], ["putative_human_oncogene_bcl-3", 0.3058], ["TNF-alpha_mRNA", 0.3058], ["phosphorylation-dependent_signal", 0.3057], ["immediate-early_cytokine_gene", 0.3057], ["death_ligand", 0.3057], ["monocyte/macrophage_function", 0.3057], ["proximal_jun1_tumor_promoter-responsive_element_(TRE)-like_promoter_element", 0.3057], ["DE_anti-BCR1/25_T_cell_clone", 0.3056], ["macrophage_CSF_(M-CSF)_gene", 0.3056], ["human_T-cell_lymphotropic_virus_type_I_basal_gene_expression", 0.3056], ["immunohistochemical,_Western_blotting", 0.3056], ["granulocyte-macrophage_(GM)-CSF_receptor_alpha_subunit", 0.3056], ["IgG_Fc_receptor_type_I", 0.3055], ["protein_kinase_Calpha", 0.3055], ["Janus_kinase_(JAK)-1", 0.3055], ["cellular_expression", 0.3054], ["BCL-2_protein", 0.3054], ["Bcl-2_protein", 0.3054], ["cyclic_AMP-dependent_protein_kinase", 0.3054], ["CD4+_T-cell_line", 0.3053], ["positive_regulatory_domain_(PRD)_II_binding_protein", 0.3053], ["TNF_alpha_gene_promoter", 0.3053], ["ICR-27_TK-3", 0.3053], ["cytokinedriven", 0.3052], ["NF-kappaB-binding_sequence", 0.3052], ["CD23b_mRNA", 0.3052], ["myeloid-cell-specific_promoter", 0.3052], ["cytokine_signal_network", 0.3052], ["physiological_regulator", 0.3052], ["Stat_transcription_factor_family", 0.3051], ["double_immunostaining_technique", 0.3051], ["IFN-gamma-induced_transcription", 0.3051], ["tissue-specific_down-regulation", 0.3051], ["monocyte/macrophage_receptor", 0.3051], ["CD14_promoter", 0.3051], ["p56(lck)_signaling", 0.3051], ["CD40_stimulation", 0.3051], ["Sp1-mediated_activation", 0.3051], ["IgH_enhancer_regulation", 0.3051], ["T_helper_cell_level", 0.3051], ["Bcl-3_protein", 0.3051], ["CD4+_cell_depletion", 0.3051], ["peroxisome_proliferator_activated_receptor", 0.305], ["immunohistochemical_evidence", 0.305], ["cytotoxic_T_lymphocyte-mediated_lysis", 0.305], ["human_interleukin_9_(IL-9)_gene", 0.305], ["RAR-mediated_signaling_pathway", 0.305], ["Jun_kinase", 0.305], ["HL60_cell_binding", 0.305], ["activated_macrophage", 0.3049], ["CD4+_antigen", 0.3049], ["IL-13_receptor_complex", 0.3049], ["terminal_protein_1_gene_promoter", 0.3049], ["high-affinity_cell_surface_receptor", 0.3049], ["TPA-treated_HL-60/vinc_cell", 0.3048], ["signal-dependent_phosphorylation", 0.3048], ["AP-1-mediated_transcriptional_activation", 0.3048], ["Wingless/Wnt_signal_transduction_pathway", 0.3048], ["endothelial_VCAM-1_expression", 0.3047], ["proliferation_reduction_mechanism", 0.3047], ["glucocorticoid_effector_mechanism", 0.3047], ["tissue_factor_(TF)_expression", 0.3047], ["Ca(2+)-dependent_signal-transduction_pathway", 0.3047], ["primary_human_CD4+_T_lymphocyte", 0.3047], ["monocyte_counter-receptor", 0.3047], ["nuclear_factor_NF-IL6", 0.3046], ["Janus_kinase_function", 0.3046], ["reactive_thrombocytosis", 0.3046], ["DLCL_pathogenesis", 0.3046], ["CD23_transcription", 0.3046], ["anti-inflammatory_sesquiterpene_lactone", 0.3046], ["inflammatory_synovial_microenvironment", 0.3045], ["c-jun_mRNA_expression", 0.3045], ["human_interleukin-5", 0.3045], ["human_NF-kappa_B_p65_mutant", 0.3044], ["primary_immunomodulator", 0.3044], ["Myb-transformed_hematopoietic_cell", 0.3044], ["cell_cycle_S_phase_entry", 0.3044], ["JNK_phosphorylation_site", 0.3044], ["human_leukemic_cell_line_K562", 0.3044], ["TFG-beta_2_promoter", 0.3044], ["T_cell-independent_culture_system", 0.3043], ["anti-CD40_mAb", 0.3043], ["nonreceptor_tyrosine_kinase", 0.3043], ["lymphoid_cell-specific_factor", 0.3043], ["cytoplasmic/nuclear_signaling", 0.3042], ["gamma(c)-positive,_IL-13R_alpha1-negative_Daudi_cell", 0.3042], ["Hb-synthesizing_cell", 0.3042], ["CD19_protein", 0.3042], ["T-cell_receptor_complex", 0.3042], ["kappa_B_motif", 0.3041], ["M-CSF_receptor", 0.3041], ["CL-01_B_cell", 0.3041], ["candidate_oncogene_bcl-3", 0.3041], ["IL1B_promoter", 0.3041], ["1,25(OH)2D3-mediated_repression", 0.3041], ["phorbol_ester_PKC_agonist", 0.304], ["inducible_transcription", 0.304], ["EBV-mediated_B-cell_immortalization", 0.304], ["IL-10_inhibited_translocation", 0.304], ["monocyte_TF_expression", 0.304], ["endothelial-RAW264.7_coculture", 0.304], ["Ca2+/calmodulin-dependent_protein_kinase_IV", 0.304], ["nuclear_factor-kappaB_induction", 0.3039], ["HIV_enhancer-dependent_transcription", 0.3039], ["signaling_protein", 0.3039], ["phosphorylated_tyrosine_residues", 0.3039], ["T-cell_biology", 0.3039], ["EBNA2-dependent_enhancer", 0.3038], ["IFN-beta_transcription", 0.3038], ["serine/threonine_phosphorylation", 0.3038], ["basic_helix_loop_helix_zipper_transcription_factor", 0.3038], ["peptide_binding_interaction", 0.3037], ["T_cell_receptor_complex", 0.3037], ["mature_peripheral_T_cell", 0.3037], ["serine/threonine_kinase_inhibitor", 0.3037], ["Erk2_activation", 0.3036], ["C57MG_fibroblast_cell", 0.3036], ["CD_peptide", 0.3036], ["DSL_family_of_ligand", 0.3036], ["CD4_T-cell", 0.3035], ["oncogene_expressing_fibroblast", 0.3035], ["HIV-1_long_terminal_repeat_(LTR)-driven_gene_expression", 0.3035], ["cytosolic_tyrosine_motif", 0.3035], ["anti-intercellular_adhesion_molecule-1", 0.3035], ["C-reactive_protein", 0.3035], ["sites_of_inflammation", 0.3034], ["MEK/ERK_pathway", 0.3034], ["controlling_hematopoietic_gene_transcription", 0.3034], ["lipopolysaccharide-_(LPS)_induced_IL-1beta_promoter-driven_CAT_activity", 0.3034], ["T_cell_receptor", 0.3033], ["CD40:CD40L_engagement", 0.3033], ["T_cell_development", 0.3032], ["MAP_kinase-specific_phosphatase", 0.3032], ["CD8_interaction", 0.3032], ["activated_T_lymphocyte", 0.3032], ["platelet-activating-factor", 0.3032], ["leukocyte-derived_oxidant", 0.3032], ["unphosphorylated_27-kDa_protein", 0.3032], ["stably_infected_CD4+_cell", 0.3032], ["transcription_factor_Egr-1_activity", 0.3032], ["nucleoside_diphosphate_(NDP)_kinase_activity", 0.3031], ["cytoplasmic_NLS_receptor_complex", 0.3031], ["CD16_stimulation", 0.3031], ["T_cell_biology", 0.3031], ["cell-type-independent_lipopolysaccharide_(LPS)-responsive_enhancer_element", 0.3031], ["retinoic_acid-induced_expression", 0.3031], ["humoral_HBx_immune_response", 0.3031], ["Src_kinase", 0.3031], ["NF-kappaB-containing_nuclear_extract", 0.3031], ["NF-AT_transactivation", 0.3031], ["Src-family_kinase", 0.303], ["LPS-stimulated_CMV_transfected_cell", 0.303], ["c-fos_upregulation", 0.303], ["immunocytochemistry", 0.3029], ["As2O3-induced_apoptosis", 0.3029], ["transcriptional_repressor_activity", 0.3029], ["specific_transcription_factor", 0.3029], ["NF-kappaB_complex", 0.3029], ["immunologic_machinery", 0.3028], ["gene_regulatory_protein", 0.3028], ["T-cell-directed_TAL-1_expression", 0.3027], ["chicken_NF-M_transcription_factor", 0.3026], ["eukaryotic_gene_expression", 0.3025], ["macromolecular_synthesis", 0.3025], ["osteoclastogenic_cytokine_TNF-alpha", 0.3024], ["PI_3-kinase", 0.3024], ["MHC_I+/MHC_IIbright/CD83+/CD86+/CD14-_surface_Ag_expression", 0.3024], ["DNA-protein_kinase", 0.3024], ["nuclear_factor-kappa_B/Rel", 0.3024], ["UV-induced_activation", 0.3024], ["CD4+_infected_T-lymphoid_cell", 0.3024], ["monocyte_chemoattractant_protein_1", 0.3023], ["nuclear_NF-kappa_B_complex", 0.3023], ["TNF_alpha_gene_induction", 0.3022], ["enhancer_binding_protein", 0.3022], ["DQalpha_and_DQbeta_trans_heterodimeric_HLA-DQ_molecule", 0.3022], ["macrophage-_and_B-cell-specific_PU.1", 0.3022], ["local_cellular_immune_response", 0.3022], ["in_vitro_colony_formation_assay", 0.3022], ["TNF_mRNA", 0.3021], ["immunohistochemically", 0.3021], ["T-cell_accumulation", 0.3021], ["PMA-stimulated_T-cell_line", 0.3021], ["octamer_transcription_factor", 0.3021], ["transcription_enhancement", 0.3021], ["tumor-suppressor_protein_pRb", 0.3021], ["AP-1_transcriptional_activation", 0.3021], ["granulocyte-monocyte_colony_stimulating_activity", 0.302], ["anti-inflammatory_corticosteroid", 0.302], ["ICAM-1_(CD54)_expression", 0.302], ["monocytic_cell_adhesion", 0.302], ["key_macrophage_growth_factor", 0.302], ["cell_line_NK3.3", 0.302], ["granulocyte-colony_stimulating_factor_(G-CSF)_receptor", 0.3019], ["proinflammatory_LPS_receptor", 0.3019], ["TGF-beta_receptor", 0.3019], ["interferon-gamma_promoter", 0.3019], ["TPA/Ca(2+)-induced_transactivation", 0.3018], ["IL-9_gene", 0.3018], ["receptor-ligand_pair", 0.3018], ["CCAAT/enhancer_binding_protein_(C/EBP)_epsilon", 0.3018], ["hematopoietic_precursor_cell_line", 0.3018], ["T-cell_receptor", 0.3018], ["Fcgamma_receptor", 0.3018], ["activator_protein-2_(AP-2)_binding_consensus_site", 0.3017], ["Th2_cell_differentiation", 0.3017], ["injury-induced_apoptosis", 0.3017], ["Sp1_phosphorylation", 0.3017], ["Lin-_murine_bone_marrow_progenitor_cell", 0.3017], ["mouse_macrophage_RAW_264.7_cell", 0.3017], ["transcription_factor_activator_protein_1", 0.3016], ["rapamycin-regulated_signal", 0.3016], ["NF-kappaB/NFAT_protein", 0.3016], ["E-selectin-NF-kappa_B_oligomer", 0.3016], ["beta-adrenergic_receptor_kinase_1_carboxyl-terminal_peptide", 0.3016], ["intracellular_adhesion_molecule-1", 0.3016], ["cAMP-dependent_second-messenger_pathway", 0.3016], ["in_vitro_transcription", 0.3016], ["immunoglobulin_heavy_chain_gene_cluster", 0.3016], ["signalling_mechanism", 0.3016], ["growth-regulated_expression", 0.3015], ["phosphorylating", 0.3015], ["TRAF_signaling", 0.3015], ["antiviral,_CD8(+)_CTL_response", 0.3015], ["mouse_IL-4_gene", 0.3015], ["antiinflammatory_mechanism", 0.3014], ["primary_leukemic_T_cell", 0.3014], ["enzymatic_activation", 0.3014], ["T-cell-derived_chromosome_encoding_a_factor", 0.3014], ["NF-kappaB_binding_activity", 0.3014], ["nuclear_calcium/calmodulin-dependent_protein_kinase_II", 0.3014], ["T_cell_stimulation", 0.3014], ["cellular_stress_agent", 0.3014], ["erythroid_transcription_factor", 0.3014], ["recombinant_caspase_6", 0.3013], ["plasma_IL-1", 0.3013], ["potent_lipid_proinflammatory_mediator", 0.3012], ["monoclonal_antibody_Ki-67", 0.3012], ["in_vitro_transcription_studies", 0.3012], ["c-jun_gene_expression", 0.3012], ["immune-mediated_disease", 0.3012], ["CD34(2+)/CD38-", 0.3012], ["human_IL-4_receptor", 0.3012], ["IkappaB-alpha_protein_level", 0.3011], ["immunoglobulin_heavy_chain_(IgH)_gene", 0.3011], ["casein_kinase_II", 0.3011], ["immunosuppressive_therapy", 0.301], ["transcription_factor_function", 0.301], ["activator_protein_1_transcription_factor", 0.301], ["hemo-lymphoid_progenitors", 0.301], ["macrophage_inflammatory_protein_(MIP)-1alpha", 0.301], ["transcriptional_down-regulation", 0.3009], ["protein_phosphatase_2A", 0.3009], ["T-cell_nuclear_extract", 0.3009], ["G-CSF-stimulated_myeloid_colony_growth", 0.3009], ["immunizing_cell", 0.3009], ["protein_Bcl-3", 0.3008], ["Fc_receptor_I", 0.3008], ["liganddependent", 0.3008], ["Wnt_signaling_cascade", 0.3008], ["I_kappa_B_beta_degradation", 0.3007], ["polyomavirus_enhancer_binding-protein_2", 0.3007], ["hybrid_CD8-Nef_protein", 0.3007], ["CIITA-mediated_transactivation", 0.3007], ["fetal/neonatal_T-cell_activation", 0.3007], ["monocytic_cell_line_Mono_Mac_6", 0.3007], ["developmental_stage-specific_gene_expression", 0.3007], ["human_peripheral_blood_mononuclear_cell_(PBMC)_response", 0.3006], ["T-cell_surface_molecule", 0.3006], ["TNF-alpha-stimulated_(10_U/ml,_6_h)_HUVEC", 0.3006], ["C_motif-1/lymphotactin_promoter", 0.3005], ["antisense_myb_RNA_expression", 0.3005], ["effector_cell", 0.3005], ["signal_transduction_molecule", 0.3005], ["vascular_cell_adhesion_molecule_(VCAM)-1", 0.3005], ["immunogenetic_basis", 0.3005], ["IL-1ra_mRNA", 0.3005], ["polyomavirus_enhancer-binding_protein_2", 0.3005], ["high-proliferative_potential_colony-forming_cell", 0.3004], ["NF-kappa_B-dependent", 0.3004], ["c-Fos_promoter_serum_response_element", 0.3004], ["lymphoid_cell-specific_nuclear_factor", 0.3004], ["independent_transcriptional_activation_domain", 0.3004], ["transcription_factor_effect", 0.3004], ["precursor_B_cell", 0.3003], ["c-fos_and_c-jun_gene", 0.3003], ["transcription_factors", 0.3003], ["CD4_molecule", 0.3003], ["dexamethasone-induced_transcription", 0.3003], ["kappa_B_cis-acting_element", 0.3003], ["human_interferon_regulatory_factor_1_gene", 0.3003], ["endothelial_MCP-1_secretion", 0.3002], ["high_affinity_IgE_receptor", 0.3002], ["IL-13-treated_human_peripheral_monocyte", 0.3002], ["gamma_delta_T_cell_development", 0.3002], ["tyrosine_phosphorylation_status", 0.3002], ["PHA-stimulated_T_lymphocyte", 0.3002], ["TNF_producing_cell_line", 0.3002], ["V_beta_T-cell_receptor", 0.3001], ["T_cell_antigen_receptor_complex", 0.3001], ["kappa_3_binding_factor", 0.3001], ["transactivators_of_megakaryocyte-specific_promoters", 0.3001], ["single_signal_transduction_pathway", 0.3001], ["in_vitro_clonal_growth_assay", 0.3001], ["murine_transcription_factor", 0.3001], ["HIV-1_IIIB-infected_monocytoid_cell", 0.3001], ["TNF_gene_induction", 0.3001], ["TCR-ligand", 0.3], ["T_cell_receptor_(TCR)_responsiveness", 0.3], ["in-vitro-translated_20-kDa_protein", 0.3], ["constitutive_MHC_class_II_mRNA_expression", 0.3], ["IL-4_treatment", 0.3], ["adjacent_regulatory_motif", 0.2999], ["reverse_transcription_polymerase_chain_reaction_(RT-PCR)_assay", 0.2999], ["different_transduction_pathway", 0.2999], ["phospholipase_C_gamma_1_overexpression", 0.2999], ["human_IL-1beta_promoter", 0.2999], ["S6_kinase", 0.2998], ["cytokine_message", 0.2998], ["SOCS-1_gene_expression", 0.2998], ["potential_therapeutic_target", 0.2998], ["IFN-gamma-dependent_up-regulation", 0.2998], ["MARCKS-related_protein", 0.2997], ["BCL-6_protein_level", 0.2997], ["autologous_CD4+_T_cell", 0.2997], ["TGF-beta1", 0.2996], ["TCR_alpha_enhancer_complex", 0.2996], ["IkappaB_proteolysis", 0.2996], ["c-erbA/T3_receptor", 0.2996], ["C-terminal_antibody", 0.2996], ["v-abl_kinase_activity", 0.2996], ["immunologic_function", 0.2996], ["PMA/PHA_stimulated_tax_transfected_cell", 0.2996], ["enhancer/promoter_combination", 0.2995], ["Ets_transcription_factor", 0.2995], ["ETS_transcription_factor", 0.2995], ["ets_transcription_factor", 0.2995], ["peroxisome_proliferator-activated_receptor-alpha", 0.2995], ["inflammatory_cell_infiltration_score", 0.2995], ["whole-cell_competitive_binding_radioassay", 0.2995], ["T-helper-cell_epitope", 0.2995], ["human_pro-interleukin-1beta_gene", 0.2995], ["vascular_cell_adhesion_molecule-1_gene", 0.2995], ["BL-2_cell", 0.2995], ["TCR-mediated_NF-AT_response", 0.2994], ["interferon-gamma-induced_nuclear_binding_factor", 0.2994], ["CD18_antigen", 0.2994], ["IFN-gamma_receptor_alpha-chain_expression", 0.2994], ["stimulated_and_unstimulated_T_cell", 0.2994], ["CD4+_cell", 0.2994], ["plasma_cell-specific_repressor_function", 0.2994], ["EPO-induced_cellular_proliferation", 0.2994], ["immunoglobulin-like_transcript-2/leukocyte_Ig-like_receptor_1", 0.2993], ["c-Fos_protein", 0.2993], ["c-fos_protein", 0.2993], ["B_cell_Ag_receptor", 0.2993], ["STAT_pathway", 0.2993], ["peripheral_T_cell_specificity", 0.2993], ["calyculin_A-induced_STAT3_phosphorylation", 0.2992], ["NO-induced_downstream_signaling", 0.2992], ["immunosuppressive", 0.2992], ["C-terminal_regulatory_module", 0.2992], ["antioxidant-mediated_inhibition", 0.2992], ["superoxide_formation", 0.2992], ["anti-inflammatory_property", 0.2992], ["deactivating_cytokine", 0.2992], ["BEAS-2B_cell", 0.2991], ["thrombin_receptor_agonist_peptide", 0.2991], ["neutrophil_stimulation", 0.2991], ["E2F-dependent_regulation", 0.2991], ["terminal_B-cell_differentiation", 0.2991], ["polymorphonuclear_neutrophil_transendothelial_migration", 0.2991], ["transcription_initiation_complex_assembly", 0.2991], ["CD4+CD45R0+CD45RA-CD29highCD11a+", 0.2991], ["nongenomic_signaling_pathway", 0.2991], ["IFN-gamma_and_GM-CSF_mRNA", 0.299], ["peroxisome_proliferator-activated_receptor", 0.299], ["IL-2_dependent", 0.299], ["inducible_NO_synthase_(iNOS)_gene", 0.299], ["B_lymphocyte_stimulation", 0.299], ["CD8+_CD28+_population", 0.299], ["NF-kappaB_binding_sequence", 0.299], ["T_cell-dependent_B_cell_maturation", 0.299], ["T_cell_surface_molecule", 0.299], ["K46_B_cell", 0.299], ["human_interleukin_9_gene", 0.299], ["cobalt_chloride-induced_signaling", 0.299], ["TNFRp55-deficient_mice", 0.299], ["T_helper_type_1_(TH1)_cell", 0.2989], ["IL-8_promoter_region", 0.2989], ["human_TNF_transgene_accelerated_pathology", 0.2989], ["AML1a-transfected_K562_cell", 0.2989], ["potent_transcriptional_repressor", 0.2989], ["monocyte/macrophage-specific_stimulator", 0.2988], ["Janus_protein-tyrosine_kinase_3", 0.2988], ["human_TNF-alpha_promoter", 0.2988], ["Janus_protein_kinase_(JAK)1", 0.2988], ["inducible_promoter_activity", 0.2988], ["B-cell_development_and_differentiation", 0.2987], ["nuclear_factor-kappa_B", 0.2987], ["serum-independent_HL60_cell_line", 0.2987], ["monocytic_THP-1_cell", 0.2987], ["human_inflammatory_pathology", 0.2987], ["t_cell_nuclear_extract", 0.2987], ["eosinophil-committed_HL-60-C15_cell", 0.2987], ["in_vitro_binding_analysis", 0.2986], ["Janus_family_tyrosine_kinase", 0.2986], ["inflammatory_stimuli", 0.2986], ["thymidine_kinase_(TK)_gene", 0.2985], ["multiple_intracellular_protein", 0.2985], ["in_vitro_transcription_method", 0.2985], ["human_neutrophil_gene_expression", 0.2985], ["Lck-negative_JCaM1_cell", 0.2985], ["increased_apoptosis", 0.2985], ["transcription_factor_AP-2", 0.2985], ["monocyte_chemotactic_protein-1_secretion", 0.2985], ["erythroid_Kruppel-like_factor_(EKLF)_activity", 0.2985], ["MAP_ERK_kinase_kinase-1", 0.2985], ["immunoglobulin_heavy-chain_(IgH)_gene", 0.2985], ["B_cell-derived_cDNA", 0.2985], ["CD11c_promoter-_luciferase_construct", 0.2984], ["monocyte-macrophage_lineage", 0.2984], ["monocyte_apoptosis", 0.2984], ["B-lymphocyte_precursor", 0.2984], ["CD40_triggering", 0.2983], ["adenylyl_cyclase_(AC)_cascade", 0.2983], ["B_cell_type_Oct-2_protein", 0.2983], ["IL-1alpha_promoter", 0.2983], ["endotoxin_(LPS)_signal_transduction", 0.2983], ["T-cell_tumorigenesis", 0.2983], ["cell-cycle_analysis", 0.2982], ["p70_I_kappa_B_protein", 0.2982], ["kappa_B-specific_complex", 0.2982], ["phosphorylated_c-Jun", 0.2982], ["leukemia_inhibitory_factor", 0.2982], ["NF-kappa_B-like_binding_activity", 0.2982], ["human_recombinant_tumor_necrosis_factor", 0.2982], ["HIV-1_kappaB_oligonucleotide", 0.2982], ["finely_granular_Sudan_black_B_and_myeloperoxidase_cytochemical_reactivity", 0.2982], ["IL-13R_alpha_chain", 0.2982], ["calcium-dependent_PMA_and_ionomycin_pathway", 0.2981], ["JAK/STAT_activation", 0.2981], ["T_helper_cell_differentiation", 0.2981], ["immunosuppressive_drug", 0.2981], ["C_beta_2_gene", 0.2981], ["NF-kappaB2_p52", 0.2981], ["ICR27_lymphoblast", 0.2981], ["TcR_transduction_mechanism", 0.2981], ["erythropoietin-induced_signal_transduction", 0.2981], ["molecular_immunology", 0.2981], ["tyrosine-phosphorylated", 0.298], ["cdk2dependent", 0.298], ["adenocarcinoma_reactive_human-mouse_chimeric_monoclonal_antibody", 0.298], ["PDGF(B)_mRNA", 0.298], ["CD23b_promoter", 0.298], ["myristoylated,_alanine-rich_C_kinase_substrate", 0.298], ["inducible_early_growth_response_protein", 0.298], ["B_cell_specific_activity", 0.2979], ["immunoglobulin_G_(IgG)_Fc_receptor", 0.2979], ["HIV_long_terminal_repeat_activation", 0.2979], ["B_cell-specific_nuclear_factor", 0.2979], ["CD33+,_CD56+,_CD11a+,_CD13lo,_CD15lo,_CD34+/-,_HLA-DR-_,_CD16-", 0.2979], ["activated_human_neutrophil", 0.2979], ["human_IL-5_receptor", 0.2979], ["leukemic_cell_proliferation", 0.2979], ["inducible_C1_protein", 0.2978], ["MHC_class_II_antigens_expression", 0.2978], ["kappa_B-binding_activity", 0.2978], ["interferon_beta_expression", 0.2978], ["IL-3_promoter-linked_reporter_construct", 0.2977], ["HL-60-C15_cell", 0.2977], ["murine_multipotential_FDCP-mix_A4_cell", 0.2977], ["HIV-1_transcriptional_activation", 0.2977], ["Stat3-activation", 0.2977], ["LPS-stimulated_control_cell", 0.2976], ["intercellular_adhesion_molecule-1_gene", 0.2976], ["lymphoid_lineage-determining_factor", 0.2975], ["granulocyte_colony-stimulating_factor_(G-CSF)_receptor", 0.2975], ["cytoplasmic_IkappaB-alpha", 0.2975], ["signal_transducers_and_activators_of_transcription_6", 0.2975], ["G-protein_coupled_chemokine_receptor", 0.2975], ["NF-M-estrogen_receptor_expressing_progenitor", 0.2973], ["developing_immune_response", 0.2973], ["JAK/STAT_inhibitory_gene", 0.2973], ["competitive_reverse_transcription_polymerase_chain_reaction", 0.2973], ["PI3-kinase_inhibitor", 0.2973], ["ROS-dependent_signalling_pathway", 0.2973], ["GM-CSF_receptor_alpha_promoter", 0.2973], ["pRb_hyperphosphorylation", 0.2973], ["ubiquitin-proteasome_system", 0.2973], ["hemoglobin-producing_cell", 0.2972], ["IL-4-dependent_induction", 0.2972], ["activated_B_lymphocyte", 0.2972], ["nuclear_factor_Kappa-B", 0.2972], ["human_IL4_promoter", 0.2971], ["single-cell_reverse_transcriptase-polymerase_chain_reaction", 0.2971], ["host_NK_cell_response", 0.2971], ["tissue-specific_transcriptional_activator", 0.2971], ["c12_cell", 0.297]]